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Abstract 
 
KELLY DANIEL SULLIVAN: Cotranscriptional Processing of Histone pre-mRNA 
(Under the direction of Dr. William F. Marzluff) 
 Metazoan histone mRNAs are unique in that they lack introns and poly(A) 
tails; thus these mRNAs require a single endonucleolytic cleavage for maturation.   
Cleavage of histone mRNA is guided by two cis-elements, a stemloop (SL) 5’ of the 
cleavage site and a 3’ purine-rich histone downstream element (HDE).  Binding of 
the stemloop binding protein to the SL and basepairing of the U7 snRNA component 
of the U7 snRNP recruit a cleavage factor that contains the endonuclease CPSF73 
which cleaves the pre-mRNA.  I show here that a subset of poly(A) factors are 
required for histone pre-mRNA processing in Drosophila melanogaster.  I present 
evidence that CPSF73, CPSF100, and Symplekin are required for histone pre-
mRNA processing and that they form a stable complex.  RNAi depletion of these 
factors results in misprocessing and polyadenylation of endogenous histone H2A 
mRNA. Knockdown of CPSF73, CPSF100 or Symplekin results in codepletion of the 
other factors. Coimmunoprecipitation experiments show that these proteins interact 
with one another and with the histone specific factors SLBP and Lsm11.  I present 
chromatin immunoprecipitation data demonstrating that CPSF73 and Symplekin 
associate with both histone and poly(A) genes at similar levels in vivo, but that 
CstF50, a poly(A) specific factor associates with poly(A) genes at a much higher 
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level.  Experiments combining RNAi and ChIP reveal that knockdown of SLBP 
results in recruitment of additional components of the poly(A) apparatus (CstF50) to 
histone genes.  I also present ChIP data which show that knockdown of factors 
(CPSF160, CstF64) that codeplete proteins required for both poly(A) and histone 
pre-mRNA processing (CPSF73, Symplekin) specifically deplete the pool of these 
factors associated with poly(A) genes, consistent with two distinct processing 
complexes.  I also present evidence in mammalian cells that CPSF73 is the 
exonuclease which degrades the 5’ downstream cleavage product potentially 
resulting in transcription termination.  Finally, I describe a role for the histone pre-
mRNA processing factor SLBP in nuclear export of the mature mRNA.  A detailed 
molecular analysis of the histone mRNA in cells with extremely low levels of SLBP 
reveals that the major lesion in histone mRNA metabolism is retention of mature, 
properly processed mRNA in the nucleus. 
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Chapter 1 
Introduction 
 
Histones and Chromatin Structure 
The eukaryotic genome is organized into nucleoprotein complexes termed 
nucleosomes.  These units are composed of an octamer of positively charged 
histone proteins and approximately 147 bp of DNA (Luger et al., 1997).  Each 
nucleosomal octamer consists of a core of two H3-H4 dimers, flanked on each side 
by an H2A-H2B dimer.  The core histone proteins have structured C-termini which 
interact with DNA and unstructured N- terminal tails which can be highly modified 
(Strahl and Allis, 2000).  Individual nucleosomes are packaged together by the linker 
histone H1 resulting in further compaction of the genetic information into chromatin.  
This organization of the genome is critical for protection against DNA damage and 
regulation of gene expression. 
 Histones fall into two categories, replication-dependent and –independent.  
The replication-dependent histones consist of the core proteins H2A, H2B, H3, H4 
and the linker H1 and are encoded by non-polyadenylated mRNAs.  These proteins 
are synthesized during S-phase of the cell cycle, in concert with DNA replication, 
and assembled into new chromatin structures.  The replication-independent or 
2 
 
variant histones are encoded by polyadenylated mRNAs and synthesized throughout 
the cell cycle.  They participate in a variety of pathways including transcription. 
activation (H3.3), DNA damage response (H2A.X) and kinetochore assembly 
(CENPA) (Sarma and Reinberg, 2005). As the genome is duplicated during S 
phase of the cell cycle, newly synthesized histones must be assembled into 
nucleosomes, a process mediated by chromatin remodeling factors and histone 
chaperones.  The replication-coupling assembly factor (RCAF), composed of 
chromatin-assembly factor-1 (CAF-1) and anti-silencing factor-1 (ASF1), directs 
formation of nascent H3-H4 dimers into chromatin (Tyler et al., 1999).  CAF-1 is a 
multi-subunit complex with three polypeptides (p150, p60 and p48) which interacts 
with proliferating cell nuclear antigen (PCNA) (Shibahara and Stillman, 1999).  
PCNA is the sliding clamp which forms around the replication fork and promotes 
processivity of DNA polymerase during DNA synthesis.  The result of this interaction 
is a functional coupling of DNA replication and chromatin assembly.  A number of 
chaperones have also been shown to mediate the exchange of core histones with 
variant histones during transcription and DNA damage repair (Eitoku et al., 2008). 
  Histone Gene Organization and Histone Locus Bodies  
 Eukaryotic replication-dependent histone genes (I will refer to these 
replication-dependent histone genes simply as histone genes throughout) generally 
display a clustered organization.  In yeast the genes encoding histone proteins 
which dimerize with one another, H2A and H2B and H3 and H4 are present in pairs 
that are transcribed divergently from a common promoter (Hereford et al., 1979).  In 
Drosophila all five histone genes are contained in a 5 kb unit on the long arm of 
3 
 
chromosome 2 which is repeated ~100 times.  Here again H2A-H2B and H3-H4 are 
divergently transcribed from opposite strands with only very short distances between 
their transcription start sites (Lifton et al., 1978; Pardue et al., 1977).  The only 
Drosophila histone H1 gene is also present in this repeat.  Mammals display a more 
complex organization of replication-dependent histones, and there are more than 75 
genes encoding these five proteins with no repeating structure.  Human histone 
genes are located in two clusters on chromosomes 1 and 6 (Marzluff et al., 2002).   
 In higher eukaryotes histone genes associate with subnuclear bodies which 
coordinate factors required for histone gene expression.  Mammalian histone genes 
are localized close to Cajal Bodies (CBs) which contain the U7 snRNP (Shopland et 
al., 2001) and NPAT (Ma et al., 2000).  CBs are sites of spliceosomal snRNP 
assembly (Carmo-Fonseca et al., 1992).  CBs also contain coilin, which appears to 
function in a structural role, and Flice-associated huge protein (FLASH) which is 
required for processing (Barcaroli et al., 2006a; Barcaroli et al., 2006b).  In 
Drosophila the histone genes associate with the Histone Locus Bodies (HLBs) which 
contain the U7 snRNP as well as components of the cleavage factor and are distinct 
structures from CBs (Liu et al., 2006).  Mammalian HLBs may be defined as 
structures containing U7 snRNP and NPAT that are adjacent to histone genes 
(Ghule et al., 2008). 
Histone Gene Expression 
 Expression of histone genes is highly regulated and tightly linked to the cell 
cycle.  In mammalian cells assembly of newly-replicated DNA into chromatin 
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requires an estimated 108 histones for each cell division.  Regulation of histone 
biosynthesis is critical as production of too many histones results in chromosome 
loss (Meeks-Wagner and Hartwell, 1986). Histone genes are transcribed throughout 
the cell cycle, although their transcription rates increase 3-5 fold at the beginning of 
S-phase (DeLisle et al., 1983).  A positive transcription factor, p220NPAT (NPAT), is 
present in CBs throughout the cell cycle.  Phosphorylation of NPAT by cyclin E/Cdk2 
as cells approach S-phase results in increased expression of histone mRNAs (Ma et 
al., 2000; Zhao et al., 2000).  Concomitant with increased transcription is an 
elevated level of histone pre-mRNA processing which stabilizes the mRNAs and 
results in a 35-fold increase in histone mRNA levels (Fig. 1).  This increase in 
histone pre-mRNA processing at the onset of S-phase is accomplished via 
upregulation of SLBP levels (Whitfield et al., 2000).  Thus, throughout S-phase, 
histone genes are highly transcribed, their pre-mRNAs efficiently processed and 
packaged into mature messenger ribonucleoproteins (mRNPs) with SLBP, at which 
point they are ready for export to the cytoplasm and translation.  At the end of S-
phase, both histone mRNAs and SLBP are degraded.  Histone mRNAs are 
degraded as a result of stopping DNA synthesis, and SLBP is degraded as a result 
of phosphorylation by cyclinA/Cdk1 (Koseoglu et al., 2008). 
 Replication-dependent Histone mRNAs 
 Metazoan replication-dependent histone mRNAs have a 7-methyl-guanosine 
cap on the 5’ end like polyadenylated mRNAs.  However, histone mRNAs are unique 
in that they contain no introns and are not polyadenylated, ending instead in a 
conserved stemloop (SL) structure.  This SL, located 30-50 nts 3’ of the translation 
5 
 
stop codon, is highly conserved and consists of a 6 nt stem and a 4 nt loop (Fig. 2).  
The SL is bound by the stemloop binding protein (SLBP) which participates in all 
aspects of histone mRNA metabolism (see below).  Variant histone mRNAs are 
polyadenylated like all other mRNAs. 
Mammalian Histone pre-mRNA 3’ End Formation 
 Cleavage and polyadenylation of most pre-mRNAs is guided by two cis-acting 
elements, the polyadenylation signal (AAUAAA) 5’ to the cleavage site and a G/U 
rich element 3’ to the cleavage site.  These sequences bind to the cleavage and 
polyadenylation specificity factor (CPSF) complex and the cleavage stimulation 
factor (CstF) complex, respectively, to position the cleavage factor (Mandel et al., 
2008).  Cleavage requires a large number of additional polypeptides although the 
cleavage reaction is catalyzed by CPSF73.   Analogously,  histone pre-mRNA 
processing is mediated by two cis-acting elements; the SL 5’ to the cleavage site, 
which is bound by SLBP (Fig. 2), and a purine-rich histone downstream element, 
which base pairs with the U7 snRNA component of the U7 small nuclear 
ribonucleoprotein (U7 snRNP) (Mowry and Steitz, 1987).  Cleavage of both classes 
of pre-mRNAs preferentially occurs after the CA dinucleotide.  SLBP is a 32 kDa 
protein with a unique 73 aa RNA binding domain (RBD) (Wang et al., 1996). Once 
SLBP binds to the SL, the U7 snRNP is recruited to the HDE and its interactions with 
the HDE are stabilized by SLBP (Dominski et al., 1999).  U7 snRNP is composed of 
U7 snRNA and a heteroheptameric ring of proteins.  U7 snRNP contains SmB, 
SmD3, SmE, SmF, and SmG, like spliceosomal snRNPs, but SmD1 and SmD2 are 
replaced by the Sm-like proteins Lsm10 and Lsm11 (Pillai et al., 2001; Pillai et al., 
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2003).  The U7 snRNA itself is similar to spliceosomal snRNAs with a 5’ 2,2,7 
timethylguanosine cap and a stemloop at the 3’ end.  In mammals, ZFP100 acts as 
a bridging factor, binding both SLBP and Lsm11 to stabilize U7 snRNP binding and 
help recruit the cleavage factor (Dominski et al., 2002; Wagner et al., 2006).  
ZFP100 is the limiting factor in mammalian histone pre-mRNA processing and is 
required for entry into S-phase (Wagner and Marzluff, 2006).  The cleavage reaction 
is carried out by a subset of polyadenylation factors consisting minimally of CPSF73, 
CPSF100, and Symplekin (Fig. 3, top) (Wagner et al., 2007).  CPSF73 has been 
identified as the endonuclease for both polyadenylated (Mandel et al., 2006) and 
histone mRNAs(Dominski et al., 2005b).  CPSF73 and CPSF100 are members of 
the metallo-β-lactamase family of zinc-dependent endonucleases and are both 
required for cleavage, though CPSF100 lacks residues critical for catalysis (Kolev et 
al., 2008).  After cleavage, SLBP remains associated with the mRNA and escorts it 
into the cytoplasm (Fig. 4).  
Histone pre-mRNA Processing in Drosophila 
 Histone pre-mRNA processing is remarkably well conserved from Drosophila 
to mammals (Fig. 3).  Cleavage is mediated by SLBP and the U7 snRNP in both, 
although it does not require SLBP in mammals, while in Drosophila SLBP is required 
in vitro (Dominski et al., 2005a).  No orthologue of ZFP100 has been identified in 
Drosophila (Wagner et al., 2007).   Each of the canonical histone genes contains 
multiple poly(A) sequences downstream of the normal cleavage sites which are used 
when histone pre-mRNA processing factors are absent, such as in SLBP (Lanzotti et 
al., 2002) and U7 snRNA (Godfrey et al., 2006) null mutant flies.  Interestingly, each 
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of these mutants displays a different developmental phenotype, with the SLBP null 
being lethal and the U7 snRNA mutant being sterile, likely as a result of a later onset 
of histone misprocessing in the U7 snRNA mutant.  A characteristic of Drosophila 
histone genes is the presence of strong RNA polymerase pause sites just 
downstream of the cleavage site in Drosophila (Adamson and Price, 2003) which 
may allow for assembly of the processing machinery on the nascent RNA. 
Translation and Degradation of Histone mRNAs 
 Polyadenylated mRNAs are bound to the cap binding complex (CBC) on their 
5’ end and poly(A) binding protein on their poly(A) tails; these proteins interact with 
eIF4G, resulting in a circular RNA which is ready for multiple rounds of efficient 
translation.  Histone mRNAs are translated by a similar mechanism; their 5’ ends are 
bound by the CBC, however, since they lack poly(A) tails, a different mechanism 
circularizes the mRNA.  SLBP is associated with the 3’ end of the mRNA after the 
cleavage reaction and binds the SLBP interacting protein 1 (SLIP1) (Cakmakci et al., 
2008) which binds to eIF4G resulting in a circular mRNA which can be efficiently 
translated (Fig. 4). 
 At the end of S-phase or when DNA synthesis is inhibited, histone mRNAs 
are rapidly degraded (Fig. 4) in a manner that is dependent upon translation; 
treatment with cycloheximide, a general translational inhibitor, stabilizes the mRNAs 
(Kaygun and Marzluff, 2005b).  This mechanism of degradation also requires the SL 
and SLBP (Kaygun and Marzluff, 2005b; Pandey and Marzluff, 1987) and requires 
that the stemloop to be close to the termination codon.  SLBP recruits Upf1 and a 
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terminal urydylyl transferase (TUTase) to the 3’ ends of histone pre-mRNAs which 
add an 8-12 nt oligo(U) tail.  The oligo(U) likely serves as a platform for binding of 
the Lsm1-7 complex(Mullen and Marzluff, 2008).  This complex, in turn, recruits the 
decapping enzymes freeing the 5’ end for degradation by the 5’-3’ exonuclease 
Xrn1.  There is also a role for the exosome in 3’-5’ degradation of histone mRNAs, 
which results in a bidirectional decay mechanism for histone mRNAs in mammals.   
Cleavage and Polyadenylation of pre-mRNAs 
 Transcription of protein coding genes in eukaryotes yields pre-mRNAs which 
must be processed into mature transcripts, ready for export and capable of being 
translated.  Processing events include 5’ capping, splicing (in many cases) and 
proper formation of the 3’ end.  For all pre-mRNAs except histone mRNAs, proper 
formation of the 3’ end requires endonucleolytic cleavage and addition of a long 
(~250nt) poly(A) tail.  Polyadenylation is required for nuclear export (Huang and 
Carmichael, 1996), stability (Coller et al., 1998) and efficient translation (Preiss and 
Hentze, 1998) of mRNAs.  Cleavage and polyadenylation requires a large protein 
complex with as many as 85 polypeptides (but no RNAs) playing roles (Shi et al., 
2009).  
 Cleavage and polyadenylation is guided by multiple cis acting elements most 
notably the poly(A) site (PAS), AAUAAA, and the downstream sequence element 
(DSE), which is G/U rich.  These sites interact with the highly conserved CPSF and 
CstF complexes respectively.  The CPSF complex contains five subunits in 
mammals, CPSF30, CPSF73, CPSF100, CPSF160, and Fip1p (Fig. 5).  CPSF160, 
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the largest subunit of the CPSF complex, interacts directly with the AAUAAA to 
facilitate cleavage (Zhao et al., 1999a), and also with CPSF100 (Murthy and Manley, 
1995) and Fip (Murthy and Manley, 1992).  CSPF73 and CPSF100 are members of 
the metallo-β-lactamase family of endonucleases.  CPSF73 is the nuclease for 
cleavage of polyadenylated mRNAs, and CPSF100 is also required for cleavage, 
though its nuclease domain is inactive (Kolev et al., 2008).  CPSF30 is required for 
cleavage and polyadenylation and binds a U-rich sequence element upstream of the 
PAS (Barabino et al., 2000).  Fip1p, factor interacting with Pap1p, was initially 
identified as a protein which interacts with the poly(A) polymerase, Pap1p (Preker et 
al., 1995).  Fip1p also interacts with CPSF160 (Kaufmann et al., 2004), CPSF30, 
and CstF77 (Helmling et al., 2001), directing Pap1p to the correct poly(A) site. 
Another component of the CPSF complex required for proper 3’ end formation and 
polyadenylation is Symplekin.  Pta1p, the yeast orthologue of Symplekin was 
originally identified as required for pre-tRNA processing (O'Connor and Peebles, 
1992a), while Symplekin itself was found to be associated with tight junctions (Keon 
et al., 1996). Symplekin may be a scaffolding protein (Fig. 5) as it binds to a large 
number of proteins including CPSF73 (Zhelkovsky et al., 2006), CPSF100 (Kyburz 
et al., 2003), CstF64 (Takagaki and Manley, 2000a) and the RNA Pol II CTD 
phosphatase Ssu72 (Skaar and Greenleaf, 2002).  Symplekin is also the heat labile 
factor required for histone pre-mRNA processing (Kolev and Steitz, 2005). 
 The CstF complex is composed of 3 subunits, CstF50, CstF64, and CstF77 
(Fig. 5).  The CstF64 subunit binds directly to the G/U rich DSE (Takagaki and 
Manley, 1997) and also to CstF77 (Hatton et al., 2000) and.  CstF77, identified as 
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the suppressor of forked (su(f)) in Drosphila, assists in poly(A) site selection as 
mutations in this gene result in poly(A) site switching (Juge et al., 2000).  CstF77 
exists as a homodimer, and this dimerization appears to be critical for its function 
(Bai et al., 2007; Benoit et al., 2002).  Additionally, CstF77 binds CstF50 and 
CPSF160, linking the complexes upstream and downstream of the cleavage site.  
The final component of the CstF complex, CstF50, binds CstF77 as mentioned and 
also homodimerizes.  The entire CstF complex is likely present as a homodimer in 
polyadenylation (Mandel et al., 2008). 
 Higher eukaryotes require additional factors termed mammalian cleavage 
factor (CF) Im and IIm which further aid in cleavage and polyadenylation as well as 
linking this process with others such as splicing and transcription.  CFIm is composed 
of three subunits of 25, 59 and 68 kDa (Fig. 5), and it functions as a heterodimer of 
the 25 kDa subunit and one of the others, with different combinations contributing to 
various activites.  The 25 and 68 kDa subunits reconstitute in vitro cleavage activity 
in the presence of partially purified 3’ processing complexes (Ruegsegger et al., 
1998).  All three subunits crosslink to RNA in a sequence dependent manner  
(Ruegsegger et al., 1998) with a preference for UGUAA (Brown and Gilmartin, 
2003), a sequence generally found upstream of poly(A) sites.  CFIm aids in 
recognition of both canonical and non-canonical poly(A) sites (Venkataraman et al., 
2005).  CFIIm is composed of Pcf11 and Clp1 both of which are highly conserved 
among all eukaryotes (Fig. 5).  Mutations in yeast Pcf11 result in cell death without 
affecting 3’ end formation (Sadowski et al., 2003), but instead result in aberrant 
transcription termination (Zhang et al., 2005).  Clp1 interacts with Pcf11 and is 
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required for cleavage but not polyadenylation (Kyburz et al., 2003).  Clp is an RNA 5’ 
kinase also important for tRNA splicing and activation of siRNAs (Weitzer and 
Martinez, 2007). 
 Eukaryotic pre-mRNA 3’ end formation is an incredibly complex mechanism 
involving many proteins, some of which have, undoubtedly, yet to be identified, and 
yet serve to cleave a single phosphodiester bond.  This process is critical for cell 
viability as improperly processed mRNAs are not exported from the nucleus 
efficiently or translated.  Recent work has demonstrated that this process and others 
are coordinated with transcription to ensure fidelity. 
Cotranscriptional Processing of pre-mRNAs 
 Transcription and RNA processing were traditionally thought of as discrete 
processes, that is to say, only after a full length transcript was produced, was it 
released from the template then cleaved and polyadenylated and then spliced.  
There has been mounting evidence over the last 20 years, however, that these 
phenomena are intertwined.  The current model of RNA processing is a 
cotranscriptional one in which nascent RNA molecules are processed as they are 
extruded from transcribing RNA Pol II.   
 Targeting of pre-mRNA processing factors to nascent transcripts occurs in 
one of two ways; 1) direct recruitment via interaction with RNA pol II (usually with the 
C-terminal domain or CTD) or 2) association of subnuclear structures such as CBs 
or splicing speckles with sites of transcription or possibly a combination of the two.  
The CTD of RNA Pol II is disordered and composed of a heptad with a consensus 
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sequence of YSPTSPS which is repeated 26 times in yeast and 52 times in 
mammals.  Phosphorylation can occur on each of the serines (S2, S5, and S7) and 
each has a different role in recruitment of processing factors to RNA Pol II.  
Additionally, a peptidyl-prolyl isomerase, Pin1, binds to and acts upon the 
phosphorylated CTD, greatly expanding the number of of possible comformations 
this structure can adopt. 
 Phosphorylation of the CTD of RNA Pol II occurs in a distinct pattern 
throughout the bodies of genes (Fig. 6).  Prior to initiation, the CTD is not 
phosphorylated.  During initiation of transcription at the 5’ ends of genes the CTD is 
primarily phosophorylated on S5 by the Cdk7 subunit of the general transcription 
factor TFIIH (Cismowski et al., 1995; Komarnitsky et al., 2000).  At the transition to 
the elongation step of transcription, or promoter clearance, phosphorylation of the 
S2 position by positive elongation factor b or P-TEFb (cyclin T/Cdk9) occurs 
(Marshall et al., 1996).  This phosphorylation occurs throughout the coding region of 
genes (Komarnitsky et al., 2000) and in vitro is enhanced on CTD repeats already 
phosphorylated on S5 (Jones et al., 2004), fittingly nicely with the model of 
phosphorylation state switching during active transcription.  Phosphorylation of S7 
has been claimed to occur on a class of genes which do not encode mRNAs, but 
rather snRNAs which have a unique 3’ end.  Phosphorylation may be required for 
proper 3’ end formation as it recruits the integrator complex which contains the 
cleavage factor, however, the kinase responsible for it remains unknown (Egloff et 
al., 2007a). 
13 
 
 Examples of interactions between RNA processing factors and the CTD of 
RNA Pol II abound (Neugebauer, 2002; Phatnani and Greenleaf, 2006) so in this 
section I will limit my discussion to a few prominent examples for which there is 
compelling evidence in vivo.  Recruitment of the 5’ RNA capping enzyme (HCE) to 
nascent RNAs is mediated by S2 phosphorylation of the CTD.  Interestingly, 
although the enzyme can bind either the S2 or S5 form of the CTD in vitro, the S2 
CTD actually stimulates its guanylyl transferase activity (Ho and Shuman, 1999).  
The evidence for cotranscriptional splicing is extensive (Kornblihtt et al., 2004), 
however, there is little evidence for direct interactions between spliceosomal proteins 
or snRNPs and the CTD, with the lone example being the yeast protein Prp40p 
which is a component of the U1 snRNP (Morris and Greenleaf, 2000).  While direct 
evidence for binding is lacking, indirect evidence is substantial (Misteli and Spector, 
1999; Moore et al., 2006).  A large class of splicing factors which are not catalytic 
and contain serine-arginine rich domains, the SR proteins, have been shown to 
interact with the CTD in yeast two hybrid screens and by coimmunoprecipitation 
(Yuryev et al., 1996).  Cotranscriptional splicing is clearly vital to the cell as changes 
in transcription kinetics alter exon inclusion rates (Listerman et al., 2006) and loss of 
the splicing factor ASF/SF2, which is recruited cotranscriptionally, results in genomic 
instability due to the formation of R-loops (highly unstable DNA-RNA hybrids) (Li and 
Manley, 2005). 
 As previously discussed, proper 3’ end processing of pre-mRNA is crucial for 
proper gene regulation and this process also occurs cotranscriptionally.  Both the 
CPSF and CstF complexes contain components which interact directly with the S2 
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phosphorylated CTD of RNA Pol II.  Initial insights into coupling of 3’ end formation 
and transcription revealed that not only was the CTD required for proper cleavage 
and polyadenylation, but that several factors (CstF50 and CstF77) bind directly to 
the phosphorylated CTD resulting in the CstF complex binding to phosphorylated 
CTD columns (McCracken et al., 1997).  The yeast orthologue of CPSF160 has also 
been shown to bind the CTD directly (Dichtl et al., 2002), providing evidence for 
direct recruitment of both major cleavage complexes to RNA via the polymerase.  
Additionally, transcription termination factors (see below) such as Xrn2 (Kaneko et 
al., 2007) and Pcf11 (Sadowski et al., 2003; Zhang and Gilmour, 2006) are recruited 
cotranscriptoinally demonstrating that RNA Pol II is only capable of terminating after 
forming the proper 3’ end. 
Transcription Termination 
 One area of cotranscriptional regulation of gene expression which lags behind 
some others is our understanding of the mechanism of transcription termination.  
After initiation of transcription, capping of the mRNA, conversion of RNA Pol II to a 
processive form for elongation by PTEF-b, identification of exons and 3’ end 
formation, the polymerase is still engaged on the DNA and transcribing.  Two 
models for transcription termination in eukaryotes (different from bacterial rho 
termination) have emerged recently termed the allosteric and torpedo models and 
ample evidence exists for both as well as a synergistic mechanism combining the 
two.  Both rely on the observation that interfering with polyadenylation prevents 
transcription termination.  In the allosteric model, after cleavage and 
polyadenylation, Pcf11 bridges the RNA to the CTD of RNA Pol II releasing the 
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transcript from the template and resulting in a conformational change in RNA Pol II 
which reduces its processivity and eventually leads to termination(Fig. 7A).  Pcf11 
binds to RNA and the CTD through same domain, and competition for this site may 
facilitate dismantling of the transcription complex (Hollingworth et al., 2006; Zhang et 
al., 2005).  The torpedo model posits that the free 5’ end of the nascent RNA 
generated by 3’ end formation is a substrate for the 5’-3’ exonuclease Xrn2 which 
degrades this RNA until it “catches up” with the polymerase and aids in dissociating 
it from the template (Fig. 7B).  Xrn2 localizes to the 3’ ends of genes in vivo by ChIP 
and interacts with 3’ processing factors (Kaneko et al., 2007), providing a potential 
mechanism for recruitment.  Recent evidence demonstrates that recruitment of 
Pcf11 or Rat1 (the yeast orthologue of Xrn2) enhances recruitment of the other 
factor.  This observation supports a hybrid of the two models (Luo et al., 2006a) 
where both Pcf11 interacting with the CTD and degradation of the 3’ cleavage 
product contribute to termination of transcription, as does pausing of RNA Pol II. 
Summary 
 Proper regulation of histone biosynthesis is critical for proper cell division and 
gene regulation.  These extremely abundant proteins are only made during S-phase 
and regulation of histone protein synthesis is mediated primarily at the RNA level.  
Modest increases in transcription contribute to the increase in histone mRNA 
present in S-phase in mammalian cells, but the major contributor is activation of 3’ 
end processing.  The 3’ end processing reaction is a single endonucleolytic cleavage 
downstream of the highly conserved stemloop and occurs in a fashion analogous to 
polyadenylated mRNAs with cis elements upstream and downstream of the 
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cleavage site positioning a cleavage factor.  Recent studies have shown that histone 
pre-mRNA processing is not as different from cleavage and polyadenylation as we 
once believed.  Cleavage of histone pre-mRNA actually uses some of the same 
proteins as polyadenylated mRNA, including the endonuclease CPSF73.  What is 
not known is exactly which of these proteins are required for processing of 
endogenous histone mRNAs in vivo.  We also do not know how all of these proteins 
interact with one another and more importantly how they interact with histone 
specific processing factors to generate specificity.  Another important question 
concerning histone pre-mRNA processing is whether this occurs co- or post-
transcriptionally as there are currently conflicting reports.  Furthermore, the 
mammalian 5’-3’ exonuclease Xrn2 is recruited to downstream cleavage products by 
the CstF complex to promote transcription termination on genes encoding 
polyadenylated mRNAs.  As we have no evidence of a role for CstF in histone pre-
mRNA processing, this raises the question of how transcription of histone genes is 
terminated. 
 Chapter 2 of this dissertation examines the role of the Drosophila poly(A) 
processing apparatus in histone pre-mRNA processing and presents evidence that 
this reaction occurs cotranscriptionally.  Chapter 3 presents work pertaining to the 
mechanism of transcription termination on mammalian histone genes, specifically 
showing that Xrn2 is not a major player in the pathway.  In Chapter 4, I describe an 
unexpected function for SLBP in histone mRNA export.  And the final chapter 
(Chapter 5) will summarize these data and place them into the context of the field of 
mRNA processing. 
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Figure 1.  Histone mRNA and the cell cycle.  Histone mRNA biosynthesis peaks 
in S-phase, the result of synergistic increases in transcription, 3’ end formation and 
stability.  At the end of S-phase, these same processes are down-regulated and the 
mRNA is actively degraded.  Together these mechanisms restrict histone protein 
synthesis to S-phase.  
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Figure 2.  Schematic of histone pre-mRNA processing.  Histone genes contain 
no introns, therefore, the only processing event in the maturation process is a single 
endonucleolytic cleavage.  This cleavage is mediated by two cis elements the SL, 
upstream of the cleavage site, and the HDE, downstream of the cleavage site.  
SLBP binds the SL and U7 snRNA base pairs with the HDE.  
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Figure 3.  Conservation of histone pre-mRNA processing machinery between 
mammals and flies.  A schematic showing known histone pre-mRNA processing 
components in Homo Sapiens and Drosophila Melanogaster.  
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Figure 4.  Global view of histone mRNA metabolism in mammalian cells.  
Histone genes are transcribed at or near Cajal Bodies.  Processing of the pre-
mRNAs is accomplished by SLBP, the U7 snRNP, and the cleavage complex.  
SLBP remains associated with the mature mRNA and escorts it into the cytoplasm 
where is it active in translation.  At the end of S-phase, both histone mRNAs and 
SLBP are degraded.  
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Figure 5.  Schematic of mammalian cleavage and polyadenylation machinery.  
Adapted from (Mandel et al., 2008).  Schematic of various cleavage and 
polyadenylation complexes and the DNA sequences that they bind. 
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Figure 6.  Cotranscriptional pre-mRNA processing.  Many RNA processing 
events take place while transcription is occurring rather than after transcription is 
completed and the factors responsible for these reactions are recruited via the CTD 
of RNA Pol II.  Differential phosphorylation of the CTD of RNA Pol II on Ser2 and 
Ser5 recruit different proteins at various times throughout transcriptions.  As the 
polymerase proceeds along the gene and the phosphorylation state changes, 
mRNAs are capped, spliced, cleaved and polyadenylated.  
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Figure 7.  Transcriptional termination models.  Schematics of two current models 
of transcription termination.  (A)  Allosteric model.  After cleavage and 
polyadenylation, the termination factor Pcf11 bridges the CTD of RNA Pol II to the 
nascent RNA causing a conformational change and dismantling the transcription 
complex.  (B)  Torpedo model.  The free 5’ phosphate generated by the 3’ end 
formation reaction serves as a substrate for a nuclear 5’ 3’ exonuclease (Xrn2 in 
mammals or Rat1 in yeast) which degrades the RNA until it catches up to the 
polymerase and knocks it off of the DNA template.  
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Chapter 2 
A Subset of Polyadenylation Factors is Required for Cotranscriptional Histone 
pre-mRNA Processing in Drosophila 
Introduction 
 Metazoan histone mRNAs are unique among eukaryotic mRNAs in that they 
contain no introns and end in a conserved stem-loop structure rather than a poly(A) 
tail.  Formation of a mature histone mRNA thus requires only a single 
endonucleolytic cleavage. This cleavage is directed by two cis elements, a highly 
conserved stem loop (SL) 5’ of the cleavage site and a less conserved purine-rich 
histone downstream element (HDE) 3’ of the cleavage site.  There are two histone 
specific RNA processing factors, the stem loop binding protein (SLBP) which binds 
the SL and the U7 RNA of the U7 small nuclear ribonucleoprotein (U7 snRNP) which 
base pairs with the HDE (Marzluff et al., 2008).  The U7 snRNP consists of the U7 
snRNA and a heteroheptameric ring of Sm proteins in which the spliceosomal Sm 
proteins SmD1 and SmD2 are replaced by Lsm10 and Lsm11 (Pillai et al., 2003).  
Cleavage is catalyzed by CPSF73 (Dominski et al., 2005b) and Symplekin has been 
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implicated as the scaffold which coordinates formation of the cleavage complex 
(Kolev and Steitz, 2005). Following processing, the mature mRNA is escorted into 
the cytoplasm by SLBP (Sullivan et al., 2009) where SLBP participates in efficient 
translation of histone mRNA (Sanchez and Marzluff, 2002).  
 Cleavage and polyadenylation of all other metazoan mRNAs requires two 
multi-protein complexes termed the cleavage and polyadenylation specificity factor 
(CPSF) and the cleavage stimulation factor (CstF), which recognize signals 
upstream and downstream of the cleavage site respectively.  CPSF is composed of 
CPSF30, CPSF73, CPSF100 and CPSF160. These proteins have been shown to 
interact with one another [reviewed in (Mandel et al., 2008)] and with the AAUAAA 
polyadenylation signal which is recognized by CPSF160 (Keller et al., 1991; Murthy 
and Manley, 1995). Both CPSF73 and CPSF100 have putative β-lactamase 
domains, and CPSF73 has been described as the endonuclease for both poly(A) 
(Mandel et al., 2006; Ryan et al., 2004) and histone mRNAs (Dominski et al., 2005b; 
Yang et al., 2009). CPSF100 has also been shown to play an important role in these 
reactions (Kolev et al., 2008) although it lacks critical residues required for catalysis. 
CstF is comprised of three polypeptides CstF50, CstF64, and CstF77, with CstF64 
binding the downstream GU-rich element required for polyadenylation (Yoshio and 
Manley, 1997).   
 Symplekin was originally identified as a tight junction protein in mammalian 
cells (Keon et al., 1996) and its yeast homolog, Pta1p, was previously characterized 
as being essential for pre-tRNA processing (O'Connor and Peebles, 1992b).  
Symplekin has subsequently been shown to be involved in cleavage and 
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polyadenylation via interactions with both the CPSF and CstF in yeast (Preker et al., 
1997; Zhao et al., 1999b) and mammals (Takagaki and Manley, 2000a; Vethantham 
et al., 2007).  Additionally, Symplekin was defined as the elusive heat labile factor 
(Gick et al., 1987) required for histone pre-mRNA processing (Kolev and Steitz, 
2005).  
 In Drosophila, there is only one histone gene for each of the five canonical 
histone proteins. These genes exist as a ~5kb unit which is tandemly repeated ~100 
times on the long arm of chromosome 2. This histone gene cluster localizes to 
nuclear structures termed the histone locus bodies (HLBs) which are located in close 
proximity to Cajal bodies (CBs) (Liu et al., 2006).  HLBs also contain U7 snRNP (Liu 
et al., 2006), Symplekin  [(Wagner et al., 2007); D. Tatomer,. K.D.S, M.S. and 
W.F.M., unpublished] and a cyclin E substrate, Mpm2 (White et al., 2007), consistent 
with a role for these nuclear bodies in histone pre-mRNA processing.    
 Various RNA processing events have been shown to occur 
cotranscriptionally, often as a result of the recruitment of RNA processing factors by 
the C-terminal domain (CTD) of RNA Pol II [reviewed in (Bentley, 2005; Buratowski, 
2005a; Neugebauer, 2002; Proudfoot, 2004)].  Components of the poly(A) apparatus 
have been shown to bind to the CTD of RNA Pol II (Kyburz et al., 2003; McCracken 
et al., 1997; Phatnani and Greenleaf, 2004) suggesting that at least some 
components of the polyadenylation machinery are loaded onto the polymerase.  In 
addition the CTD is important for efficient cleavage/polyadenylation reaction in vivo 
(Hirose and Manley, 1998).  Polyadenylation factors are associated with genes 
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encoding mRNAs as detected by chromatin immunoprecipitation (ChIP), consistent 
with cleavage/polyadenylation occurring cotranscriptionally. 
 Histone mRNA expression is tightly regulated and coordinated with the cell 
cycle. At the beginning of S phase, histone mRNA levels increase ~35-fold to 
produce enough histones to package newly synthesized DNA. This increase in 
mRNA is accomplished by upregulating transcription and 3’ end processing, which is 
absolutely dependent on both the U7 snRNP and SLBP in Drosophila (Dominski et 
al., 2005a). In vitro data strongly suggest that RNA Pol II pauses just 3’ of the 
processing site, possibly to allow cotranscriptional assembly of the processing 
complex (Adamson and Price, 2003).  The 3’ ends of four of the histone genes are 
less than 500 nts from the 3’ end of an adjacent gene (transcribed from the opposite 
strand, Fig. 1A).  Thus, to prevent read-through into the adjacent gene, it is essential 
to efficiently terminate transcription.  There are cryptic polyadenylation signals 
downstream of each Drosophila histone gene.  If the processing efficiency of histone 
mRNAs is reduced either by mutation or knockdown of factors required for histone 
mRNA processing, then RNA Pol II reads through and the mRNAs become 
polyadenylated (Godfrey et al., 2006; Sullivan et al., 2001).   
 A recent RNA interference screen implicated a subset of polyadenylation 
factors, Symplekin, CPSF73 and CPSF100 in histone pre-mRNA processing, while 
other polyadenylation factors did not score in the screen (Wagner et al., 2007).  To 
further investigate the role of these proteins in histone pre-mRNA processing, we 
first examined the effect of RNAi-depletion of these factors on the 3’ end of 
endogenous histone mRNA. We carried out co-immunoprecipitation (coIP) 
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experiments and chromatin immunoprecipitation (ChIP), to demonstrate that 
Symplekin, CPSF73 and CPSF-100 are part of a core cleavage factor involved in 
cotranscriptional histone mRNA 3’ end processing.     
MATERIALS AND METHODS 
RNAi and NE preparation.  Approximately 500 bp dsRNAs were produced by T7 
transcription, DNA template digestion and annealing. RNAi was performed by adding 
100 g of dsRNA to Dmel-2 cells (2 x 107) on day 1, 200 g on day 2 and 400 g on 
day 3. Following a two-day recovery, NEs were prepared as described (Wagner et 
al., 2007).  
Antibodies.  A fragment of recombinant D. Melanogaster Symplekin (amino acids 1-
767) and full length CPSF73 were expressed in E.coli and used to inoculate both 
rabbits and guinea pigs for antibody production (Pacific Immunology Corp.).  α-
CPSF73 was antigen purified against full length CPSF73. A fragment of recombinant 
D. Melanogaster SLBP (amino acids 1-175) or Lsm11 (amino acids 1-100) was used 
to inoculate rabbits for antibody production (Proteintech Group, Inc.).  The D. 
Melanogaster -CstF50 antibody (Ni et al., 2008)was a generous gift from John Lis 
(Cornell Univ.) and the -CstF77 antibody was from Bethyl Labs.  The CPSF-100 
antibody was raised against a conserved region of human CPSF-100 (Z. Dominski 
and X.Yang, unpublished) and cross-reacted with the D. Melanogaster  CPSF-100 
protein. 
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Analysis of RNA.  The S1 nuclease assay was performed as described (Lanzotti et 
al., 2002) . Poly(A) mRNA was separated from total cellular RNA using the 
Poly(A)Purist mRNA isolation kit (Ambion). 
Immunoprecipitations(IPs).  500 g of NE was incubated with pre-conjugated 
protein-A sepharose beads in RIPA (50 mM Tris, pH 8.0, 1% NP-40, 0.25% 
deoxycholate, 150 mM NaCl) or a low detergent buffer (50 mM Tris, pH 8.0, 0.1% 
NP40, 150 mM NaCl) overnight.  Washes were performed in IP buffer and the 
precipitated proteins were eluted into SDS loading buffer. 
Chromatin Immunoprecipitation.  ChIP was performed as described for 
Drosophila (Gilchrist et al., 2008) or human (Upstate protocol) and 15 µl of CPSF73, 
HA, Rpb3, hSLBP, Symplekin and CstF50 antibodies were used in each IP.  qPCR 
was performed and quantified using SYBR green (Applied Biosystems) and an 
Applied Biosystems 7900HT real-time PCR machine.   
Oligonucleotide sets used:  
Drosophila 
H2A F-AATGGAATATCTGGCCGCTGAGGT, R-
CCAGTTGCAGATGACGCGGAATAA; 
H2B F-CGGGCCCACATTACGATAAGTGAA, R-
GTGATGTTCTTCTGAGCCTTGCCA; 
H2A/H2B F-TATTTCGCTGTCTGGGTTAGGCGA, R-
TTGCCTTTCCCTTCACTTTGCCAC; 
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H3 F-AGTCCGTCTTAAAGTCCTGAGCGA, R-
AAAGAGCACCGAGCTTCTAATCCG 
H4 F-TAGTGACTTTCGTGCTGTGCGTGT, R-CTTTCCCAAGCCTTTGCCTCCTTT; 
H3/H4 F-TCTCTTTCACCGTCCACGATTGCT, R-
TACGAGCCATCTCCGATTTGGGTT; 
H3/H1 Intergenic F-ACACTGTCCCTTCAAACGCCTGTA, R-
TCCTCGCCACATATGCATTACCGT; 
Domino Exon6 F-GGCCGACGAGATGGGTCTG, R-GTAGGACGTGATACACACAT; 
Domino poly(A)1 F-GCCAAAGCTGCCGAAGAAAGAAG, R-
CACCACTGACTGCTGCTGATGAG. 
Human 
GAPDH 5’ F-ACGTAGCTCAGGCCTCAAGA, R-AAGAAGATGCGGCTGACTGT 
GAPDH 3’ F-AACAAGGCCTTTTCCTCTCC, R-CCACTAACCAGTCAGCGTCA 
H3F3A 5’ F-CTTCCCTCCATTGTGTGTGATT, R-GGCAGACGGGGAAACTTAC 
H3F3A 3’ F-TGTTGTCTGTCTTCTGTGCTGTT, R-
TTGCCACCAAGTCTATACTTTCC 
HIST1H1C 5’ F-AATGAAGAGCATGAAGCCCGAGG, R-
AACTCGGGTACAAGTGGCAAGC 
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HIST1H1C 3’ F-GCCAAAAGTGCTGCTAAGGCTGT, R-
AAGTAACAGGGCAGAACAAGAAAAG 
Immunofluorescence.  Immunofluorescence was performed as described (Wagner 
et al., 2007) using anti-Mpm2 (Sigma) and anti-CstF50 primary antibodies. 
 
 
Results 
 The histone genes in Drosophila are clustered in a tandemly repeated unit 
containing one copy of each of the five genes (Fig. 8A).  The 5’ ends (start codons) 
of two pairs of divergently transcribed genes (H2A, H2B and H3, H4) are separated 
by 227 and 297 nt, respectively. The 3’ ends of the H2A and H4 mRNAs are 
separated by 364 nt while, 257 nt separate the 3’ ends of H2B and H1 mRNAs.  
There is a 1326 nt gap between the 3’ end of the histone H3 mRNA and the start of 
histone H1.  Thus, efficient processing and transcription termination are required to 
prevent transcription into neighboring ORFs.  
 Each of the histone genes contains canonical poly(A) sites downstream of the 
normal cleavage site which are present in multiple Drosophila species.  Mutation of 
histone processing factors, SLBP (Lanzotti et al., 2002; Sullivan et al., 2001) or 
components of the U7 snRNP [(Godfrey et al., 2006) and submitted] results in the 
expression of polyadenylated histone mRNAs from each of the five histone genes. 
The presence of these polyadenylated mRNAs indicates that histone 3’ end 
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processing is inefficient, allowing us to address the role of protein factors in this 
process.  
A subset of poly(A) factors are required for histone pre-mRNA processing in 
vivo.   
 Three members of the poly(A) apparatus (CPSF73, CPSF100 and Symplekin) 
were previously shown to activate a histone misprocessing reporter (Wagner et al., 
2007) but the effect of their knockdown on expression of the endogenous histone 
mRNAs had not been examined.  To study D. Melanogaster histone pre-mRNA 3’ 
end processing in vivo, Mindy Steiniger RNAi depleted both histone and general 
poly(A) processing machinery components in D. Melanogaster Dmel-2 cells, and 
performed an S1 nuclease protection assay to assess the processing of histone H2A 
mRNA (Fig. 8).  Western and Northern blotting were used to assay the levels of 
processing factors (Fig. 9A) and their mRNAs (Fig. 10).  Previous studies 
demonstrated the formation of several polyadenylated transcripts from the histone 
H2A gene in Drosophila mutants of U7 snRNA or SLBP (Godfrey et al., 2006; 
Lanzotti et al., 2002).  Dmel-2 cells were bathed in dsRNAs targeting the transcripts 
of 3’ end processing factors for five days and RNA and nuclear extracts (NEs) 
prepared from the cells. Total RNA was hybridized to a 670 nt probe. The 3’ 340 nts 
of this probe base pair to the 5’ end (including the processing site) of H2A. The 
probe also contained 310 nts complementary to the 3’ flanking sequence which 
hybridized to polyadenylated histone H2A mRNAs (Lanzotti et al., 2002). 20 nts of 
non-histone sequence were added to the 5’ end of the probe allowing us to 
distinguish any undigested probe from any transcripts that went past the end of the 
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probe (referred to as read-through transcripts).  Hybridization of the probe was 
followed by digestion with S1 nuclease to map the 3’ end of the RNA transcripts.  
Separation of the protected fragments by gel electrophoresis reveals properly 
processed histone mRNA as well as longer discrete fragments in samples depleted 
of various 3’ end processing factors (Fig. 8C).   Properly processed H2A mRNA 
yields a protected fragment of 340 nts, while misprocessed transcripts utilizing one 
of the downstream poly(A) sites resulted in several larger protected species between 
340 and 650 nts (Fig. 8C, compare lanes 10 and 12).    
 Depletion of the histone specific pre-mRNA processing factor SLBP resulted 
in substantial misprocessing in vivo and multiple polyadenylated mRNA species (Fig. 
8C, lane 10) as previously described for SLBP mutant embryos (Lanzotti et al., 
2002) and larvae (Godfrey et al., 2006).  Even when SLBP (and other factors) is 
depleted, the majority of the histone mRNA is still properly processed, indicating that 
the residual levels of the factors were sufficient for processing much of the histone 
mRNA, since in null mutants of SLBP or U7 snRNP only polyadenylated mRNA is 
produced (Godfrey et al., 2006).   
 In agreement with the results obtained with the reporter, knockdown of some 
components of the CPSF complex (CPSF73 or CPSF100) cause histone pre-mRNA 
misprocessing while knockdown of CPSF30 or CPSF160 had no effect on these 
transcripts (Fig. 8C, lanes 4-7).  Symplekin depletion also results in H2A 
misprocessing (Fig. 8C, lane 8), while Fip knockdown had no detectable effect on 
endogenous H2A mRNA (Fig. 8C lane 9) though it scored weakly on the 
misprocessing reporter (Wagner et al., 2007).  In contrast, depletion of CstF complex 
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components had no effect on histone 3’ end formation (Fig. 8C lanes 1-3).  
Interestingly, knockdown of polyadenylation factors primarily resulted in production 
of the long read-through product extending to the end of the probe (Fig. 8C, lanes 5, 
6, 8). 
 To confirm that misprocessed H2A mRNA was polyadenylated, total RNA 
was fractionated on oligo d(T) cellulose to select polyA+ RNA prior to the S1 
nuclease protection assay.  Enrichment of poly(A)+ mRNA reveals that many of the 
misprocessed species are polyadenylated (Fig. 8D, lanes 5-8, 10-11).  Depletion of 
both histone specific and general poly(A) factors resulted in a similar pattern of 
polyadenylated histone mRNAs in each sample.  The pattern of protected fragments 
from histone H2A mRNA was strikingly different between total RNA and poly(A)+ 
RNA of the CPSF73, CPSF100 and Symplekin knockdowns (compare Figs. 8C and 
8D, lanes 5, 6, 8), while the pattern of protected fragments was similar in total and 
polyA+ RNA in the SLBP and Lsm11 knockdowns (Figs. 8C and 9D, lanes 10 and 
11).  Most of the longest transcripts detected in depletion of the polyadenylation 
factors were not selected on dT cellulose and hence were not polyadenylated. Note 
that this protected fragment corresponds to the entire 310 histone 3’ flanking 
sequence in the probe, and represents protection by all transcripts, regardless of 
their 3’ ends, that extend past the end of the probe.  The finding that in the CPSF73, 
CPSF100 and Symplekin knockdowns the majority of the misprocessed RNA is not 
polyadenylated, but rather represents an unprocessed read-through transcript, is 
consistent with a defect in polyadenylation as well as histone pre-mRNA processing 
when these factors are depleted.  In contrast, depletion of histone specific factors 
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SLBP and Lsm11 resulted in similar ratios of polyadenylated H2A mRNA in both 
total and poly(A)+ RNA, suggesting that there is little if any read-through 
unprocessed RNA accumulated.  These data indicate that a subset of 
polyadenylation factors (CPSF73, CPSF100 and Symplekin) is required for proper 
histone pre-mRNA 3’ end formation in vivo.  Depletion of these factors results in 
accumulation of not only misprocessed polyadenylated histone mRNAs, as is seen 
in knockdowns of histone specific pre-mRNA processing factors, but also in 
unprocessed read-through transcripts, due to reduction in efficiency of 
polyadenylation. 
Components of the core cleavage factor are codepleted by RNAi in vivo.  
 Mindy next determined the levels of poly(A) and histone processing factors in 
each of the RNAi treated NEs by western blotting to confirm that knockdown was 
efficient.  Strikingly, we found that depletion of some factors resulted in codepletion 
of other factors, suggesting that they are present in a complex.  Similar results have 
been observed for some homologous polyadenylation factors in yeast (Kyburz et al., 
2003; Zhao et al., 1999b). Depletion of CPSF73, CPSF100 or CPSF160 results in 
codepletion of CPSF73, CPSF100 and Symplekin, while CSPF30 depletion has only 
a mild affect on the level of CPSF100 (Fig. 9A, lanes 1-3 and 10).  Additionally, 
knockdown of Symplekin also causes codepletion of CPSF complex components 
CPSF73 and CPSF100 (Fig. 9A lane 4).  Note that there are not antibodies available 
for all the factors that we knocked down.  Depletion of the CstF subunits CstF64 and 
CstF77, resulted in codepletion of CstF50 (Fig. 9A, lanes 12 and 13), although 
knockdown of CstF50 showed only modest codepletion of CstF77 (Fig. 9A, lane 7). 
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There was no effect on the histone specific factors SLBP and Lsm11 with 
knockdown of the polyadenylation factors with the lone exception of a variable SLBP 
depletion in CPSF30 knockdowns, which was not sufficient to affect histone mRNA 
processing.  Knockdown of SLBP had a minor affect on CPSF100 level while Lsm11 
knockdown did not affect any other factors tested (Fig. 9A, lanes 5-6).   
Notably, while knockdown of CPSF160 also resulted in reduction in the levels of 
CPSF73, CPSF100 and Symplekin, CPSF160 depletion does not have an effect on 
histone pre-mRNA processing ((Wagner et al., 2007) and Figs. 8C and 8D, lane 7).  
Similarly, knockdown of CstF64 resulted in codepletion of Symplekin (Fig. 2A, lane 
12), but also did not affect histone pre-mRNA processing (Figs. 8C and 8D, lane 2).  
None of the knockdowns significantly affect mRNA levels of other factors, indicating 
that the codepletions are not due to the reduction of levels of specific mRNAs 
(Figure 10).  These data indicate that components of both the CPSF and CstF 
complexes can affect the stability of proteins within their respective complexes.  
Additionally, Symplekin protein levels are reduced by knockdown of the CPSF 
components CPSF73, CPSF100 and CPSF160 as well as CstF64 but not the other 
CstF subunits. 
CPSF73, CPSF100 and Symplekin form a stable complex and also interact with 
histone mRNA specific processing factors 
 To directly test for protein-protein interactions among Drosophila 3’ end 
processing factors, coIP experiments were performed with NEs from Dmel-2 cells.  
Mindy prepared polyclonal CPSF73 and Symplekin antibodies which were effective 
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for IP, and used these to characterize the interactions between endogenous 
Symplekin and the members of the CPSF complex.  CPSF100 and Symplekin coIPs 
with CPSF73 under stringent conditions (50 mM Tris, pH 8.0, 1% NP40, 0.25% 
deoxycholate, 150 mM NaCl, Fig. 9B, lane 4).  This result was confirmed by coIP of 
CPSF73 and CPSF100 with the α-Symplekin antibody (Fig. 9B, lane 8).  The high 
efficiency of coIP of these three endogenous factors strongly the supports the idea 
that CPSF73, CPSF100 and Symplekin are part of a stable complex(es) in vivo.   
 To determine if components of the cleavage factor interact with specific 
histone pre-mRNA processing factors, coIP experiments with α-SLBP and α-Lsm11 
antibodies were performed using NE from Dmel-2 cells.  CPSF73 coIPs with both 
SLBP and Lsm11 (Fig. 9C, lanes 3-5) under less stringent conditions (50mM Tris, 
pH 8.0, 0.1% NP-40, 150 mM NaCl), although neither interaction is as strong as that 
between CPSF73 and Symplekin as these interactions are undetectable under 
stringent conditions (data not shown).  Symplekin also coIPs with SLBP and, to a 
lesser extent, Lsm11 (Fig. 9C, lanes 3-5).  While over 50% of the Symplekin, 
CPSF73 and CPSF100 coimmunoprecipitated with one another, only about 1% of 
the CPSF73 or Symplekin precipitated with SLBP or Lsm11.  CstF77 did not coIP 
with Symplekin, CPSF73, Lsm11 or SLBP, consistent with depletion of CstF77 not 
having an effect on the concentrations of these proteins.  These interactions are not 
RNA dependent as neither RNAse treatment of the IPs nor actinomycin D treatment 
of the cells prior to nuclear extraction prevented coimmunoprecipitation (Fig. 11). 
 Collectively, these data point to a core complex of cleavage factor 
components consisting of CPSF73, CPSF100 and Symplekin which interact very 
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strongly with one another.  This core complex may then bind different accessory 
proteins depending on the type of pre-mRNA to be processed.  A schematic of 
possible interactions is shown in Figure 9D, indicating how a common core of 
CPSF73, CPSF100 and Symplekin might interact to form two different cleavage 
factors for processing of poly(A) mRNAs (Fig. 9D, left) versus histone mRNAs (Fig. 
9D, right). 
Components of the cleavage factor associate with histone genes in vivo 
 RNA processing factors have been shown via ChIP to associate with genes 
(Komarnitsky et al., 2000; Licatalosi et al., 2002a; Proudfoot, 2004; Swinburne et al., 
2006), either as complexes bound to the nascent RNA or by direct association with 
RNA Pol II.  I investigated whether any of these factors associate with the 
Drosophila histone genes in vivo.  Primer sets located within the coding regions of 
four of the genes (H2A, H2B, H3, and H4) as well as three noncoding regions, 
including the promoter regions of H2A/H2B and H3/H4 plus a region downstream of 
the H3 gene in the largest intergenic region contained in the repeat were used to 
amplify regions of the ~5kb histone gene cluster (Fig. 12A).  There are multiple 
polyadenylation sites in this 1.4 kb intergenic region that are only used when histone 
mRNA processing is affected (Lanzotti et al., 2002), and the probe is located 472 to 
657 nts after the histone processing site and 669 nts 5’ of the histone H1 start 
codon.  It should be noted that the small size of the histone genes (~400 bp) 
approaches the limit of the resolution of the chromatin shearing required for the ChIP 
assay (200-500 bp fragments) and thus differences between the 5’ and 3’ ends of 
these genes may not be readily distinguishable.   
46 
 
 As a control for the association of canonical poly(A) factors with a gene 
encoding a polyadenylated mRNA, primers were also designed to exon 6 and the 
first of two poly(A) sites located in the domino gene (Fig. 12A).  In contrast to the 
histone genes, these probes are well separated.  ChIP experiments were performed 
with antibodies to CPSF73, CstF50, RNA Pol II (Rpb3) and Symplekin.  The relative 
amounts of DNA associated with each fragment were quantified using qPCR and 
SYBRGreen fluorescence.  Using an antibody which recognizes the Rpb3 subunit of 
RNA Pol II and hence all forms of RNA Pol II without preference for phosphorylation 
state of the CTD, I found that RNA Pol II associates with all portions of the histone 
genes and the domino gene.  Within the promoter and coding regions of each of the 
genes, the polymerase occupancy is between 40% and 80% of maximum whereas 
there is no RNA Pol II present in the intergenic region between the H3 and H1 genes 
(Fig. 3B, blue bars).   
 I next examined the localization of two components of the cleavage factor, 
CPSF73 and Symplekin.  The domino gene shows an increased pattern of 
recruitment of both factors at the 3’ end of the gene relative to exon 6 (Figure 12B, 
red and green bars).  Both CPSF73 and Symplekin are localized throughout the 
histone gene cluster with peak levels similar to those found at the 3’ end of the 
domino gene.  Again, essentially no Symplekin or CPSF73 was detected in the 
intergenic between histone H3 and histone H1 in control cells.  As a control, we 
carried out ChIP analysis with CstF50, a factor which has no role in histone pre-
mRNA processing.  CstF50 showed strong localization to the 3’ end of the domino 
gene and a much lower level of association with the histone genes than CPSF73 or 
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Symplekin.  Not surprisingly, there is little localization of CstF50 with the H3/H1 
intergenic region (Fig. 12B, purple bars).  Thus CPSF73 and Symplekin, factors 
involved in histone mRNA maturation, display cotranscriptional recruitment to 
histone genes as well as a canonical poly(A) gene.    
Mammalian SLBP associates with histone genes in vivo.   
 To determine whether histone specific processing factors associate with 
histone genes in vivo, I wanted to perform ChIP experiments with and antibody 
recognizing either SLBP or a U7 snRNP component.  As our dSLBP and dLsm11 
antibodies gave high background signals in my ChIP assay, I elected to carry out 
ChIP experiments in HeLa cells stably expressing HA-tagged SLBP.  This allowed 
me to IP with both an HA antibody as well as an antibody which recognizes 
endogenous SLBP.    I designed oligonucleotide sets to amplify the 5’ and 3’ ends of 
three genes; GAPDH, H3F3A, which encodes a polyadenylated H3.3 mRNA, and 
HIST1H1C, which encodes a canonical replication dependent histone mRNA.  Both 
the HA and SLBP antibodies gave very low signals on the GAPDH and H3F3A 
genes which I concluded to be background levels, however, both gave significant 
signals on the HIST1H1C gene.  The HA antibody gave lower signals at both ends of 
the gene (not much above background), but showed a 2-fold increase from the 5’ to 
the 3’ end of the gene, consistent with cotranscriptional recruitment of SLBP (Fig. 
13, black bars).   These low levels of ChIP signal may be due to the fact that the HA-
SLBP is overexpressed and may not be incorporated into active complexes at the 
same frequency as endogenous protein.  ChIP experiments with the SLBP antibody 
gave signals well above background on both the 5’ and 3’ ends of the HIST1H1C 
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gene and showed a similar 2-fold increase in signal at the 3’ end of the gene (Fig. 
13, purple bars).  These data are consistent with SLBP being recruited to histone 
genes cotranscriptionally. 
SLBP knockdown causes recruitment of additional poly(A) factors to histone 
genes 
 Since knockdown of SLBP resulted in misprocessing and polyadenylation of 
histone mRNAs (Fig. 8C, lane10) I investigated how recruitment of the processing 
machinery to the histone genes was affected by depletion of SLBP.  ChIP lysates 
were prepared from Dmel-2 cells in which SLBP was depleted by RNAi and IPs were 
performed as in previous experiments.  In these knockdown experiments I focused 
on the H3 gene using the primer sets which correspond to the 5’ end and promoter 
region (primer set H3/H4), the 3’ end of the coding region (primer set H3) and the 
region between the H3 and H1 genes which contains the two distal poly(A) sites 
(primer set H3/H1 intergenic).  The domino poly(A) site was used as a control.   RNA 
Pol II drops from ~60% maximal occupancy at the 3’ end of histone H3 genes in 
control cells to ~40% in this same region in SLBP knockdown cells (Fig. 14A, top 
left). At the same time, RNA Pol II occupancy in the intergenic region increases from 
less than 10% in control cells to >40% in SLBP knockdown cells.  CPSF73 and 
Symplekin show similar recruitment patterns at the promoter and 3’ end in control 
and SLBP knockdown samples, however, both of these proteins also display a 
dramatic increase in ChIP signal in the intergenic region in SLBP knockdown cells 
(compare Fig. 14A, top right and bottom left).  The most remarkable difference 
between control and SLBP knockdown cells is the enrichment of CstF50 across the 
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histone H3 gene (Fig. 14A, bottom right).  In control cells, this protein is recruited at 
only a low level, however, in cells depleted of SLBP it shows occupancy of >50% of 
maximum at the 3’ end and intergenic regions.  The intergenic region which contains 
two distal poly(A) sites experiences an increase in CstF50 from ~5% to ~70% in 
SLBP knockdown cells.  This is consistent with recruitment of CstF50 to histone 
genes as part of the polyadenylation of histone pre-mRNAs in the absence of SLBP. 
 Immunofluorescence experiments also revealed an increased recruitment of 
CstF50 to HLBs when SLBP is RNAi-depleted (Figure 14B).  Cells were analyzed by 
immunofluorescence for Mpm2, an antigen that localizes to HLBs (White et al., 
2007) and hence histone genes in S-phase Drosophila cells (>50% of cells), and 
CstF50.  CstF50 is generally localized throughout the nucleoplasm in control cells, 
consistent with a role in processing a large number of genes.  Foci of CstF50 were 
clearly visible in some of the SLBP knockdown cells and in 64% of the cells these 
foci colocalized with Mpm2, consistent with them being in the HLB.  In control cells, 
CstF50 foci were generally not visible, although in 34% of cells there were significant 
amounts of CstF50 that overlapped in localization with Mpm2 (Fig. 14B).  Thus 
SLBP knockdown results in an increased association of CstF50 with the HLB.   
 To determine the effect of simultaneously depleting both a histone and a 
poly(A) factor on histone pre-mRNA processing, protein lysates and RNA were 
made from Dmel-2 cells depleted of both SLBP and CstF50. Efficient knockdown of 
both proteins in the double knockdown was confirmed by western blot (Fig. 14C).  
An S1 nuclease protection assay was then performed on the RNA from the double 
knockdown as well as on RNA from SLBP and CstF50 individual knockdowns. SLBP 
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knockdown again resulted in substantial misprocessing and polyadenylation (Fig. 
14D, lanes 2 and 6) while depletion of CstF50 had no effect on histone pre-mRNA 
processing (Fig. 14D, lanes 3 and 7).  The double knockdown, however, shows an 
intermediate phenotype in which the distal poly(A) site is preferentially used for 
polyadenylation (Fig. 14D, lanes 4 and 8), consistent with both histone pre-mRNA 
processing being affected by SLBP depletion and polyadenylation being affected by 
CstF50 depletion.  Collectively, the data in Figure 4 demonstrate a role for the CstF 
complex in polyadenylation of misprocessed histone mRNAs and that CstF50 is not 
required for normal processing. 
Depletion of Symplekin by RNAi-depletion of CPSF160 or CstF64 does not 
affect recruitment of the cleavage factor to histone genes  
 Knockdown of CstF64 or CPSF160 results in codepletion of factors required 
for histone pre-mRNA processing yet does not result in polyadenylation of histone 
mRNAs (Fig. 8C, lanes 2 and 7).  Knockdown of CPSF160 codepletes CPSF73, 
CPSF100 and Symplekin, while CstF64 knockdown results in depletion of Symplekin 
(Fig. 9A, lanes 10 and 12).  To determine whether this codepletion affects 
association of common cleavage factor components with either histone or poly(A) 
genes, I prepared lysates from CstF64 and CPSF160 knockdown cells and 
performed ChIP.  ChIP profiles on histone genes in the CstF64 knockdown cells 
showed a similar pattern as in control cells.  RNA Pol II ChIP profiles showed 
maximum occupancy at the 3’ end of the H3 gene with no significant association in 
the intergenic region between H3 and H1. Also, RNA Pol II had approximately 60% 
of maximal association with the promoter region of H3 and the proximal domino 
51 
 
poly(A) site (Fig. 15A, top left).   These numbers reveal a slightly increased 
association of RNA Pol II on both ends of the histone gene relative to the domino 
gene.  CPSF73 is associated with both the 5’ and 3’ ends of histone genes (Fig. 
15A, top right).  Symplekin shows a similar pattern of association with the histone 
gene as both RNA Pol II and CPSF73, although there is a substantial decrease in 
the relative amount of Symplekin associated with the domino poly(A) site (Fig. 15A, 
bottom left).  The reduction in Symplekin at the 3’ end of the domino gene with no 
effect on its association with the histone genes, is striking.  This is consistent with 
CstF64 knockdown resulting in codepletion of Symplekin but with no effect on 
histone mRNA processing.  
 I next examined the effect of CPSF160 knockdown on association of RNA Pol 
II and RNA processing factors with the histone H3 gene and the proximal domino 
poly(A) site.  Similar to the CstF64 knockdown, there is a slight increase of RNA Pol 
II association with the histone gene while there is a modest decrease in its 
association with the domino 3’ end (Fig. 15B, top left).  CPSF73, one of the factors 
codepleted by CPSF160 knockdown shows a modest decrease in association with 
the 5’ end of histone H3 gene but a high level of association with the 3’ end of 
histone H3 gene (Fig. 15B).  Strikingly, CPSF73 levels are down to 10% of 
maximum value in CPSF160 knockdown cells on the poly(A) site of the domino gene 
(Fig. 15B, top right).  Symplekin profiling reveals that its association with the histone 
genes is slightly higher in the CSPF160 knockdown that in wild type cells, but that 
binding to the proximal domino poly(A) site decreases (Fig. 15B, bottom left).  These 
data show that codepletion of Symplekin and CPSF73 by knockdown of 
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polyadenylation factors which are not required for histone 3’ end processing, does 
not affect recruitment of CPSF73 or Symplekin to histone genes, but it does affect 
recruitment to the domino gene.  Together these data suggest that there are two 
distinct cleavage complexes and that knockdown of a factor which is not required for 
histone pre-mRNA processing (not present in the histone cleavage complex) may 
codeplete the polyadenylation cleavage complex, but not the histone cleavage 
complex. 
SLBP is in a complex with RNA Pol II 
 As many RNA processing factors are recruited to nascent RNA 
cotranscriptionally by associating with the CTD of RNA Pol II (Proudfoot et al., 
2002), I wanted to test whether SLBP associates with the polymerase.  I performed 
IP experiments using antibodies against Ser2P CTD, Ser5P CTD or Rpb3 and 
looked for coIP of SLBP, Symplekin or CPSF73.  To determine whether there was 
any interaction between RNA Pol II and SLBP, I decided to perform IP experiments 
on formaldehyde crosslinked cell lysates under conditions similar to those used for 
the ChIP experiments and these experiments revealed an interesting result.  I began 
by looking for association of Symplekin and CPSF73 with the polymerase as these 
are components of the general polyadenylation machinery and I believed it more 
likely that I would find interactions between these proteins and RNA Pol II.  As 
expected, both Symplekin and CPSF73 interact with the Ser2P CTD which is the 
modification associated with the 3’ ends of genes (Fig. 16A, lane 4).  Both proteins 
also precipitate with the Rpb3 antibody which has no preference for the 
phosphorylation state of the CTD (Fig. 16A, lane 3), but only Symplekin shows an 
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association with the Ser5P form of RNA Pol II indicating that this protein may 
associate with the 5’ ends of genes (Fig. 16A, lane 5).  Lanes 6 and 7 of figure 16A 
demonstrate that both CPSF73 and Symplekin efficiently IP under crosslinked 
conditions.  It should be noted that the coIP of Symplekin and CPSF73 with the myc 
antibody is aleatoric as SLBP does not coIP with myc and in the vast majority of 
experiments performed, neither does Symplekin or CPSF73.   
 In crosslinked lysates, SLBP coIPs with the Rpb3 antibody, but not the Ser2P 
or Ser5P phosphospecific antibodies (Figure 16A, lanes 3-5); indicating that this 
association, whether direct or indirect, is not dependent on either of the well 
characterized modifications of the CTD.  Interestingly, we are also able to pull down 
SLBP with Symplekin under crosslinked conditions, an interaction we are unable to 
observe in NEs, though we can readily detect the reciprocal interaction (Figure 16, 
lane 7).  These data indicate that SLBP and RNA Pol II exist in a complex together. 
 To determine whether or not associations between RNA Pol II and 3’ end 
processing factors was dependent upon active transcription, cells were treated with 
actinomycin D, a general transcription inhibitor, and NEs prepared.  IP of Symplekin 
and CstF77 demonstrated that association of these factors with RNA Pol II was, 
indeed, dependent on active transcription as actinomycin D treatment abrogated 
these interactions (Fig. 16B, lanes 3-4).  The interaction between SLBP and RNA 
Pol II, however, was not dependent on active transcription (Fig. 16B, lanes 3-4), 
indicating that this association may be due to high concentrations of RNA Pol II and 
SLBP in HLBs.  The significance of this association is a subject worthy of further 
study. 
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Discussion 
 All mRNAs in eukaryotic cells are transcribed by RNA polymerase II, and the 
first step in 3’ end formation of all mRNAs is endonucleolytic cleavage.  Cleavage is 
coupled with polyadenylation for most genes, but cleavage is the only step in 3’ end 
formation of the metazoan replication-dependent histone mRNAs.  In the last few 
years, it has become apparent that there are factors shared between these two 
processes, and that CPSF73 catalyzes the endonucleolytic cleavage of both 
polyadenylated mRNAs (Mandel et al., 2006; Ryan et al., 2004)and histone mRNAs 
(Dominski et al., 2005b).  Here Mindy and I provide evidence that a subset of poly(A) 
factors, CSPF73, CPSF100 and Symplekin, which are involved in both 
polyadenylation and histone pre-mRNA processing, are present in a complex in 
Drosophila cells.   
CPSF73, CPSF100 and Symplekin comprise the mRNA processing core 
cleavage factor.   
 Depletion of the cleavage and poly(A) factors CPSF73, CPSF100 and 
Symplekin from Drosophila cultured cells results in misprocessing of histone pre-
mRNA.  In contrast to depletion of SLBP or U7 snRNP where most of the read-
through mRNAs are polyadenylated, when CPSF73, CPSF100 or Symplekin are 
depleted the majority of misprocessed histone mRNAs are run-on transcripts that 
are not polyadenylated (Fig. 8).  These data are consistent with knockdown of each 
of these three factors also causing defects in polyadenylation in vivo (Wagner et al., 
2007).  These experiments confirm that only a subset of poly(A) components are 
required for proper histone pre-mRNA processing in vivo. 
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 A striking finding is that depletion of some proteins using RNAi results in 
codepletion of other components (Fig. 9). Since RNAi does not significantly affect 
the mRNA levels of other factors (Fig. 10), a likely interpretation of this result is that 
the codepleted factors are present in a complex and that reduction of a single 
component results in degradation of the other components.  For example, depletion 
of CPSF73 causes codepletion of CPSF100 and Symplekin, and similarly, depletion 
of CPSF100 or Symplekin results in depletion all three components.  Depletion of 
these factors does not result in codepletion of SLBP, CstF50 or CstF77.  Depletion 
of a U7 specific protein, Lsm11, does not affect the levels of any other factors we 
tested, although it does reduce the level of Lsm10 (Wagner et al., 2007).  These 
results are consistent with the interpretation that there is a stable complex(es) 
containing CPSF73, CPSF100 and Symplekin. Additionally, a second complex exists 
containing, Cst50, Cst64 and Cst77, in agreement with the biochemical studies in 
mammalian cells of Manley and coworkers (Hatton et al., 2000; Takagaki et al., 
1990).  
 The presence of a stable complex containing CPSF73, CPSF100 and 
Symplekin is further supported by IP experiments using either -CPSF73 or -
Symplekin antibodies in stringent conditions (buffer containing an ionic detergent).  A 
substantial fraction (more than 50%) of the endogenous CPSF73, CPSF100 and 
Symplekin in NEs coprecipitate with one another (Fig. 9).  Thus these three proteins 
are part of a stable complex(es) in vivo.  I observe much less efficient CoIP between 
Symplekin or CPSF73 with SLBP or Lsm11, although there is also significant 
coimmunoprecipitation of these endogenous factors.  I propose that the core 
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cleavage factor is recruited to the histone pre-mRNA via interactions with histone-
specific proteins SLBP and Lsm11. At any one time only a small fraction of the 
cleavage factor is associated with the other histone processing factors.  It is likely 
that there are other components of the histone processing factor which have not yet 
been identified, given the large number of polypeptides required for cleavage of 
polyadenylated mRNAs (Mandel et al., 2007).   
The core cleavage factor is associated with histone genes in vivo.  
 To determine whether processing factors are associated with nascent histone 
pre-mRNAs, ChIP assays were performed using RNA Pol II, histone pre-mRNA 
processing factors and polyadenylation factors.  These experiments revealed that 
under normal conditions RNA Pol II does not proceed more than 472 nts 3’ end of 
the histone mRNA, suggesting that processing occurs shortly after transcription of 
the HDE.  These results agree with the in vitro results of Adamson and Price 
(Adamson and Price, 2003) who detected strong pause sites just downstream of the 
HDE of all 5 Drosophila histone genes.  Pausing of RNA Pol II at these sites could 
allow time for the processing complex to assemble and subsequent transcription 
termination.  I also detected association of histone pre-mRNA processing factors 
CPSF73 and Symplekin with the 3’ end of histone genes in vivo, consistent with 
formation of the processing complex on genes.  ChIP experiments with SLBP and 
Lsm11 antibodies were inconclusive due to high background levels.  These data 
suggest that the cleavage complex is recruited cotranscriptionally to the histone pre-
mRNA.   
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 I did not observe large amounts of CstF50 associated with the histone genes 
under normal conditions.  However when SLBP was knocked down, RNA Pol II was 
detected 3’ of the normal processing site, and in addition to CPSF73 and Symplekin, 
CstF50 was also associated with the histone genes, consistent with its role in 
polyadenylation.  Finally, ChIP studies on lysates in which CPSF160 or CstF64 are 
knocked down show selective depletion of Symplekin and/or CPSF73 from poly(A) 
genes, with no affect on their recruitment to histone genes,  supporting the notion of 
distinct cleavage complexes for histone and poly(A) genes.  
Two distinct complexes, both containing the core cleavage factor, are required 
for histone mRNA and poly(A) mRNA 3’ end formation.  
 Even though knockdown of either CPSF160 or CstF64, proteins only required 
for polyadenylation, reduces the level of Symplekin, the association of Symplekin 
with the 3’end of histone genes was not affected under these conditions.  Similarly, 
knockdown of CPSF160 codepletes CPSF73 and CPSF100, yet association of 
CPSF73 with the 3’ end of histone genes was unaffected in a CPSF160 knockdown 
(Figure 15). However, there was a reduction in the association of Symplekin and 
CPSF73 with the 3’ end of the domino gene.  These data are consistent with the 
CPSF complex, which contains CPSF160, being one of the stable complexes 
containing Symplekin.  Symplekin and CPSF73 continue to associate with the 
histone genes in the CPSF160 and CstF64 knockdowns, and in vivo histone RNA 
processing is not affected, suggesting that a distinct cleavage factor is recruited to 
the histone pre-mRNAs. ChIP experiments also show that there was no RNA Pol II 
associated in the intergenic region, consistent with the failure to detect read-through 
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transcripts in vivo.  Collectively, these results support our hypothesis that there are 
distinct cleavage complexes for these two classes of genes, and that one complex 
may be depleted without affecting the levels or functionality of the other.  
 Interestingly, a comparison of histone and poly(A) pre-mRNA 3’cis elements 
provides support to this model. Histone pre-mRNAs have two important cis 
elements, the highly conserved stem loop (SL) which binds the SLBP and a less 
conserved histone downstream element (HDE) which base pairs to U7 snRNA in the 
U7 snRNP. The SL and the HDE are analogous to the highly conserved AAUAAA 
hexamer and the less conserved GU-rich downstream element (DSE) in the 3’ UTR 
s of canonical poly(A) mRNAs. The AAUAAA hexamer interacts with CPSF160 while 
CstF64 binds the DSE.  In both cases there is endonucleolytic cleavage between 
these elements due to recruitment and/or activation of a cleavage factor containing 
CPSF73 and CPSF100 as well as Symplekin.  Thus there is a common core of the 
cleavage factor that is utilized for maturation of both histone and poly (A) mRNAs. 
 It is likely that the cell physically maintains these two separate complexes, 
and directs them to the proper targets.  For polyadenylation, CPSF160, a component 
of the polyA specific machinery directly binds the AAUAAA and thus brings CPSF73 
and CPSF100 to the pre-mRNA, albeit in an inactive form, since cleavage requires 
assembly of additional factors.  For histone mRNA, recruitment of the cleavage 
factor components is the last step in processing.  Concentration of the U7 snRNP in 
the HLB near the histone genes is critical for efficient processing of histone mRNA in 
vivo (Wagner et al., 2007).  Possibly a U7 snRNP component or an as yet unknown 
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protein, with a high local concentration in the HLB can recruit the histone cleavage 
factor to the HLB.    
Histone pre-mRNA 3’ end processing is cotranscriptional.   
 The factors involved in transcription of the histone genes include many 
proteins required for transcription of canonical polyadenylated mRNAs.  Unlike 
mammalian snRNAs, there is no evidence that formation of the histone mRNA 3’ 
end is affected by the promoter used for transcription (Pilch and Marzluff, 1991; 
Whitelaw et al., 1986).  A histone reporter driven by the Drosophila actin promoter 
forms histone 3’ ends just as effectively as the same reporter driven by the 
endogenous histone promoter (B. Burch and W.F.M., unpublished). Also a histone 
promoter driving a polyadenylated mRNA results in efficient polyadenylation (B. 
Burch, E.J. Wagner and W.F.M., unpublished).    It is possible that sequences in the 
coding region of the histone mRNA also affects processing efficiency in vivo.   The 
~400 nt coding regions of histone genes are highly conserved (Debry and Marzluff, 
1994) and there are factors that can bind to the nascent transcript that could help 
recruit processing factors (Friend et al., 2007). Thus, I believe that a major factor in 
efficient histone pre-mRNA processing is a high local concentration of the 
processing factors at the HLB together with the intrinsic pause site after the HDE 
which would allow time for assembly of the processing complex. 
 Many factors that participate in transcription and processing of canonical 
poly(A) mRNAs via interaction with the CTD [P-TEFb (Taube et al., 2002), capping 
enzymes (Schroeder et al., 2000)] are likely also recruited to the histone genes.  
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There is substantial evidence that some components of the polyadenylation 
machinery can bind to the CTD of RNA Pol II [reviewed in (Buratowski, 2005a; 
Neugebauer, 2002)], possibly shortly after initiation of transcription, and coordinate 
transcription with 3’ end processing.  CstF50, CstF64 and CstF77 interact directly 
with the CTD, with a preference for the phosphorylated CTD, possibly to facilitate 3’ 
end processing of poly(A) transcripts in mammals (McCracken et al., 1997) and 
yeast (Barilla et al., 2001).   The yeast CPSF160 orthologue can also bind directly to 
the CTD (Dichtl et al., 2002).  The interactions of CstF with the CTD may account for 
our observation that a factor not involved in histone 3’ end processing, CstF50, has 
20-25% occupancy on the histone genes.  Moreover, recent studies have suggested 
that there is substantial difference in the modifications on RNA Pol II in Cajal bodies 
(Xie and Pombo, 2006) which may account for the fact that we cannot detect 
interactions between SLBP and RNA Pol II with Ser2P or Ser5P CTD, but we do 
detect this interaction using an antibody which recognizes a subunit of RNA Pol II 
which is independent of the CTD.  While I believe that SLBP is in a complex with 
RNA Pol II, I currently have no functional data for this interaction and it could be a 
result of high concentration of these proteins at histone genes.  Therefore, I currently 
favor a model of a high local concentration of processing factors in HLBs rather than 
direct recruitment by the CTD of RNA Pol II.  
D. melanogaster histone mRNA 3’ end processing.   
 The histone genes are localized near the histone locus body (HLB), a site at 
which U7 snRNP but not SLBP is concentrated.  There is also a locally high 
concentration of Symplekin in the HLB [(Wagner et al., 2007); D. Tatomer,. K.D.S, 
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M.S. and W.F.M., unpublished].  As histone genes are transcribed, SLBP binds the 
SL and U7 snRNP associates with the HDE.  RNA Pol II pauses after the HDE is 
transcribed (Adamson and Price, 2003), allowing time for the SLBP and U7 snRNP 
complex to assemble on the histone pre-mRNA.  The cleavage factor, containing at 
least Symplekin, CPSF73, CPSF100 and possibly other factors, associates with the 
SLBP/U7snRNP/pre-mRNA complex and cleaves the pre-mRNA (Figure 17A).  
Under normal conditions I do not observe RNA Pol II downstream of the cleavage 
site, suggesting that transcription termination occurs rapidly after processing, as has 
been suggested for mammalian histone genes (Chodchoy et al., 1991) .  It is 
possible that CPSF73 rapidly degrades the 3’ cleavage product after processing 
(Yang et al., 2009) promoting transcription termination.  If there is a deficiency in any 
of these factors, processing does not occur while the RNA Pol II is paused and RNA 
Pol II may eventually resume transcription and transcribe the polyadenylation sites. 
If the deficiency is in a protein only required for efficient histone pre-mRNA 
processing (SLBP or Lsm11), additional factors for poly(A) pre-mRNA processing 
will be recruited and the histone pre-mRNA will be cleaved and polyadenylated 
(Figure 17B). If the deficiency is in a protein necessary for both histone processing 
and processing of poly(A) transcripts, RNA Pol II will continue to transcribe and only 
small amounts of polyadenylation may occur.  The result is read-through transcripts 
which are likely rapidly degraded.  
 Read-through transcription also occurs when NELF (a negative elongation 
factor) is depleted in Drosophila (Gilchrist et al., 2008; Wagner et al., 2007) and 
human cells (Narita et al., 2007).  This may be due to inefficient pausing of RNA Pol 
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II resulting in inefficient histone 3’ end formation. Read-through transcription also 
occurs when the U7 snRNP is not concentrated at the HLB (Wagner et al., 2007), 
probably as a result of inefficient recruitment of U7 snRNP while RNA Pol II is 
paused.  Thus, efficient processing in vivo requires the proper concentration of 
processing factors at the histone locus, pausing by RNA Pol II and likely other 
factors involved in coordinating processing and transcription.  Deficiencies in any of 
these processes cause read-through past the normal termination site and 
subsequent polyadenylation of many of the read-through transcripts.  The molecular 
details of how these multiple pathways intersect at the processing site to accomplish 
efficient processing and transcription termination remain to be elucidated. 
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Figure 8. Knockdown of pre-mRNA processing factors results in 
misprocessed histone mRNA.  (A) A schematic of one of the tandem repeat units 
of the histone gene locus is shown.  The numbers indicate the distance between the 
5’ or 3’ ends of the mRNAs.  The distance between the H3 and H1 genes is the 
distance between the 3’ end of the H3 mRNA and the translation start codon of the 
histone H1 gene.  (B) Schematic of S1 nuclease protection assay.  A 670 nt DNA 
fragment containing 650 nts of the 3’ end of H2A gene and 20 nts of plasmid 
-32P-dCTP on the 3’ end. The probe was 
hybridized to total cell RNA and digested with S1 nuclease.  Properly processed 
H2A mRNA yields a protected fragment of 340 nt extending to the 3’ end of the 
mRNA while misprocessed transcripts give fragments ranging in size from 340-
600nt.  Any read-through protect a 650 nt fragment.  (C)  Dmel-2 cells were treated 
with dsRNAs targeting the indicated proteins above each lane for 5 days and total 
RNA was harvested by Trizol extraction.  12.5 µg of total RNA was subjected to S1 
nuclease protection assay and protected fragments were resolved on a 6% 
acrylamide gel.  Diagrams at left indicate RNA species corresponding to protected 
fragments.  The undigested probe is shown in lane 13.  Read-through transcripts 
(RT) are marked with an arrow.  (D) 25 µg of total RNA was purified on oligo(dT) 
cellulose and the purified poly(A)+ RNA was used for S1 nuclease protection assay 
as in (B).  The undigested probe is shown in lane 13.  A small amount of properly 
processed mRNA nonspecifically binds to the oligo(dT) cellulose. 
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Figure 9.  The core cleavage factor interacts with histone specific processing 
factors.  (A) Dmel-2 cells were treated with the indicated dsRNA for 5 days and NEs 
were prepared.  15 µg of NE were resolved by SDS-PAGE and western blots were 
performed using indicated antibodies.  The loading control is a cross-reacting band 
from the Symplekin blot.  (B) 500 µg of Dmel-2 NE was used in IP experiments with 
indicated antibodies under RIPA (high detergent) conditions.  Precipitates were run 
on SDS-PAGE gels and western blots performed as in A.  α-HA and beads alone IPs 
were included as controls.  Inputs represent 2.5% of starting material. (C) IPs were 
performed as in A except under low detergent conditions.  Western blots performed 
as in A. (D) Diagram of core cleavage factor interactions with poly(A) and histone 
specific RNA processing factors.  
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Figure 10.  Codepletion is not due to reduced mRNA levels.  10 ug of total RNA 
from knockdown cells was resolved on a 1.5% Formaldehyde agarose gel and 
transferred to Hybond-N+ membrane.  Probes for CPSF73, 100 and 160, CstF64 
and SLBP were used to assess mRNA levels, top panels, and values were 
normalized to ribosomal RNA, bottom panels.    
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Figure 11.  Interactions between cleavage factor and histone pre-mRNA 
processing factors are not RNA-dependent.  IPs were performed as in figure 9 
from untreated NEs with or without 30 ug/mL RNAase A, or from NEs treated with 
actinomycin D (1ug/mL final concentration) for 30 min.  
70 
 
  
71 
 
Figure 12.  RNA processing factors are recruited to histone genes in vivo.  (A) 
Diagram of ChIP assay design.  Oligonucleotide sets target short regions in the 
histone gene cluster.  These sets correspond to the coding regions of H2A, H2B, H3 
and H4, as well as the promoters of the H2A/H2B and H3/H4 pairs and the H3/H1 
intergenic region.  Control oligonucleotide sets were designed to exon 6 and the 
proximal poly(A) site of the domino gene. (B) ChIP assays were performed on 
crosslinked lysates from Dmel-2 cells using antibodies to the Rpb3 subunit of RNA 
polymerase II, CPSF73, Symplekin and CstF50.  Columns represent average 
relative ChIP signal normalized to the maximal value for each antibody.  Data are 
presented as the average of 3 independent experiments ± SD. 
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Figure 13.  SLBP associates with histone genes in mammalian cells.  ChIP 
experiments were performed on HeLa lysates using HA (black bars) or SLBP (purple 
bars) antibodies.    
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Figure 14.  Loss of a histone specific processing factor results in recruitment 
of additional poly(A) factors to histone genes.  (A) ChIP assays were performed 
using lysates prepared from Dmel-2 cells treated with control (blue) or SLBP (red) 
double-stranded RNA.  Columns represent the average relative ChIP signal 
normalized to the maximal value for each antibody.  Blue bars in each are untreated 
cells, red bars are values for SLBP knockdown cells.  Data are presented as the 
average of 3 independent experiments and the SD was less than 20%.  (B) Dmel-2 
cells treated with control double-stranded RNA (Top) or SLBP double stranded RNA 
(Bottom) were fixed and probed for CstF50 (green) and Mpm2 (red), and also 
stained with DAPI (blue).  The number of cells with Mpm2 foci, and the number of 
cells with Mpm2 foci that also contained CstF50 foci.  There was a 2-fold increase in 
the fraction of cells containing Mpm2/CstF50 foci in the SLBP knockdown cells.   (C) 
Dmel-2 cells were control treated with PTB dsRNA or dsRNA targeting SLBP and 
CstF50.  Cell lysates were resolved by SDS-PAGE and western blots were 
performed.  (D) Total RNA was prepared from cells treated with double-stranded 
RNAs against PTB, SLBP, CstF50 or both SLBP and CstF50.  S1 nuclease 
protection assays were performed on total RNA (lanes 1-4) or poly(A)+ RNA (lanes 
5-8) as in Fig. 1C, D.   
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Figure 15.  Knockdown of poly(A) specific factors does not affect recruitment 
of core cleavage factor to histone genes.  Lysates from untreated cells (panel A 
and B, blue) and from cells treated with dsRNA targeting CstF64 (panel A, red) or 
CPSF160 (panel B, green) were made and ChIP assays were performed as in Fig. 
3B.  SD’s were less than 20% among 3 different analyses.  
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Figure 17.  3’ end processing factors associate with RNA Pol II. (A)  IPs were 
performed as in figure 9 using crosslinked whole cell lysates from Dmel-2 cells.  
Western blots were performed using the indicated antibodies. (B)  IPs were 
performed as in figure 11 from untreated NEs or NEs from actinomycin D treated 
Dmel-2 cells. 
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Figure 17.  Model of histone pre-mRNA processing.  (A)  Model of normal histone 
3’ end formation.  (B) Additional poly(A) factors are recruited to histone genes to 
participate in cleavage and polyadenylation in the absence of histone specific RNA 
processing proteins.   
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Chapter 3 
CPSF73 is both the endonuclease and a processive 5’ to 3’ exonuclease in 
histone pre-mRNA processing 
Introduction 
 3’ end processing is an essential step in converting eukaryotic mRNA precursors 
(pre-mRNAs) to mature mRNAs.  Metazoan pre-mRNAs are processed at the 3’ end by 
two distinct mechanisms (Zhao et al., 1999a).  The vast majority of mRNA precursors 
are processed by cleavage coupled to polyadenylation.  This mechanism depends on 
the presence of two sequence elements in the precursor; a highly conserved 
polyadenylation signal AAUAAA and a less conserved G/U-rich downstream element 
(Colgan and Manley, 1997).  Cleavage occurs between the two sequence elements, 
usually about 20 nucleotides 3’ to the AAUAAA.  The upstream cleavage product is 
subsequently polyadenylated.  Cleavage/polyadenylation is executed by a large 
complex composed of at least 12 proteins.  The AAUAAA interacts with a 5-subunit 
cleavage/polyadenylation specificity factor (CPSF) (Kaufmann et al., 2004) whereas the 
G/U-rich downstream element interacts with a 3-subunit cleavage stimulation factor 
(CstF) (Colgan and Manley, 1997).  Among other proteins, the 
cleavage/polyadenylation machinery also includes poly(A) polymerase that catalyzes 
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addition of the poly(A) tail (Colgan and Manley, 1997) and Symplekin, which plays a yet 
uncharacterized role in 3’ end processing (Takagaki and Manley, 2000a).  An 
increasing number of both genetic and biochemical studies indicate that 
endonucleolytic cleavage that proceeds polyadenylation is carried out by CPSF73, the 
73 kDa subunit of CPSF (Mandel et al., 2006; Ryan et al., 2004).  CPSF73 is a member 
of the metallo-β-lactamase family of mostly hydrolytic enzymes that utilize zinc ions 
during catalysis (Aravind, 1999; Callebaut et al., 2002).  A small group of the metallo-β-
lactamase proteins function in metabolism of DNA and RNA substrates as both 
endonucleases and/or 5’-3’ exonucleases (Callebaut et al., 2002; Dominski and 
Marzluff, 2007; Mathy et al., 2007a).   
 A distinct 3’ end processing mechanism operates on metazoan replication-
dependent histone pre-mRNAs (Dominski and Marzluff, 2007).  These transcripts are 
cleaved between a highly conserved stem-loop structure and a purine-rich histone 
downstream element (HDE) directly producing the mature histone mRNAs that end with 
the stem-loop followed by a 5-nucleotide single-stranded tail.  3’ end processing of 
histone pre-mRNAs critically depends on the HDE, which interacts with U7 snRNP.  
The interaction is mediated by formation of a double stranded RNA between the HDE 
and the 5’ end of U7 snRNA, an approximately 60-nucleotide component of the U7 
snRNP.  The U7 snRNP contains an unusual Sm complex, in which the Sm proteins D1 
and D2 are replaced by two related proteins; Lsm10 and Lsm11 (Pillai et al., 2001; 
Pillai et al., 2003).  The stem-loop structure forms a tight complex with the stem-loop 
binding protein (SLBP).  SLBP also binds a 100 kDa zinc finger protein (ZFP100), 
which in turn interacts with Lsm11.  This bridging interaction is believed to stabilize U7 
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snRNP on the HDE (Dominski and Marzluff, 2007).  In common with cleavage and 
polyadenylation, 3’ end processing of histone pre-mRNAs also involves Symplekin 
although its role remains to be elucidated (Kolev and Steitz, 2005).   
 UV-cross linking studies demonstrated that the cleavage site in histone pre-
mRNAs interacts in a U7-dependent manner with CPSF73 thus strongly suggesting 
that the same endonuclease functions in generation of both polyadenylated and 
nonadenylated (histone) mRNAs (Dominski et al., 2005b).  Following the in vitro 
cleavage reaction, the downstream product containing the HDE is rapidly degraded to 
mononucleotides by a nuclease that also depends on the U7 snRNA giving rise to 
mononucleotides (Dominski et al., 2005b).  Our preliminary data suggested that also 
this reaction is catalyzed by CPSF73 (Dominski et al., 2005b). 
 In this study Zbigniew Dominski, Xiao Cui-Yang, and I show that degradation of 
the DCP is a result of a processive 5’-3’ exonuclease activity and further support the 
involvement of CPSF73.  We also identify important features of the RNA substrate that 
dictate whether CPSF73 functions as an endonuclease or 5’ exonuclease and provide 
in vivo data suggesting that degradation of the DCP formed after histone pre-mRNA 
processing does not require by Xrn2, consistent with CPSF73 degrading the DCP.    
Material and Methods 
Preparation and labeling of RNA substrates.   Most RNAs were synthesized in 
Dharmacon (Colorado) and depending on the quality of synthesis, were used either 
directly or gel purified to isolate the full length product.  RNA substrates containing a 
single internal label were constructed by ligating two RNA fragments using DNA 
ligase and a bridging oligonucleotide.  Prior to ligation, the downstream fragment 
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was labeled at the 5’ end with 32P using T4 polynucleotide kinase, as described 
(Dominski et al., 2005b).  All RNA substrates were named based on the number of 
nucleotides present in front of the DCP, for example DCP, DCP+5 or DCP-2.  
Names of the substrates containing a single internal label additionally reflected the 
position of a modified nucleotide relative to the DCP sequence: 2’-O-methyl (m), 
deoxy (d) or phosphorothioate (s).  The DCP+10 and DCP+15 substrates were 
constructed by ligating the 5’ end of the DCP-9/s to a 19- or 24-nucleotide RNA 
fragment, respectively.  The ligation products were gel purified, quantified and 
labeled at the 5’ end with 32P using T4 polynucleotide kinase.  The internally labeled 
86-nucleotide H2a pre-mRNA containing the stem-loop structure and the HDE was 
synthesized by T7 transcription in the presence of 32P(αUTP), as described 
(Dominski et al., 1999).   
Preparation of nuclear extracts and RNA processing and degradation .  Nuclear 
extracts were prepared from mouse myeloma cells, as described (Dominski et al., 
1999).  Unless otherwise indicated, all processing and degradation reactions were 
carried out 90 min in the presence of 20 mM EDTA, as described (Dominski et al., 
1999).  The efficiency of degradation was calculating by comparing the amount of the 
released radioactive mononucleotide to the input substrate used in the reaction.  The 
U7-dependence of processing and degradation reactions was determined by using 100 
ng of an anti-M oligonucleotide that is complementary to the first 17 nucleotides of the 
mammalian U7 snRNA (Dominski et al., 2005b). A 2’O-methyl anti-D oligonucleotide 
directed to the first 19 nucleotides of the Drosophila U7 snRNA was used at the same 
concentration as a negative control (Dominski et al., 2005b).  In some reactions, the 
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U7-dependence was also confirmed by using 500 ng (a 1,000-fold excess relative to 
the labeled substrate) of an RNA containing the wild type sequence of the HDE (wtHDE 
RNA).  A corresponding RNA containing a 4-nucleotide mutation replacing the AAGA 
with UUCU within the HDE (mutHDE) was used at the same concentration as a 
negative control.  Processing and degradation reactions were inhibited by NP-40 at a 
final concentration of 0.05%.   
Analysis of processing products.  After 90 min incubation, processing reactions 
were treated for 1 hour with proteinase K at 0.5 μg/μl, diluted 5 times with a 7M urea 
dye and analyzed in low resolution 8% polyacrylamide/7M urea gels to asses the 
reaction efficiency.  The same samples were additionally analyzed in high resolution 
gels allowing for separation fragments that differ by one nucleotide.  
Mononucleotides containing a phosphate at the 5’ end were identified by 
electrophoresis in 12% gels based on co-migration with mononucleotides generated 
by S1 nuclease, which leaves a 5’ phosphate, or products of KOH hydrolysis, which 
migrate 0.5 nucleotide faster due to the presence of an additional phosphate at the 
3’ end.  The length of larger products was determined in high resolution 8% gels by 
comparison with appropriate size markers containing the same sequence (5’ labeled 
RNAs used for ligation) or with products of partial KOH hydrolysis.  In other cases, 
the length of final processing products was determined by comparison with the 
length of processing intermediates generated due to random stalling of the U7-
dependent exonuclease at each nucleotide.  
Xrn1 ribonuclease assay.  The activity of yeast Xrn1 was tested in a buffer containing 
30 mM Tris-HCl at pH 8.2, 2 mM MgCl2, 50 mM NH4Cl, 0.5 mM DTT, and 20 μg/ml 
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bovine serum albumin, as described (Mathy et al., 2007).  Each reaction contained 1 ng 
of an RNA substrate and 10 ng of Xrn1 in a final volume of 10 μl and was incubated at 
32o C for 15 min. 
RNA interference.  RNAi was performed using a two-hit method(Wagner and 
Garcia-Blanco, 2002).  Briefly, 7x106 HeLa cells were plated into 24-well plates and 
transfected with 3 µL of 20 µM stock siRNAs (Xrn2-1, Xrn2-2, or a combination of 
both) 24 hours later.  A day after the first siRNA treatment, cells were split 1:3 into 6-
well plates and after another 24 hours were retransfected with 4 µL of siRNA.  72 
hours after the second transfection, samples were collected either by addition of 
Trizol (Invitrogen) or NP-40 lysis buffer directly to the wells.  siRNA target sequences 
in the human Xrn2 mRNA were GGGAAGAAAUAUUGGCAA (Xrn2-1) and 
AAGAGUACAGAUGAUCAUG (Xrn2-2).   
qRT-PCR.  2.5µg of total cell RNA was treated with DNase (Promega) and reverse 
transcription reactions were performed with MMLV-RT (Invitrogen) using random 
hexamers to prime the cDNA.  cDNA from the reaction was added directly to qPCR 
reactions containing 2X SYBR GREEN PCR Master Mix (Applied Biosystems) and 
oligonucleotide primers.  PCR was performed using a 7900HT PCR System (Applied 
Biosystems) and data were analyzed using SDS 3.2 software (Applied Biosystems).  
The oligonucleotides used were:  Hist2H2AA 3’ End F: 
GGAGCAGTACGGCCTGGAT, Hist2H2AA 3’ End R: 
CGACGAGGAACTGAACAAGCT, Hist2H2AA #1 Downstream F: 
GGGACCCACTCATCGAAGAG, Hist2H2AA #1 Downstream R: 
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CGCGCCGTCTTCCATCT, Hist2H2AA #2 Downstream F: 
CCAGGGCGCTTTGGAAA,  
Hist2H2AA #2 Downstream R: GAGCTGGGTCTTGGCTTCAC, GAPDH 3’ End F: 
CCGCACCTTGTCATGTACCA, GAPDH 3’ End R: 
CCCTAGAATAAGACAGGACAAGTAACTG, GAPDH Downstream F: 
TCGCTCCAGTCCTAGGCTATCT, GAPDH Downstream R: 
GGCTGCCCACAGAATAGCTT. 
 
Results 
The U7-dependent degradation of the DCP+1 substrate containing a site specific 
radioactive phosphate.   
 To study 3’ end processing of histone pre-mRNAs in vitro Zbig and Xiao use an 
86-nucleotide derivative of the mouse H2a-614 pre-mRNA that contains all necessary 
processing elements, including the stem-loop and the HDE (Fig. 18A).  The H2a 
substrate labeled by random incorporation with 32P UTP is processed in a mouse 
nuclear extract to an upstream cleavage product containing the stem-loop, and to 5’ 
monophosphate nucleosides that result from the degradation of the downstream 
cleavage product (DCP) (Fig. 18B, lane 2)(Dominski et al., 2005b).  3’ end processing 
of histone pre-mRNAs proceeds in the presence of 20 mM EDTA, which inhibits 
virtually all nonspecific nucleases present in the mouse nuclear extract.  Blocking the 5’ 
end of the U7 snRNA by a complementary 2’-O-methyl oligonucleotide (anti-M) at 10 
ng/μl prevents binding of the U7 snRNP to the RNA substrate and abolishes 
processing (Fig. 18B, lane 3).  A 2’O-methyl oligonucleotide with an unrelated 
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sequence targeted to the 5’ end of the Drosophila U7 snRNA (anti-D), routinely used at 
the same concentration to measure the extent of nonspecific effects, does not affect 
processing (not shown).  A synthetic RNA substrate with a sequence corresponding to 
the DCP or extended at the 5’ end by one or more nucleotides are also degraded in a 
U7-dependent manner in nuclear extracts from mammalian (Dominski et al., 2005b; 
Walther et al., 1998) and Drosophila cells (Dominski et al., 2005a).  Thus, the 
degradation of the DCP can be uncoupled from the endonucleolytic cleavage of histone 
pre-mRNA. 
 In their previous studies Zbig and Xiao used a DCP+1 RNA labeled at the 5’ end 
with a radioactive phosphate (Dominski et al., 2005a).  The U7-dependent degradation 
of this substrate was monitored by the accumulation of 32P labeled mononucleotide.  
Since substrates labeled at the 5’ end have a number of limitations, including the 
inability to follow degradation further into the body of the RNA, in the current studies 
Zbig and Xiao used a DCP+1 RNA containing a single internal radioactive phosphate.  
The 39-nucleotide DCP+1 RNA was constructed by ligating an 18-nucleotide upstream 
fragment (U. Half) with a 5’ labeled 21-nucleotide downstream fragment (D. Half) (Fig. 
18C).  The DCP+1 RNA contained a hydroxyl group at the 5’ end and a single 
radioactive phosphate between residues 17 and 18 of the DCP, near the center of the 
HDE.  Incubation of this RNA in a mouse nuclear extract under standard conditions (20 
mM EDTA) resulted in a release of the labeled mononucleotide from the body of the 
RNA with a small amount of the product visible after 5 min incubation (Fig. 18D, lanes 
1-5).  The nuclease functions processively since no intermediates were detected during 
the 60 min reaction.  The anti-M oligonucleotide at 10 ng/μl blocked degradation of the 
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DCP+1 substrate whereas the anti-D oligonucleotide at the same concentration had no 
effect (Fig. 18D, lanes 6-8) demonstrating that nuclease activity depends specifically on 
binding of the U7 snRNP to the HDE.   
 In order to release the radioactive nucleotide, the nuclease had to remove nearly 
half of the HDE that is required to recruit the U7 snRNP.  Zbig and Xiao carried out a 
competition experiment to determine whether RNAs containing only partial HDE 
sequences can bind the U7 snRNP and therefore inhibit processing of the H2a-614 
pre-mRNA.  Zbig and Xiao used the downstream and the upstream DCP halves (D. 
Half and U. Half, respectively) (Fig. 18C), each at a 1,000-molar excess over the pre-
mRNA substrate.  Neither the D. Half nor the U. Half RNAs, containing 9 and 6 
nucleotides of the HDE, respectively affected the processing of the pre-mRNA 
substrate (Fig. 18E, lanes 5 and 6).  In contrast, the same molar excess of the DCP+1 
RNA containing the entire HDE prevented cleavage of the H2a-614 pre-mRNA (Fig. 
18E, lane 4).  Thus, the removal of the first six nucleotides of the HDE during the 
degradation of the DCP likely displaces the U7 snRNP from the RNA substrate.  Zbig 
and Xiao also tested whether 5’ labeled D. Half and U. Half RNAs can be degraded in a 
mouse nuclear extract in a U7-dependent manner.  Consistent with the inability of 
partial HDE sequences to bind the U7 snRNP, neither substrate generated U7-
dependent degradation products (not shown).  
 In Fig. 17C the DCP+1 substrate was labeled internally with a single radioactive 
phosphate and contained a hydroxyl group at the 5’ end.  The fact that this substrate 
was efficiently degraded demonstrates that the U7-dependent nuclease does not 
require a phosphate at the 5’ end.  To determine whether the addition of a 5’ phosphate 
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can stimulate the degradation efficiency, Zbig and Xiao incubated the DCP+1 RNA with 
T4 polynucleotide kinase and unlabeled ATP and tested the resulting 5’ phosphorylated 
substrate in a nuclear extract.  The efficiency of degradation was not significantly 
increased indicating that the U7-dependent nuclease activity does not prefer substrates 
with a 5’ phosphate.   
The exonuclase degrades a substrate containing a radioactive phosphate 
downstream of the HDE.   
 The above experiments demonstrated that the U7-dependent 5’ exonuclease 
can remove at least the first 19 nucleotides of the DCP+1 RNA releasing labeled 5’ 
UMP.  To determine whether the exonuclease can progress further into the body of the 
RNA substrate to remove the entire U7 binding site Zbig and Xiao used a 60-nucleotide 
substrate (3’extDCP) created by ligating the DCP+1 RNA to a 5’ labeled 21-nucleotide 
RNA designated 3’ext.  In the 3’extDCP substrate the only radioactive phosphate was 
located 12 nucleotides downstream of the 3’ end of the HDE (Fig. 19A).  Incubation of 
the 3’extDCP substrate in a mouse nuclear extract resulted in a U7-dependent 
accumulation of labeled 5’ AMP indicating that the 5’ exonuclease can remove at least 
40 nucleotides from the 5’ end (Fig. 19B, lane 6), progressing completely through the 
HDE and displacing the U7 snRNP.  Compared to the degradation of the DCP+1/m19 
(Fig. 19B, lane 2), the degradation of the 3’extDCP was less efficient.  Since the two 
substrates have the same sequence for the first 39 nucleotides, including the HDE, the 
most likely explanation for the inefficient degradation of the 3’extDCP is an inhibitory 
effect of the additional 21 nucleotides located at the 3’ end on the recruitment of the U7 
snRNP (see also below).  As observed for other substrates, the degradation efficiency 
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of the 3’extDCP substrate can be significantly improved by the presence of a high 
excess of the mutHDE RNA (Fig. 19B, lane 12). 
Switching between the 5’ exonuclease and endonuclease modes.   
 In Zbig and Xiao previous study we used a DCP substrate that was extended at 
the 5’ end by 5 nucleotides and contained a phosphorothioate modification at the 
cleavage site (Dominski et al., 2005b).  This substrate, previously called HDE+5/s and 
renamed here to DCP+5/scs (Fig. 20A), when labeled at the 5’ end and incubated in a 
mouse nuclear extract yielded labeled mononucleotide diagnostic of the 5’ exonuclease 
(Dominski et al., 2005b).  There was no detectable 5-nucleotide fragment produced 
demonstrating that this substrate is not cleaved endonucleolytically (Dominski et al., 
2005b).  In the nuclear extract used in these studies, incubation of the DCP+5/scs 
substrate again predominantly yielded labeled mononucleotide (Fig. 20B, lane 1). One 
explanation for the predominant 5’ exonucleolytic degradation was that the presence of 
phosphorothioate at the cleavage site makes endonucleolytic attack by CPSF73 less 
favorable than cleavage at the most proximal bond lacking any modification.  To test 
this possibility Zbig and Xiao designed a new substrate, DCP+5/s5’, containing a 
phosphorothioate modification at the first phosphodiester bond rather than within the 
cleavage site (Fig. 20A).  However, also this substrate was nearly exclusively cleaved 
after the first nucleotide releasing labeled mononucleotide.  These results indicate that 
CPSF73 preferentially utilizes the 5’ exonucleolytic mode of its activity if a substrate 
contains only five nucleotides upstream of the cleavage site.  To determine whether the 
predominant cleavage after the first nucleotide results from the inherent inability of the 
DCP+5 substrate to undergo endonucleolytic cleavage, Zbig and Xiao next analyzed 
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the pattern of degradation of DCP+5/m5’ RNA in which the first nucleotide was modified 
by a 2’-O-methyl group (Fig. 20A).  This modification renders phosphodiester bonds 
fully resistant to hydrolysis by CPSF73 and hence it was expected to block the 5’ 
exonuclease activity.  The U7-dependent products generated by incubation of this 
substrate in a nuclear extract were resolved by high resolution gel electrophoresis next 
to products of complete digestion of the same RNA by yeast 5’ exoribonuclease Xrn1 
and endonuclease S1 (Fig. 20B, lanes 3 and 4).  These two nucleases generate a 
phosphate at the 5’ end and thus their products serve as appropriate size markers for 
the CPSF73 generated products.  To unambiguously determine the size of the 
degradation products Zbig and Xiao also used a mixture of two chemically synthesized 
fragments: mACC and mACCC (Fig. 20B, lane 6).  As expected, degradation of the 
DCP+5/m5’ RNA in the nuclear extract did not release labeled mononucleotide and 
instead generated a group of major U7-dependent products consisting of 2, 3 and 4 
nucleotides (Fig. 20B, lane 2).  There was also a small amount of a 5-nucleotide 
product (arrow) that resulted from hydrolysis at the natural endonucleolytic cleavage 
site.  Interestingly, as judged by the accumulation of labeled mononucleotide, the first 
phosphodiester bond in the DCP+5/m5’ RNA was readily hydrolyzed by Xrn1 (Fig. 20B, 
lane 3).  This could be a biologically relevant feature of Xrn1 5’ exonuclease as many 
mRNAs that are degraded by Xrn1 in vivo contain 2’ O-methyl modified nucleotides 
near the 5’ end as a part of the cap structure.  We conclude that CPSF73 strongly 
prefers to cleave after the first nucleotide of the DCP+5 RNA although it is also 
inherently capable of cleaving this substrate endonucleolytically.   
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 The minimal H2a pre-mRNA substrate that we routinely use to analyze 3’ end 
processing in vitro contains 38 nucleotides upstream of the cleavage site, including the 
stem-loop (Fig. 18A).  To determine the minimal length upstream of the cleavage site 
that allows endonucleolytic cleavage, Zbig and Xiao constructed DCP+10 (Fig. 20A) 
and DCP+15 (Fig. 20C) RNA substrates.  In these substrates, the cleavage site was 
preceded by 10 or 15 nucleotides found in the same position in the H2a pre-mRNA 
(Fig. 18A).  Incubation of the DCP+10 substrate with a mouse nuclear extract yielded a 
U7-dependent product that migrated significantly slower than mononucleotides (Fig. 
20C, lane 3).  Generation of each product was blocked by the anti-M oligonucleotide 
thus it was dependent on the U7 snRNP (Fig. 20C, lane 4).  Electrophoresis in a high 
resolution gel next to appropriate size markers revealed that DCP+10 was cleaved 
endonucleolitycally within the expected site generating a 10-nucleotide product (Fig. 
20D, lane 5).  The DCP+15 RNA was also cleaved endonucleolytically generating a 15 
nucleotides long product {I would put this in the paper (Fig. 20D, lane 3).   
 Thus cleavage is endonucleolytic if the 5’ end of the transcript extends 21 nt of 
the start of the HDE, and exonuclolytic if the 5’ end of the transcript extends between 9 
and 16 nts 5’ of the HDE.  Consistent with previously published results (Mowry et al., 
1989), no secondary structure is required for endonucleolytic cleavage.  The cleavage 
site is the same as found in the histone pre-mRNA, consistent with the previous 
demonstration  (Scharl and Steitz, 1994) that the position of the HDE (and hence the 
U7 snRNP) determines the cleavage site. 
Xrn2 knockdown stabilizes downstream products in GAPDH but not histone pre-
mRNAs in vivo.  
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  According to the “torpedo model” for termination of transcription by RNA 
polymerase II on polyadenylated mRNAs, degradation of the downstream cleavage 
product in the nascent transcript promotes release of the RNA polymerase II from the 
DNA template resulting in termination of transcription (Buratowski, 2005b; Luo and 
Bentley, 2004; Rosonina et al., 2006; Tollervey, 2004).  In support of this model, the 
nuclear 5’ to 3’ exonuclease Xrn2 has been implicated in transcription termination in 
yeast and mammalian cells (Kaneko et al., 2007; Kim et al., 2004; Luo et al., 2006b; 
West et al., 2004).  Our in vitro results suggest that CPSF 73 rather than Xrn2 could be 
the 5’ exonuclease that degrades the downstream cleavage product in histone pre-
mRNAs in vivo potentially promoting termination of transcription.  To test this 
possibility, I used two different siRNAs targeted to the Xrn2 mRNA and efficiently 
reduced the level of Xrn2 in HeLa cells (Fig. 21A, lanes 2-4).  I analyzed the effect of 
knockdown of Xrn2 on the downstream cleavage products of both the polyadenylated 
GAPDH transcript and the Hist2H2AA transcripts.  Each of these genes is quite close 
to another gene and hence transcription termination must occur within ~1000 
nucleotides of the 3’ cleavage site (Fig. 21A).  The transcription termination site of the 
mouse orthologue of the Hist2H2AA gene has been mapped about 600 nucleotides 
after the cleavage site (Chodchoy et al., 1991).  I designed oligonucleotides that target 
a region of the GAPDH pre-mRNA 233-295 nucleotides downstream from the cleavage 
site as well as primers sets which target regions 140-197 and 457-526 nucleotides 
downstream of the Hist2H2AA cleavage site (Fig. 21B).  To determine the relative 
amounts of the downstream cleavage product to the mature mRNA I also used 
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oligonucleotides which amplify target sequences upstream of the 3’ cleavage site in 
each transcript (3’ end regions). 
To determine what effect Xrn2 knockdown had on stabilization of downstream 
products of GAPDH and Hist2H2AA pre-mRNAs, qRT-PCR was performed.  
Relative amounts of downstream products were determined by comparing CT values 
of downstream PCR reactions with those of the 3’ end reactions for each knockdown 
and normalizing these to the values from control treated cells.  Typically, I observed 
a difference in CT values of about 8 cycles between the downstream fragment and 
the 3’ fragment from the mRNA in control cells, implying the concentration of the 
downstream fragment was between 0.1 and 1% mature mRNA, and the levels of the 
mature mRNA did not change in the Xrn2 knockdown cells.  This analysis allowed 
me to determine ΔΔCT values which represent relative differences in the amounts of 
downstream products in the knockdowns compared to control cells.  Negative values 
denote fewer cycles for the PCR reaction to reach the threshold value in knockdown 
cells than control cells, indicating that was a higher concentration of the RNA 
species in the sample.  I used two different siRNAs against Xrn2 as well as a mixture 
of the two, and they all reduced with Xrn2 levels, with the combination being most 
effective (Fig. 21B, lane 2).  Xrn2 knockdown had little effect (less than 1 cycle 
difference) on the amounts of Hist2H2AA downstream products (Fig. 21C).  In 
contrast, there was a substantial increase in the amount of downstream product from 
the GAPDH transcript (indicative of its stabilization) in all three knockdowns of Xrn2.  
Knockdown of Xrn2 with either individual siRNA resulted in a stabilization of ~2 
cycles while the combination knockdown revealed a change of 4 cycles (Fig. 21C), 
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consistent with the degree of knockdown of Xrn2 observed by Western blotting.  
Taken together, these data indicate the Xrn2 is involved in the degradation of the 
GAPDH downstream product but not the Hist2H2AA downstream products.  This is 
consistent with the possibility that the 5’ exonuclease activity of CPSF73 (and not 
Xrn2) is involved in degradation of the downstream product after cleaving the pre-
mRNA.  Note that knockdown of any component of the 3’ end processing machinery 
would result in the increase of the downstream fragment due to failure to process the 
pre-mRNA, and hence direct analysis of the effect of knocking down of CPSF73 is 
not possible.   
Thus our results strongly support the idea that CPSF73 is responsible for 
endonuclolytic cleavage, and then processive degradation of the downstream 
fragment assisting in the termination of transcription by RNA polymerase II.  
Discussion 
The U7-dependent nuclease degrades the downstream cleavage product in the 5’ 
to 3’ direction and stalls at modified nucleotides.   
 Histone pre-mRNAs are cleaved at the 3’ end by a multi-component processing 
machinery that includes the U7 snRNP bound to a region downstream of the cleavage 
site (Dominski and Marzluff, 2007).   Following cleavage in vitro, the downstream 
cleavage product (DCP) is rapidly degraded to mononucleotides by a nuclease that 
also depends on the U7 snRNP.  To demonstrate that degradation is carried out by a 5’ 
to 3’ exoribonuclease Zbig and Xiao incorporated differently modified nucleotides into 
specific sites in the DCP RNA: 2’-O-methyl nucleotides, deoxynucleotides and 
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phosphorothioate nucleotides.  Each modification resulted in the accumulation of 
intermediate products whose size clearly demonstrated that degradation begins from 
the 5’ end and stalls at the modified nucleotide, thus it behaves as a typical 5’ 
exonuclease.  The strongest block was created by a 2’-O-methyl modification, which 
nearly completely stopped progression of the exonuclease.  A single deoxynucleotide 
located in the same position was relatively well tolerated by the U7-dependent 
exonuclease whereas the phosphorothioate modification had an intermediate ability to 
block the degradation of the DCP.   
 The U7-dependent 5’ exonuclease activity is processive and proceeds past the 
HDE, suggesting that it can readily displace the U7 snRNP from the substrate.  Thus, 
binding of the U7 snRNP to the HDE is only required to recruit the 5’ exonuclease and 
initiate degradation.  It is not known whether the exonuclease acts by itself to displace 
the U7 snRNP or requires assistance from other proteins present in the nuclear extract.  
However, given that the reaction occurs in the presence of EDTA, the involvement of a 
conventional helicase in unwinding the RNA duplex formed between the U7 snRNA 
and the HDE seems unlikely.  
The distance of the 5’ end of the transcript from the HDE determines whether 
CPSF73 acts as an endonuclease or an exonuclease.    
 UV-cross-linking studies strongly suggest that the downstream cleavage 
product is degraded by CPSF73.  Cross-linking of this protein to the first scissile 
bond in the DCP RNA was dependent on the U7 snRNP, but also perfectly 
correlated with the efficiency of degradation. CPCF-73 was also cross-linked to the 
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DCP-2/s RNA that contains only 9 nucleotides upstream of the HDE and 
corresponds to a substrate partially truncated from the 5’ end.   
 Initiation of exonucleolytic degradation occurs when the 5’ end of the 
substrate is between 9 and 16 nts 5’ of the start of the HDE.  A substrate that 
contains 21 nts 5’ of the HDE is cleaved endonucleolytically (with the downstream 
cleavage product subsequently degraded exonucleolytically).  Surprisingly, a DCP 
derivative containing 16 nucleotides 5’ of the start of the HDE (DCP+5), and which 
contains the normal endonucleolytic cleavage site, ACCCA, was also degraded from 
the 5’ end.  Endonucleolytic cleavage of this substrate could be activated by blocking 
degradation from the 5’ end of the DCP+5 RNA with a 2’O-methyl group.  Thus, 
CPSF73 preferentially uses the 5’ exonuclease mode on the DCP+5 RNA although it 
is intrinsically capable of cleaving this substrate endonucleolytically. Interestingly, as 
many as four major sites located close to the 5’ end were cleaved upon blocking the 
5’ end of the DCP+5, with the natural cleavage site being used only rarely.  Thus, 
the processing complex assembled on the DCP+5 substrate leaves CPSF73 
flexibility in selecting sites for endonucleolytic cleavage.  Importantly, exclusive 
cleavage at the correct site was achieved by adding 5 more nucleotides to the 5’ end 
of the DCP+5 RNA (DCP+10 substrate) instead of blocking this end by a 2’O-methyl 
group.  Perhaps, the region upstream of the cleavage site in the DCP+10 substrate 
is sufficiently long to interact with a component of the processing machinery, or with 
a site on CPSF73 itself, which may stabilize its interaction with CPSF73 directing 
cleavage to the correct site.  An important role in preventing the 5’ exonuclease 
mode in processing of the DCP+10 RNA may also be played by the fact that the 5’ 
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end is located too far away from the HDE and thus not easily accessible for 
CPSF73.  Similarly, if the number of nts 5’ of the start of the HDE is 7 or less, the 
substrate is not degraded, suggesting that CPSF73 cannot bind these substrates 
and initiate degradation (although it readily degrades these substrates during 
processive , exonucleolytic degradation of the DCP.  Thus failure to degrade these 
substrates is du to the inability to initiate degradation.  
Two critical observations argue against the possibility that the two known and 
closely related 5’ exonucleases, Xrn1 and Xrn2, are directly responsible for the in vitro 
degradation of the DCP in histone pre-mRNA.  First, both Xrn1 and Xrn2 depend on 
divalent ions and are completely inactivated by low concentrations of EDTA (Solinger et 
al., 1999; Stevens and Poole, 1995).  Second, the 5’ exonuclease activity of Xrn1 or 
Xrn2 requires the presence of a 5’phosphate (Solinger et al., 1999; Stevens, 1978; 
Stevens, 1980; Stevens and Poole, 1995).  We confirmed that these two features 
indeed characterize Xrn1 from S. cerevisiae (a gift from L. Benard and C. Condon) 
using a set of our RNA substrates (data not shown).  In contrast to Xrn1 and Xrn2 
nucleases, the U7-dependent 5’ exonuclease efficiently degrades substrates containing 
a 5’ hydroxyl.   
While the U7-dependent activity degrading the DCP in histone pre-mRNA differs 
from the Xrn 5’ exonucleases, it is similar to RNase J1, which together with CPSF73 
belong to the β-CASP subfamily of the metallo-β-lactamase proteins (Callebaut et al., 
2002; Mandel et al., 2006).  RNase J1 was initially characterized as an endonuclease 
involved in processing of mRNA precursors in Bacillus subtilis (Even et al., 2005) and 
subsequently shown to also function as a 5’ to 3’ exonuclease in mRNA degradation 
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and rRNA processing (Mathy et al., 2007b).  The ability to act as both an endonuclease 
and a 5’ to 3’ exonuclease is also shared by DNA-specific nucleases of the β-CASP 
subfamily; Artemis, Apollo and Snm1 (Dominski, 2007).  Altogether, this analysis 
strongly supports the notion that CPSF73 possesses both endonuclease and 5’ 
exonuclease activities. 
In contrast to our results, a bacterially expressed N-terminal fragment of human 
CPSF73 functions only as an endonuclease and fails to degrade RNA substrates in the 
5’-3’ direction (Mandel et al., 2006).  One explanation is that the 5’ exonuclease activity 
of CPSF73 requires an assistance of a second component of the processing complex 
and can be only observed in nuclear extracts or reconstituted systems.  It is also 
possible that the 5’ exonuclease (but not the endonuclease) activity of CPSF73 vitally 
depends on the C-terminal portion of the protein.  This interpretation is supported by 
recent crystallographic studies, which demonstrated the importance of the C-terminal 
domain for the activity of RNase J1 (de la Sierra-Gallay IL et al., 2008). 
 Previously, an activity that degrades the DCP during histone pre-mRNA 
processing has been identified in mammalian nuclear extracts by Walther et al 
(Walther et al., 1998).  In contrast to our studies, this activity stalled at guanine 
nucleotides and hence generated a family of fragments trimmed at the 5’ end rather 
than mononucleotides.  Further studies are required to determine its relation to 
CPSF73 although the dependence on the U7 snRNP and resistance to EDTA 
suggest that the two activities represent the same enzyme.  
Xrn2 is not required for degradation of the DCP in histone pre-mRNA in vivo. 
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  Recent in vivo and in vitro studies demonstrated that the degradation of the 
downstream cleavage product during cleavage/polyadenylation involves the well 
characterized 5’ exonuclease, Xrn2 (Kaneko et al., 2007; Kim et al., 2004; Luo et al., 
2006a; West et al., 2004).  I demonstrated that downregulation of Xrn2 by RNAi 
does not result in significant stabilization of the downstream cleavage product 
generated from the Hist2H2AA transcript while as expected the corresponding 
product from the transcript encoding GAPDH was in the same cells was stabilized by 
knocking down Xrn2, inagreement with previous studies of polyadenylated mRNAs 
(Luo et al., 2006a; West et al., 2004).  Thus, it is likely that the 5’ exonuclease 
activity of CPSF73 degrades the DCP in histone pre-mRNA also in vivo while the 
same function for all other protein-encoding transcripts is carried out by Xrn2.  The 
difference may reflect the fact that 3’ end processing of conventional pre-mRNAs is 
controlled by the upstream AAUAAA signal, which recruits CPSF subunits, including 
CPSF73 (Murthy and Manley, 1995), whereas in 3’ end processing of histone pre-
mRNA the recruitment of CPSF73 critically depends on the downstream HDE, which 
interacts with the U7 snRNP.  Following processing of histone pre-mRNA CPSF73 
likely remains associated with the U7 snRNP and is perfectly positioned to use its 
preferential 5’ exonuclease activity to degrade the downstream cleavage product.  In 
polyadenylated mRNAs, the CPSF73 remains associated with the rest of CPSF and 
the upstream product while it is undergoing polyadenylation.  It is possible that Xrn2 
plays a supportive role in the degradation process by acting on histone transcripts 
after random dissociation of CPSF73.  This interpretation is consistent with our in 
vivo results demonstrating that the most distal region of the histone transcript is 
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moderately stabilized by siRNA-mediated depletion of Xrn2, although the levels of 
the region 200 nts from the cleavage site is not altered by Xrn2 (Fig. 21C).    
 One obvious function for the 5’ exonuclease activity of CPSF73 in vivo may 
be to degrade the region immediately downstream of the cleavage site and therefore 
to liberate the U7 snRNP from its base pairing association with the HDE for another 
round of 3’ end processing, as previously suggested (Walther et al., 1998).  
Moreover, an attractive possibility is that the CPSF73 continues degradation into 
more downstream regions of the nascent histone pre-mRNA ultimately resulting in 
the displacement of RNA polymerase II from the DNA template and termination of 
transcription, as postulated for Xrn2 in the torpedo mechanism.  Indeed, mutations 
within the 3’ end processing elements in histone pre-mRNAs, the stem-loop and the 
HDE, prevent transcription termination in vivo (Chodchoy et al., 1991), suggesting 
that as in cleavage/polyadenylation (Buratowski, 2005b) 3’ end processing of histone 
pre-mRNA is functionally linked to the release of RNA polymerase II from histone 
genes.   
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Figure 18.  The U7-dependent degradation of the downstream cleavage 
product generated during 3’ end processing of histone pre-mRNAs.  A.  A 
fragment of the 86-nucleotide mouse histone H2a pre-mRNA substrate 
encompassing processing elements (top sequence) and the base pair interaction 
between the HDE (indicated with a thick line) and the U7 snRNA (bottom sequence).  
The cleavage site and the downstream cleavage product (DCP) are indicated with 
an arrowhead and a double arrowed line, respectively.  The Sm site in the U7 
snRNA is indicated with a box.  B.  In vitro processing of the internally labeled 86-
nucleotide H2a substrate in a mouse nuclear extract (NE) under control conditions 
(lane 2) or in the presence of an oligonucleotide blocking the U7 snRNA (anti-M, 
lane 3).  Lane 1 contains the unprocessed input pre-mRNA (Unproc).  The 48-
nucleotide processing product (Proc) results from cleavage of the input after the fifth 
nucleotide 3’ of the stem-loop.  C.  The sequence of the DCP+1 RNA containing a 
single radioactive phosphate between nucleotides 17 and 18 of the DCP sequence 
(see Materials and Methods for the terminology used to designate RNA substrates).  
The DCP+1 RNA was constructed by ligating the upstream and the downstream 
halves, with the downstream half containing the radioactive phosphate at the 5’ end 
(indicated with an asterisk).  The HDE interacting with the U7 snRNA is underlined.  
D.  A 60-min time course of the U7-dependent degradation of the DCP+1 RNA in a 
mouse nuclear extract (lanes 1-5) and the effect of an oligonucleotide blocking either 
the mouse U7 snRNA (anti-M, lane 7) or Drosophila U7 snRNA, used as a 
nonspecific control (anti-D, lane 8).  E.  In vitro processing of the 5’ labeled H2a-614 
pre-mRNA either under control conditions (lane 2) or in the presence of a 1,000-fold 
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molar excess of RNA competitors containing either complete (lane 4) or partial HDE 
(lanes 5-6).  Processing shown in lane 3 was carried out in the presence of the anti-
M oligonucleotide.  
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Figure 19.  Degradation of the 3’extDCP RNA containing a single radioactive 
phosphate downstream of the HDE.  A.  The sequence of the 60-nucleotide 
3’extDCP RNA.  The HDE is underlined and the position of the radioactive 
phosphate is indicated with an asterisk.  The 3’ext RNA is indicated with a double 
arrowed line.  B.  The U7-dependent degradation of the 3’extDCP RNA under 
control conditions (lane 6 and 10) or in the presence of various RNA competitors, as 
indicated at the top of each lane.  The degradation efficiency for the DCP+1/m19 
RNA (Fig. 3A) is shown in lanes 1-4 for comparison. 
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Figure 20.  Switching between the 5’ exonuclease and endonuclease modes.  A.  
The sequence of DCP derivatives extended at the 5’ end by 5 or more nucleotides and 
labeled at the 5’ end (asterisk).  The position of phosphothioate (s) and 2’O-methyl (m) 
modifications are indicated.  B.  A high resolution gel analysis of the U7-dependent 
products generated by incubation of the DCP+5/scs (lane 1) and DCP+5/m5’ (lanes 2 
and 5) substrates in a mouse nuclear extract.  Lanes 3 and 4 contain products of 
complete digestion of the DCP+5/m5’ RNA with the yeast Xrn1 5’ exonuclease or S1 
nuclease, respectively.  Lane 6 contains a mixture of two synthetic oligonucleotides 
labeled at the 5’ end, mACCC and mACCC that serve as size markers.  C.  The U7-
dependent cleavage of the DCP+10 substrate under control conditions or in the 
presence of the anti-U7 oligonucleotides, as indicated.  Degradation of the DCP-2/s 
(lane 1) substrate is shown to indicate the position of mononucleotides. 
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Figure 21 
Xrn2 is not required for degradation of Hist2H2AA downstream cleavage 
product in vivo.  A.  siRNA-mediated downregulation of Xrn2 in HeLa cells.  
Individual Xrn2-1 and Xrn2-2 siRNAs (lanes 3 and 4) as well as their combination 
(lane 2) were used to reduce levels of Xrn2.  HeLa cells were collected 72 hours 
after second siRNA transfection and subjected to Western blot analysis using an α-
Xrn2 antibody.  A cross-reacting band detected with the Xrn2 antibody serves as the 
loading control.  B.  Probe design for qRT-PCR.  Primers were designed to probe 
regions within the mature mRNAs (3’ End) of both GAPDH and Hist2HAA for 
normalization purposes.  Additional oligonucleotide sets were designed targeting 
regions 140-197 nucleotides and 457-526 nucleotides downstream of Hist2H2AA 
cleavage site (H2A #1 Downstream and H2A #2 Downstream, respectively) as well 
as a region 233-295 nucleotides downstream of the GAPDH cleavage site (GAPDH 
downstream).  C.   HeLa cells were treated as in (A) and RNA prepared by Trizol 
extraction.  RT reactions were performed using MMLV-RT and resultant cDNAs 
were subjected to qPCR using primers described in (B).  ΔΔCT values were 
calculated using the equation (CTsiRNADownstream-CTsiRNA3’End)-(CTControlDownstream-
CTControl3’End) where CTsiRNADownstream and CTsiRNA3’End represent CT values for a 
given siRNA treated sample amplified with the indicated primer set and 
CTControlDownstream and CTControl3’End represent CT values for control treated 
samples amplified using the same indicated primer set.  The absolute CT value for 
the fragment within both the GADPH and histone mRNAs varied by less than one 
cycle among the different samples, indicating there was not a significant change in 
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either mature mRNA as a result of the siRNA treatments.  A negative ΔΔCT value 
indicates the treatment resulted in an increase in the relative amount of the RNA 
fragment.  The results are an average of 3 independent experiments.   
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Chapter 4 
SLBP Knockdown Results in Nuclear Retention of Histone mRNA 
INTRODUCTION 
 The replication-dependent histone mRNAs are the only eukaryotic cellular 
mRNAs that are not polyadenylated, ending instead in a conserved stemloop 
(Marzluff, 2005).  These mRNAs lack introns and undergo a single processing 
reaction cleaving the nascent pre-mRNA from the DNA template, and producing the 
mature mRNA. The cleavage reaction requires the stem loop (SL) 5’ of the cleavage 
site and a purine-rich region, the histone downstream element (HDE), located about 
10 nts 3’ of the cleavage site.  The HDE basepairs with the U7 small nuclear RNA, 
which is a component of the U7snRNP (Mowry and Steitz, 1987).  The stem loop 
binding protein (SLBP) binds to the SL and helps stabilize the interaction of U7 
snRNP with the pre-mRNA. Several lines of evidence support this model.  Pulldown 
of biotinylated histone pre-mRNA from nuclear extracts results in the concomitant 
pulldown of the U7snRNA (Dominski et al., 1999; Dominski et al., 2001) which is 
enhanced by SLBP.  In vitro processing of histone pre-mRNA is absolutely 
dependent on SLBP if the HDE does not interact strongly with U7snRNA    
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(Dominski et al., 1999).  The factor ZFP100 interacts with both the SLBP/SL 
complex (Dominski et al., 2002) as well as the U7snRNP specific Sm-like protein 
Lsm11 (Azzouz et al., 2005; Wagner et al., 2006) and is limiting for histone pre-RNA 
processing in vivo (Wagner and Marzluff, 2006).  Mutations in the stemloop that 
abolish binding of SLBP result in no expression of processed histone mRNA in vivo 
(Pandey et al., 1994). 
 The requirement of SLBP for in vitro processing of histone pre-mRNA in 
nuclear extracts from mammalian cells on many substrates is not absolute.  Extracts 
depleted of SLBP are incapable of processing the H1t histone pre-mRNA but are 
competent to process the H2A-614 histone pre-mRNA (Dominski et al., 1999).  The 
differences between these two substrates is that U7snRNP basepairs more 
extensively with the HDE of H2A-614 than with the H1t HDE.  
 Once the U7snRNP is bound to the HDE, a cleavage factor is recruited 
containing at least CPSF73, (Dominski et al., 2005b) and Symplekin (Kolev and 
Steitz, 2005).  CPSF73 is likely the endonuclease that cleaves the histone pre-
mRNA from the DNA template (Dominski et al., 2005b).  The other components of 
the cleavage factor and the mechanism of recruitment of the cleavage factor to the 
U7snRNP/SLBP/SL complex have not been elucidated. 
 The molecular events that take place following processing in the nucleus and 
prior to the translation of histone mRNA in the cytoplasm are less well understood.  
What is clear is that the histone mRNA is rapidly exported (within 5 min; 
(Schochetman and Perry, 1972)) and export in Drosophila S2 cells (Erkmann et al., 
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2005a) and Xenopus oocytes (Huang and Steitz, 2001) is dependent on TAP.  SLBP 
is present in the cytoplasm only when histone mRNA is present (Erkmann et al., 
2005b), where it is specifically associated with the histone mRNP (Townley-Tilson et 
al., 2006; Whitfield et al., 2004).  In Xenopus oocytes, expression of SLBP 
stimulates the translation of reporter genes ending in a stem loop (Sanchez and 
Marzluff, 2002).  Recently it has been reported that SLBP interacts with a novel 
protein, SLIP1, which also interacts with EIF4G and plays a role in translation of 
histone mRNA (Cakmakci et al., 2008).  These data are all consistent with a role of 
SLBP in the translation of histone mRNA.   
 In late S phase or when DNA replication is inhibited, histone mRNAs are 
rapidly degraded.  The rapid decay of existing histone mRNA likely requires SLBP.  
Upf1 binds to SLBP at the 3’ end of histone mRNA immediately after inhibition of 
DNA replication and is required for histone mRNA degradation (Kaygun and 
Marzluff, 2005a).  Recently we reported that an oligo(U) tail is added to the 3’ end of 
histone mRNA shortly after inhibiting DNA replication (Mullen and Marzluff, 2008).  
This oligo(U) tail provides a binding site for Lsm1-7 which binds to the 
oligouridylated histone mRNA together with SLBP.  The Lsm1-7 complex likely 
recruits the enzymes that degrade histone mRNA as it does for polyA mRNAs 
(Parker and Song, 2004).  SLBP is a cell-cycle regulated protein which accumulates 
just before entry into S-phase to activate histone pre-mRNA processing and SLBP is 
degraded at the end of S-phase.  Stabilization of SLBP by mutating the 
phosphorylation sites required for degradation does not affect degradation of histone 
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mRNA (Zheng et al., 2003), indicating that SLBP degradation is not required for 
histone mRNA degradation.    
 In order to understand the critical roles of SLBP in cells, Tom Mullen, Eric 
Wagner and I knocked down SLBP using RNA interference in U2OS cells.  
Previously, we and others had shown that reduction of SLBP levels results in a 
reduction in the rate of cell growth and an accumulation of cells in S-phase (Wagner 
et al., 2005; Zhao et al., 2004).  However, a thorough molecular analysis of the affect 
of SLBP knockdown on histone mRNA metabolism has not been reported.  Here we 
show the major lesion in histone mRNA metabolism as a result of knocking down 
SLBP is not in histone pre-mRNA processing, but in the export of histone mRNA to 
the cytoplasm.  Properly processed histone mRNA accumulates in the nucleus.  
Together these results implicate SLBP as having a critical histone mRNA export 
function in mammalian cells, as well as its known roles in histone pre-mRNA 
processing, histone mRNA translation and regulation of histone mRNA half-life.   
MATERIALS AND METHODS 
RNA interference   
 RNAi was performed using a two-hit method as previously described using 
Lipofectamine 2000 (Wagner and Garcia-Blanco, 2002).  Briefly, 110,000 U2OS or 
95,000 HeLa cells were plated into 24 well plates and the following day, siRNAs 
were transfected into cells.  A day following the first hit of siRNA, cells were replated 
into 6 well dishes, allowed to grow an additional day and then transfected with the 
second hit of siRNA.  Cells were harvested 48-72 hours following the second hit for 
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analysis.  The siRNA sequences of the C2 (control) and S2 (SLBP) have been 
previously described (Wagner et al., 2005).   
DNA Synthesis and Mitotic Index Measurements by FACS 
 We quantified the percentage of bromodeoxyuridine (BrdU) labeled cells in S 
phase and phospho-histone H3 in mitosis as previously described (Doherty et al., 
2003).  As controls for these assays cells were treated with 5 mM HU for 1 hour prior 
to addition of the BrdU.  To measure DNA synthesis in S phase, RNAi-treated cells 
were pulsed with a 1 mM stock solution of BrdU (10 M final concentration) for 1 
hour.  Acid-treated nuclei were resuspended with 100 l of a solution containing -
BrdU antibody conjugated to FITC (Becton Dickinson) diluted 1:5 in IFA (10 mM 
HEPES pH 7.4, 150 mM NaCl, 4% FBS, 0.1% NaN3) plus 0.5% Tween-20 and 
incubated in the dark, at room temperature for 2 hours.  Following the incubation, 2 
ml of IFA plus 0.5% Tween-20 was added and nuclei recovered by centrifugation.  
Nuclei were resuspended in 500 l of the IFA plus 0.5% Tween solution containing 5 
g/ml RNase A and 50 g/ml propidium iodide.  Nuclei were incubated overnight at 
4C and analyzed on a Becton-Dickinson (Becton Dickinson) FACScan using 
Summit Software (Dako Cytomation).  
 To measure the mitotic index using phospho-histone H3 as a marker, cells 
fixed with 1% formaldehyde in PBS for 30 minutes.  Fixed cells were pelleted at 
1200 rpm for 5 minutes at 4C and the supernatant removed.  Cells were 
resuspended in 1.5 ml PBS and then 3 ml of cold 100% ethanol was added and cells 
stored at 4C overnight.  The cells were resuspended in 100 l of a solution 
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containing 0.5 g of phospho-histone H3 (serine 10) antibody (Upstate 
Biotechnology) and 5 g/ml RNase A in IFA plus 0.5% Tween-20 for 2 hours at room 
temperature. The cell pellet was resuspended in 100 l of the IFA plus 0.5% Tween-
20 solution containing an anti-rabbit secondary antibody conjugated to FITC (Santa 
Cruz Biotechnology) for 1 hour at room temperature.  The cells were resuspended in 
500 l of the IFA plus 0.5% Tween solution containing 5 g/ml RNase A and 50 
g/ml propidium iodide and analyzed by FACS.   
Northern Blot Analysis and S1 Nuclease Protection Assays   
 Northern blot analysis to replication-dependent histone genes and 7SK 
snRNA was performed as described previously (Mullen and Marzluff, 2008).  Briefly, 
2 g of total RNA was resolved on 6% urea-polyacrylamide gels, transferred to 
Hybond N+ nitrocellulose (Amersham Biosciences), and probed in QuickHyb 
(Stratagene) overnight at 60C.  Probes were generated by random primed, 32P-
dCTP labeling (PrimeIt II Kit, Stratagene) of PCR products generated to the 
complete ORF of cloned human histone genes and to 7SK RNA (Mullen and 
Marzluff, 2008).   
 S1 nuclease protection assays to map the 3’ ends of histone H2a 
(HIST2H2AA) and H3 (HIST2H3A/C) were performed as previously described 
(Kaygun and Marzluff, 2005a).  Probes for 3’ end labeling were generated by 
digestion of the HIST2H2AA gene with AscI and the HISTH3A/C gene with BssHI.  
The digested plasmid DNA was 3’ end labeled with 32P-dCTP and Klenow (New 
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England BioLabs) and hybridized with total cell RNA.  Protected fragments were 
resolved on 6% urea-polyacrylamide gels.   
Western Blot Analysis 
 Protein lysates from RNAi treated cells were prepared as previously 
described (Mullen and Marzluff, 2008) and the concentrations quantified using 
Bradford reagent. Primary antibodies used in this study include rabbit anti-SLBP  
(Wang et al., 1996), mouse anti-Symplekin  (BD Biosciences), rabbit anti-fibrillarin 
(Abcam), rabbit anti-Hsp90 (Cell Signaling Technology), rabbit anti-histone H3 
(Abcam).  Protein were resolved on 12% SDS-polyacrylamide gels and transferred 
to nitrocellulose before detection using appropriate primary and secondary 
antibodies.   
In Situ Hybridization 
 In situ hybridizations were performed as described (Erkmann et al., 2005a).  
RNAi treated cells were grown on coverslips and washed with PBS and fixed in 
3.7% PFA in PBS for 10 min. at room temperature.  Cells were then washed again 
and permeabilized in 0.5% Triton X-100 in PBS.  Pre-hybridization was performed 
for 10 min. at 37C using a solution of 4x SSC and 50% formamide preheated to 
37C.  Cover slips were inverted onto a 5-10 µl drop of hybridization solution (50% 
deionized formamide, 10% dextran sulfate, 1x Denhardt’s solution, 4x SSC, 1 mg/ml 
E. coli tRNA) containing 1 ng/µl DIG labeled H2A or H3 probe.  Probes were 
denatured for 5 min. at 80ºC and cooled on ice prior to addition to hybridization 
solution.  Hybridizations were performed overnight at 37ºC in a humidified chamber.  
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Cells were washed once with 2X SSC at 37 ºC, 3 times in 60% formamide in 0.2x 
SSC at 37ºC, once [??] in 2 X SSC at room temperature, and 3X with 0.5% Tween-
20 in 4X SSC.  Coverslips were inverted onto 8 µl drops of 0.5% Tween-20 in 4X 
SSC containing mouse Cy3 α-DIG antibody diluted 1:200 and incubated at 37ºC for 
1h in a humidified chamber.  Coverslips were washed 3X with 0.5% Tween-20 in 4X 
SSC and inverted onto 8 µl drops of with 0.5% Tween-20 in 4X SSC  containing Cy-
3 α-mouse secondary antibody diluted 1:200.  Secondary incubation was performed 
for 45 minutes at 37ºC in a humidified chamber.  Coverslips were washed 3 X with 
0.5% Tween-20 in 4X SSC before being fixed with 3.7% PFAin PBS for 5 min. at 
room temperature.  After a PBS wash, coverslips were DAPI stained and mounted 
onto slides using Fluorsave reagent (Calbiochem).  Images were acquired using a 
Zeiss LSM 510 confocal microscope and analyzed using ImageJ software. 
CAT Assay 
 CAT assays were performed essentially as described (Cullen, 2004).  3x105 
293T cells were co-transfected with 25 ng of reporter plasmid and 500 ng of MS2-
fusion plasmid using Lipofectamine-2000.  48h after transfection cells were 
harvested in TEN buffer (100 mM NaCl, 10 mM EDTA, 10 mM Tris-HCl, pH 7.5), 
pelleted and resuspended in 100 µL of 100 mM Tris-HCl, pH7.5).  Cells were lysed 
by freeze-thawing three times and lysates were pelleted for 5 min at 4°C.  Equal 
amounts of lysates were added to 300 µL CAT assay buffer (5 mg/mL 
chlorampenicol in 100 mM Tris-HCl, pH 7.5 containing 1 µL/mL [3H]acetyl coenzyme 
A).  3 mL Econofuor (Packard) scintillation cocktail was added to each sample and 
counts determined in a scintillation counter. 
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RESULTS 
SLBP is required for cell growth   
 I determined the effect of knocking down SLBP in U2OS cells using a double-
stranded siRNA that specifically targets SLBP mRNA.  Previously we have shown 
that knockdown of SLBP with this siRNA results in an increase in S-phase cells, and 
that we can rescue this phenotype by expressing an RNAi-resistant SLBP (Wagner 
et al., 2005).  Moreover, Muller and colleagues (Zhao et al., 2004) demonstrated that 
reduced expression of SLBP also resulted in a defect in S phase progression and a 
reduced expression of histone mRNAs.  Both studies demonstrated S phase defects 
but did not elucidate the specific molecular defects underlying this phenotype.   
Since we initially observed variable results, which were dependent on the 
extent of SLBP knockdown, we optimized the knockdown, both for extent and 
duration allowing us to assay for histone mRNA metabolic defects, while still 
maintaining efficient SLBP knockdown.  Eric and I used Western blotting to monitor 
SLBP protein levels over various times throughout the RNAi transfection (Fig. 22A).  
Reproducible phenotypes required a knockdown of SLBP >95%, as determined by 
comparing Western blot intensities from SLBP knockdown cells and a series of 
dilutions of the control lysates (Fig. 22B).  U2OS cells were plated in 24 well dishes 
and the following day, transfected with either control (C2) or SLBP (S2) siRNA.  We 
determined the levels of SLBP every 24 hrs.  The day after the first transfection (24 
hours, Figure 22A, lanes 2 and 3) SLBP protein levels were slightly lower in C2 
treated cells than in untransfected cells (Figure 22A, lane 2).  This decrease is likely 
due to the high cell density used to achieve effective transfection, resulting in a 
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reduction in the number of S-phase cells which contain SLBP.  After 24 hours we 
split the cells out of the 24 well dishes and replated them into 6-well tissue culture 
dishes.  24 hrs later (48 hours after first siRNA treatment), we transfected the 
second dose of siRNA and monitored SLBP levels for the next 4 days.  Between 72 
and 120 hours following the initial hit of siRNA, SLBP protein levels were 
downregulated >95%, and experiments assaying histone mRNA metabolism were 
done during this time.  Note that there is clearly some residual SLBP present in the 
cells at all times.  By 144 hrs, SLBP levels had started to recover (data not shown).   
 As previously shown, knockdown of SLBP to this level resulted in an increase 
in the number of cells in S-phase (Wagner et al., 2005).  I determined the rate of 
growth of the cells by measuring cell number at the various time points in Figure 
22A.  The SLBP knockdown cells grew more slowly, resulting in 30-40% fewer cells 
after 5 days of growth.  All the cells were viable, and there was no evidence of 
apoptosis, suggesting that the cells were growing at a slower rate.   
Reducing the levels of SLBP decreases the rate of DNA synthesis and 
activates an S-phase cell cycle checkpoint. 
 To confirm that the SLBP knockdown cells were accumulating in S-phase 
Tom, Eric and I analyzed these cells by flow cytometry.  We also asked whether 
these cells were still synthesizing DNA by pulsing the C2 or S2 siRNA treated U2OS 
cells with bromodeoxyuridine (BrdU), a thymidine analog, for 30 minutes followed by 
analysis of incorporation by FACS, using a FITC coupled anti-BrdU antibody.  As a 
control we treated cells transfected with C2 (control) siRNA with 5 mM hydroxyurea 
(HU) for 1 hour to abolish BrdU incorporation.  The DNA content was measured by 
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propidium iodide staining, and the incorporation of BrdU was measured by FACS.  
As demonstrated previously, the SLBP knockdown cells accumulated in S-phase of 
the cell cycle (Figure 22B, top panel).  From the FACS analysis of BrdU-
incorporation (Figure 22B, bottom panel), it is clear that SLBP knockdown cells are 
still synthesizing DNA (all the S-phase cells incorporated BrdU), but they were 
synthesizing DNA at about ½ the rate as control cells, as judged by the intensity of 
BrdU staining.  In the control RNAi (C2) cells, there is efficient incorporation of BrdU 
as detected by a FITC-conjugated antibody to BrdU.  The characteristic arc (Hoek 
and Stillman, 2003) of BrdU incorporation is present in the control cells, showing the 
high rate of incorporation in early S-phase, and only a small percentage of cells 
under the arc not incorporating BrdU.  In contrast, the SLBP knockdown cells (S2) 
have a markedly lower BrdU-FITC signal overall and lack the characteristic arc 
observed in control cells (Figure 22B, bottom panel), suggesting that their rate of 
DNA synthesis is reduced.  C2-treated cells treated with HU for 1 hr prior to addition 
of BrdU did not incorporate BrdU.   
 We also used the BrdU FACS analysis to quantify the cell cycle phase 
distribution at a higher resolution in the SLBP knockdown cells compared to the C2 
control (Figure 22C).  We quantified the G1 and G2 phases as the populations at 2N 
and 4N respectively that did not incorporate BrdU.  We separated S phase into two 
phases, early and late, by quantifying the two populations that were between 2N and 
3N, and 3N and 4N.  It is clear from this representation (Figure 22C) that S2 cells 
accumulate both in the early part of S phase and also in late S-phase indicating the 
cells have difficulty completing S-phase.  The number of cells in G2-phase was 
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reduced by 40%, consistent with cells progressing through S-phase more slowly but 
through G2/M and G1 normally.   
 Tom also determined the mitotic rate in the SLBP knockdown cells using an 
antibody to phosphorylated histone H3 (serine 10) as a mitotic marker.  Positive cells 
were measured by FACS and were quantified as a percentage of the control (Figure 
22D).  It is clear from the mitotic index data that SLBP knockdown cells are going 
through mitosis at approximately half the rate of C2 control cells, consistent with the 
finding that G2 cells are reduced by 40%.  This is in agreement with the 
interpretation that there is not a block in progression through G2, but rather a block 
in completing S-phase (and hence in entering G2).  
 Tom next determined whether the reduced rate of DNA replication resulted in 
activation of the S-phase checkpoint, a consequence of defective chromosome 
replication, damaged DNA, or environmental stress (Sancar et al., 2004).  It has 
been shown previously that overexpression of a dominant negative chromatin 
assembly factor 1 (CAF1) or RNAi to CAF1 produces a similar DNA replication 
phenotype as knocking down SLBP (Hoek and Stillman, 2003; Ye et al., 2003). We 
hypothesized that reducing the levels of SLBP might result in impaired histone 
protein biosynthesis and hence mimic the defective chromatin assembly phenotype 
since the chromatin assembly machinery would not have enough histone proteins to 
properly assemble chromatin. 
 Tom assessed the phosphorylation of Chk1, a kinase that is activated by the 
ATR kinase when DNA replication stress is sensed in S-phase cells.  As a control, 
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he again used C2 control cells treated with HU for 1 hour since HU treatment is 
known to activate the DNA replication checkpoint (Sancar et al., 2004).  There was 
increased Chk1 phosphorylation on both serine 345 (S345) and serine 317 (S317) in 
response to SLBP knockdown (Figure 22E).  The levels of Chk1 phosphorylation on 
each of these serine residues was higher than that in control cells but less than that 
in the HU-treated C2 siRNA population. This result supports the notion that reducing 
the levels of SLBP results in a partial inhibition of DNA replication phenotype that is 
directly sensed by the S-phase checkpoint sensor and effector molecules.   
A minimal SLBP rescues the cell-cycle defect.   
 SLBP functions in all aspects of histone mRNA metabolism from 3’ end 
formation to degradation at the end of S-phase (Marzluff et al., 2008).  I wanted to 
determine which of these functions was responsible for the accumulation of cells in 
S-phase when SLBP is knocked down.  To this end, HA-tagged SLBP constructs 
were made which were mutant for translation (SAVEE) (Sanchez and Marzluff, 
2002), RNA processing (9AA), and RNA binding (RR/KK) (Dominski et al., 2001), 
and resistant to the siRNA used to downregulate endogenous SLBP (Wagner et al., 
2005).  These constructs or a fully functional SLBP (Figure 23, top) which was 
resistant to the siRNA were cotranscfected into cells along with the second dose of 
siRNA and cells were harvested for flow cytometry 72 hours later.  Surprisingly, each 
of the mutants rescued the cell-cycle phenotype to the same extent as the fully 
functional SLBP (Figure 23, bottom) indicating that mutation of any single one of 
these functions is not sufficient to generate the S-phase accumulation.  I next 
wanted to create a minimal SLBP capable of rescuing the cell-cycle phenotype and 
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generated multiple N- and C- terminal truncations to test in the assay.  I was able to 
generate a piece of SLBP containing only the translation, RNA processing and RNA 
binding domains which rescued the phenotype (Figure 23, middle).  Together these 
data indicate that the essential function(s) of SLBP lies in this region not in the first 
64 or final 63 amino acids.  I determined that this assay was not sensitive enough to 
diagnose the major lesion in histone mRNA metabolism that occurs when very low 
levels of SLBP are present and set out to characterize more fully the molecular 
phenotypes associated with the S-phase accumulation. 
Processed histone mRNA levels are only reduced 50% in SLBP knockdown 
cells.   
 Since SLBP is involved in histone pre-mRNA processing, Tom determined the 
levels of histone mRNA, both by Northern blotting and by S1 nuclease mapping to 
assess whether the 3’ end was formed properly.  Tom used Northern blots to 
determine histone mRNA levels for all five histone proteins, and each band 
represents mRNAs from 5-15 genes (Marzluff et al., 2002)since the nucleotide 
sequences of the ORFs are very conserved.  He used radiolabeled probes 
generated by PCR targeting the open reading frame (ORF) to detect histones H2A, 
H2B, H3, H4 and H1 and used 7SK snRNA as a loading control (Figure 24A).  The 
abundance of histone H2A, H2B, H3, and H4 mRNAs is reduced to 37 to 70% of 
control levels in the SLBP knockdown cells when compared to the C2 control.  This 
was a surprisingly high level, but it is consistent with previous reports (Zhao et al., 
2004) which also reported only a relatively small reduction in core histone mRNA in 
HeLa cells.   
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 Tom observed a slower migrating band in the histone H4 Northern blot 
(Figure 24A, panel 4), which was not present in the control cells.  We hypothesized 
this represented misprocessed histone mRNA since if there were polyadenylation 
signals 3’ of the genes the polymerase might read-through to that site.  Tom 
therefore performed both S1 nuclease protection assays and Northern blots using 
total cell RNA and oligo(dT) selected total cell RNA to assess whether there were 
read-through mRNAs produced in the SLBP knockdown cells.  We detected a small 
amount of misprocessed histone HIST2H2AA mRNA using S1 nuclease mapping, 
which mapped to a cryptic polyA site that is utilized when an intron is inserted into 
this gene (Pandey et al., 1990).  There were no readthrough transcripts detected 
from the HIST2H3A gene.  Tom used oligo(dT) selection to confirm that the slower 
migrating histone H4 mRNA was polyadenylated (Fig. 24C).  Tom cloned the RNA 
from both the H2a and H4 histone genes where we observed misprocessing by 
oligo(dT)-primed RT-PCR to identify (1) the particular gene that was misprocessed 
and (2) the location of the polyadenylation site.  Cloning of the histone H2A band 
using a pan-H2A primer targeting the ORF revealed this mRNA was derived from 
the HIST2H2AA gene and the polyadenylation occurred after the histone 
downstream element (HDE) (Figure 24D).  The AATAAA in the H2A is conserved in 
the mouse and hamster (Debry and Marzluff, 1994) and the orthologue of this gene 
is polyadenylated using this canonical polyadenylation signal in rodent testis (Moss 
et al., 1994).  It has been previously reported that this polyA+ mRNA is present when 
NELF1 or SLBP is knocked down (Narita et al., 2007).  Tom cloned the polyA+ 
histone H4 mRNA and this mRNA is derived from the HIST1H4J gene.  Two 
130 
 
different polyadenylation sites were found both of which use a polyadenylation signal 
present immediately 5’ of the stemloop sequence (Figure 24E), which overlaps with 
the binding site for SLBP.  This signal is not conserved in the mouse HIST1H4J 
gene.  Interestingly, the first polyadenylated species resulted from cleavage and 
polyadenylation 5 nt 3’ of the SL (21 nt from the AAUAAA), the same site where 
cleavage would occur in the presence of SLBP.  The second species of 
polyadenylated HIST1H4J resulted from cleavage and polyadenylation 34 nt 
downstream of the AAUAAA signal, just prior to the HDE.   
Histone protein levels are reduced in SLBP knockdown cells.   
 Since there was still a substantial amount of properly processed histone 
mRNA in the SLBP knockdown cells for all the core histone proteins, we suspected 
that there must be a defect in histone protein production other than in histone pre-
mRNA processing.  Previous structure-function studies on SLBP have shown that 
there is a critical domain necessary for histone mRNA translation (Gorgoni et al., 
2005; Sanchez and Marzluff, 2002).  Due to the modest decrease in properly 
processed histone mRNA in SLBP knockdown cells, we hypothesized that reduction 
of SLBP might have had a more dramatic effect on histone protein synthesis than on 
histone pre-mRNA processing.  I therefore investigated the levels of histone protein 
in SLBP knockdown cells.   Figure 25D demonstrates that SLBP knockdown is 
>90%.  I used Symplekin, a scaffold protein involved in 3’ end formation (Takagaki 
and Manley, 2000b), as a loading control.  Using an antibody against histone H3, I 
find that total histone H3 is reduced by about 50% in the SLBP knockdown cells, 
relative to the control cells.   
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 To directly test the effect of knockdown of SLBP on the amount of histone 
protein, nuclear proteins were prepared from nuclei of control cells and cells with 
SLBP knocked down.  The coomassie stained gel (Figure 25B) shows a reduction in 
total protein levels for all four core histones, consistent with the previous Western 
results for histone H3.  Similar results have been found in five independent 
experiments, and the levels of the non-histone proteins remain constant.  As judged 
by FACS analysis the DNA content per cell is the same in SLBP knockdown cells, 
which have an increased number of cells in S-phase.  We conclude that the amount 
of histone protein produced in the SLBP knockdown cells is not enough to meet the 
histone protein demands of the replicating U2OS cell, resulting in a decrease in 
histone protein in the SLBP knockdown cells and this must, at least in part, 
contribute to the DNA replication and growth defects we observed.   
Regulation of histone mRNA degradation is impaired in SLBP knockdown 
cells.    
Histone mRNA half-life is coordinately regulated with the rate of DNA 
synthesis, and at the completion of S phase or upon inhibition of DNA synthesis 
there is a rapid degradation of histone mRNA.  Histone mRNA degradation is a 
regulated process that requires translation of the histone mRNA (Graves et al., 
1987; Kaygun and Marzluff, 2005b) and involves the addition of an oligo(U) tail to 
the 3’ end in order to recruit specific decay factors for rapid, bidirectional decay of 
the mRNA (Mullen and Marzluff, 2008).  Since reducing SLBP protein levels 
produced defects in DNA synthesis and normal histone gene expression, we asked 
if downregulation of SLBP had an effect on histone mRNA degradation in HeLa 
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cells.  Tom inhibited DNA replication with 5 mM HU in both C2 control cells and 
SLBP knockdown cells for 30 and 60 minutes.  A representative Northern blot 
analysis of histone H2A mRNA is presented in Figure 25C and reveals that the rate 
of histone mRNA degradation is decreased when SLBP protein levels are 
downregulated by siRNA.  7SK snRNA was used as a loading control to normalize 
the percentage of histone H2a mRNA remaining.  Histone mRNA in the C2 control 
has been significantly reduced at the 30 minute time point and is barely detectable at 
the 60 minute time point (Figure 25C, lanes 2 and 3). In the SLBP knockdown cells, 
histone mRNA degradation is stabilized roughly 1.6 fold on average at the 30 minute 
time point and roughly 2.3 fold at the 60 minute time point (Figure 25C).  The 
reduced rate of histone mRNA degradation could reflect the inefficient translation of 
histone mRNA with low levels of SLBP, and/or a requirement for SLBP in histone 
mRNA degradation.   
Processed histone mRNA is retained in the nucleus in SLBP knockdown cells.   
 Another possibility for the low rate of histone protein synthesis is that the 
histone mRNA may be mislocalized.  Eric and I determined the subcellular 
localization of the histone mRNA in SLBP knockdown cells.  As a control experiment 
to localize histone mRNA, I synchronized HeLa cells using double thymidine block 
and released them into S phase for 3 hours and performed in situ hybridization with 
a probe to histone H2A.  Histone H2A mRNA is localized strongly around the 
nucleus in a halo-like appearance, although some signal is present throughout the 
cytoplasm (Figure 26A, time 0).  To assess probe specificity, I treated the 
synchronized cells with 5 mM HU for 15, 30, or 45 minutes since inhibition of DNA 
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synthesis results in rapid degradation of histone mRNA (Figure 26A, 15, 30 and 45 
minute time points).  As expected, histone H2A signal diminished over time and this 
provided confidence that our probe specifically detects the replication-dependent 
histone mRNAs.      
 Eric and I performed in situ hybridization to histone H2A mRNA in HeLa and 
H3 mRNA in U2OS cells in which SLBP has been knocked down.  In the control 
HeLa cells, histone H2A mRNA was present in the cytoplasm, with the halo-like 
appearance in the preinuclear region with little to no staining in the nucleus (Figure 
26B).  In contrast, in the SLBP knockdown HeLa cells, in situ hybridization revealed 
that the histone H2A mRNA was concentrated in large foci in the nucleus, although 
some signal persisted in the cytoplasm. This phenotype was rescued by expressing 
an siRNA-resistant form of SLBP (SLBP*, Wagner et al.) in HeLa cells (Figure 26B).  
We also performed in situ hybridization to histone H3 mRNA in U2OS cells where 
SLBP was knocked down (Figure 26C).  In U2OS cells the phenotype is even more 
dramatic than in HeLa cells (Figure 26C).  In U2OS cells, there is the characteristic 
halo-like staining of histone H3 mRNA in the C2 control treated cells but when SLBP 
is knocked down (S2), the histone H3 mRNA was concentrated in the nucleus 
(Figure 5C).  A similar result was also observed in SLBP knockdown U2OS cells 
when in situ hybridization to histone H2a was performed (data not shown).  Since 
the misprocessed RNA that is polyadenylated is presumably exported via the 
conventional polyA RNA export pathway, the histone mRNA which accumulates in 
the nucleus is properly processed mRNA.   
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 As an alternative approach to confirm the presence of histone mRNA in the 
nucleus, Eric and I fractionated C2 control and S2 knockdown cells into nuclear and 
cytoplasmic fractions.  We harvested protein and total RNA from these fractions as 
well as from a portion of the total cell lysate.  Hsp90 and fibrillarin were used as 
cytoplasmic and nuclear markers respectively, and they were present almost 
exclusively in the appropriate fraction (Figure 24D).  The first lanes in Figure 4D 
represent 100% of the total input from unfractionated cells.   Similarly, the ribosomal 
RNA was largely in the cytoplasmic fraction (Figure 26E, lanes 2 and 3).    
 Eric and I also analyzed the histone mRNA in each of the subcellular fractions 
from the same experiment, and simultaneously probed for histone H3 mRNA and U1 
snRNA as a control (Figure 26F).  Consistent with the nuclear localization of 
spliceosomal snRNAs, we observed that U1 was concentrated in the nuclear fraction 
of both the C2 control and S2 knockdown (Figure 26F, lanes 2 and 5).  A small 
amount of U1 snRNA was detected in the cytoplasm (Figure 26F, lanes 3 and 6).  
Histone H3 mRNA was concentrated in the cytoplasm of C2 control cells (Figure 
26F, lane 3) but in the SLBP knockdown cells, about 50% of the histone mRNA was 
in the nucleus.  Since the nuclear volume is about 10% of the volume of the 
cytoplasm (S2, Figure 26F, compare lanes 3 and 6), this result is consistent with the 
high concentration of histone mRNA in the nucleus detected by in situ hybridization.  
Sequestration of histone mRNA in the nucleus upon loss of SLBP is consistent with 
the decrease in histone protein synthesis due to decreased translation, as well as 
the failure to rapidly degrade histone mRNA when DNA replication was inhibited.      
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 Taken together these results demonstrate that the major lesion in histone mRNA 
metabolism when SLBP is knocked down more than 95% is in export of the histone 
mRNA to the cytoplasm.  Processed histone mRNA accumulates in the nucleus and 
is relatively stable. Thus the primary molecular defect in histone mRNA metabolism 
when SLBP is knocked down to 2-5% of normal levels is the retention of processed 
histone mRNA in the nucleus.    
Tethering of SLBP to non-specific mRNA results in nuclear export. 
 Many general mRNA export factors, including TAP and Rev, promote export to the 
cytoplasm when tethered to non-specific mRNAs (Yi et al RNA 2002 8 180).  To 
determine if SLBP facilitates nuclear export of mRNA I utilized a well-characterized 
CAT (chloramphenicol acetyl transferase) reporter system.  The pDM128/PL 
reporter contains a CMV driven bacterial cat gene located within an intron derived 
from  HIV-1.  Under standard conditions, the cat gene is spliced out of the reporter 
and not expressed due to its nuclear retention.  Robust cat activity can be achieved 
by the insertion of 4 MS2 binding sites adjacent to the cat gene coupled with the 
expression of a heterologous fusion protein containing the MS2 coat protein and a 
factor capable of mRNA export (i.e. TAP).  The activity results from the export of the 
cat mRNA prior to it getting spliced out of the reporter.  293T cells were 
cotransfected with either pDM128/PL or pDM128/PL-4XMS2 and HA-MS2 fused to 
TAP, Rev, or SLBP.  Expression levels of MS2 fusions were assessed by Western 
blotting 48h after transfection, using an antibody to HA or SLBP.  MS2-TAP and 
MS2-Rev resulted in increased levels of CAT activity from the pDM128/PL-4XMS2 
reporter compared to the reporter lacking MS2 sites (Fig. 27A), as has been 
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reported for other transport factors (Wiegand et al., 2002; Yang et al., 2001).  
Cotransfection of MS2-SLBP with the MS2 reporter results in CAT activity levels 
approximately 50% of those observed for TAP and Rev while coexpression of HA-
MS2 had not effect on either reporter.   Levels of MS2-SLBP, MS2-Rev, and HA-
MS2 were detected by Western blotting using an antibody to MS2 (Fig. 27B). Note 
they levels of MS2-TAP expression were lower as reported previously (Wiegand et 
al., 2002).  These data indicate that tethering SLBP to a non-specific mRNA is 
sufficient to promote nuclear export, albeit not as efficiently as TAP or Rev. 
 
DISCUSSION 
 As the only mRNAs that are not polyadenylated, metazoan histone mRNAs 
require a distinct set of factors for pre-mRNA processing, translation and regulation 
of stability.  A common factor in all these processes is SLBP, which binds the 
stemloop in the histone pre-mRNA during transcription, remains associated with the 
mRNA during translation and is involved in histone mRNA degradation (Marzluff et 
al., 2008).  Here we have ascertained the effect of knocking down SLBP in 
mammalian cells to less than 5% of the normal level.  The cells remain viable and 
continue growing at a slow rate.  Surprisingly there is only a modest effect on the 
accumulation of processed histone mRNA, but a substantial fraction of the histone 
mRNA is retained in the nucleus, suggesting a previously unrecognized role of SLBP 
in histone mRNA export in vivo.   
 We and others have previously shown that knocking down SLBP results in slow 
growth of cells, and an accumulation of cells in S-phase(Wagner et al., 2005; Zhao 
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et al., 2004).  This effect is due to the SLBP knockdown since normal growth can be 
restored by expression of an RNAi resistant SLBP (Wagner et al., 2005)..  
Progression through S-phase was slowed as judged by the release of cells from 
either nocodazole or HU blocks (Zhao et al., 2004).  This is in contrast to knocking 
down components of the U7 snRNP, which result in an arrest of cells in mid-G1 
(Wagner and Marzluff, 2006), suggesting that the cell monitors the ability to 
synthesize histone mRNA by monitoring the presence of an active U7 snRNP, but 
that cells enter S-phase normally when SLBP is reduced.   
 SLBP is a relatively unstable protein, being degraded at the end of S-phase and not 
accumulating again until just prior to entry into the next S-phase (Whitfield et al., 
2000; Zheng et al., 2003).  Thus it is relatively easy to obtain effective knockdown of 
the SLBP protein, although for the phenotypes observed here SLBP must be 
knocked down >95%, and with long exposures of the Western blots we always 
detect small amounts of SLBP in the knockdown cells.  Thus the results reported 
here reflect the phenotypes observed when SLBP is severely limiting but not absent 
from cells. 
 The most obvious effect of knocking down SLBP is a slow growth rate, and a change 
in cell cycle distribution of the cells, with an accumulation of cells in S-phase.  The 
cells continue dividing and we see no evidence of apoptosis during the 5-6 day 
course of the experiments.  The accumulation of cells in S-phase is due to a slower 
progression through S-phase as a result of a reduced rate of DNA replication (Fig. 
22).  We suggest that the reduced rate of replication is due to a failure to provide 
replication-dependent canonical histones to assemble chromatin at a high rate.  This 
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likely results in defects at the replication fork, leading to activation of the S-phase 
checkpoint, slowing the rate of DNA replication.  Similar phenotypes have been 
observed with knockdown of CAF1, the major chromatin assembly factor for the 
canonical, but not the replication-independent histones (Ye et al., 2003).   
 Surprisingly the overall level of histone mRNAs is only reduced about 2-fold in SLBP 
knockdown cells, and the great majority of the histone mRNA is accurately 
processed.  This implies that the residual SLBP in the cell must be preferentially 
used for histone pre-mRNA processing.  One possibility is that the residual SLBP 
might be concentrated in the Cajal body, where it could function in histone pre-
mRNA processing, but we were not able to detect a specific localization by 
immunofluorescence.  There is a small amount of misprocessed polyadenylated 
mRNA that accumulates from some of the histone genes, suggesting that the 
efficiency of processing is reduced in the SLBP knockdown mutants.  The 
HIST2H2AA gene has been previously shown to have a cryptic polyadenylation site 
in the HDE which is used when histone processing is disrupted by insertion of an 
intron (Pandey et al., 1994), and in round spermatids (Moss et al., 1994).  This 
mRNA is also polyadenylated when NELF, a transcription elongation inhibitor, is 
knocked down (Narita et al., 2007).  There is also a polyadenylated histone H4 
mRNA that accumulates when SLBP is knocked down.  This mRNA is derived from 
a single histone H4 gene, HIST1H4J, which contains a polyadenylation signal in the 
3’ UTR, just before the stemloop.  Although the position of the polyA tail is at the 
same site as the cleavage site for histone mRNA, it is likely that this polyadenylation 
signal, which overlaps the SLBP binding site, directs the cleavage of the HIST1H4J 
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pre-mRNA to yield the polyadenylated mRNA.  Each of these polyadenylation 
signals overlaps a cis-element required for histone mRNA processing, suggesting 
that normally the histone processing machinery preferentially associates with these 
signals. 
 Unlike the situation in Drosophila (Godfrey et al., 2006; Lanzotti et al., 2002), there is 
not extensive readthrough of histone transcripts resulting in polyadenylated mRNAs 
in mammalian cells when SLBP is reduced.  This may reflect a need in Drosophila 
for efficient termination between closely spaced histone genes, or there may be a 
role for polyadenylated histone mRNAs in some cells at some stage.  The role of 
SLBP in the processing of histone pre-mRNA may be “catalytic” allowing cells to 
perform this function, even under limiting concentration of SLBP, and the SLBP can 
then be released for processing more histone mRNAs.  In contrast the requirement 
for SLBP in other steps in histone mRNA metabolism (e.g. export or translation) is 
likely stoichiometric and the RNAi-mediated reduction in SLBP levels would interfere 
with these functions.   
Transport of histone mRNA.  Most mRNAs are transported through a pathway that 
requires TAP (yeast mex67p) as an adaptor protein for export (Erkmann and Kutay, 
2004).  TAP can be recruited to mRNAs derived from spliced pre-mRNAs by binding 
to components of the exon-junction complex deposited near the exon-exon border 
after splicing.  Unspliced mRNAs, such as histone mRNAs, must recruit TAP by a 
different mechanism.  There have been several studies relevant to histone mRNA 
export from the nucleus.  In one study the role of processing was assessed by 
forming the histone 3’ end either by a normal processing reaction or by ribozyme 
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cleavage (Eckner et al., 1991).  They found that the complete histone mRNAs were 
cytoplasmic regardless of the mechanism of 3’ end formation.  However, if the 
histone ORF was replaced with the chloramphenicol acetyl transferase ORF, then 
the mRNA formed by the processing reaction was cytoplasmic, while the mRNA 
formed by the ribozyme was retained in the nucleus.   
 Huang and Steitz studied elements in the histone ORF that were capable of directing  
transport of an heterologous mRNA in Xenopus oocytes and identified a binding site 
for the SR protein 9G8 responsible for this activity (Huang and Steitz, 2001), which 
is in a region of the histone ORF capable of conferring cytoplasmic localization on 
other unspliced mRNAs (Huang and Carmichael, 1997).  These studies suggest a 
role for the 9G8 protein in recruiting TAP, and provides a partial explanation for the 
observed conservation in the nucleotide sequence level in histone ORFs (Debry and 
Marzluff, 1994; Friend et al., 2007).  In a previous study of histone mRNA export in 
Xenopus oocytes, we found that there was not a requirement for any specific 
nucleotide sequence, including the 3’ end of histone mRNA or SLBP, for histone 
mRNA export (Erkmann et al., 2005a) in Xenopus oocytes.  This study suggested 
that there are multiple potential binding sites for proteins that could recruit TAP, and 
that in Xenopus oocytes there is a large supply of these proteins, in agreement with 
other studies which showed that the length of the RNA was a major determinant of 
its transport efficiency in Xenopus oocytes (Masuyama et al., 2004). 
 In mammalian cells with active RNA metabolism, there is likely to be competition 
among the mRNAs for the binding proteins and export factors, just as there is for 
factors involved in RNA processing.  Thus it is not surprising to find that there might 
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be more stringent requirements for export in mammalian cells than in Xenopus 
oocytes.  Our results suggest that there is a critical role for SLBP in histone pre-
mRNA export in mammalian cells.   
 Overall these results are consistent with a model where multiple factors may need to 
bind to an RNA for efficient export.  The processing reaction may facilitate 
recruitment of some of these factors (Eckner et al., 1991) and there are clearly 
sequence elements in the histone ORF that promote export (Huang and Carmichael, 
1997; Huang and Steitz, 2001) of mRNAs.  Our results suggests that association of 
SLBP is necessary to promote efficient transport of histone mRNA, but not to 
stabilize the histone mRNA in the nucleus. 
 When SLBP levels are greatly reduced, mature histone mRNAs accumulate in the 
nucleus.  A striking aspect of this result is that these mRNAs accumulate to 
substantial levels.  When mutations are introduced into the histone stem-loop that 
alter SLBP binding (Pandey et al., 1994) or the HDE is deleted preventing r U7 
snRNP binding (Chodchoy et al., 1991), or when the HDE is naturally suboptimal 
(Liu et al., 1989), then the unprocessed mRNAs do not accumulate, but rather must 
be rapidly degraded.  The same is true of improperly processed mRNAs from 
polyadenylated transcripts.  In the SLBP knockdown cells histone mRNAs are 
properly processed, and direct sequencing of the mRNAs after circular RT-PCR 
(Mullen and Marzluff, 2008) did not reveal any alterations at the 3’ end of the mRNA 
(EJW, unpublished).  Thus these mature mRNAs, which are not bound to SLBP, are 
still stable in the nucleus.  They may be stable in the nucleus since they have gone 
through the normal processing pathway, even though they can not get exported.  A 
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model for histone mRNA export in normal cells and for the nuclear retention of 
histone mRNA in SLBP knockdown cells is shown in Fig. 26.   
Decreased levels of histone protein in SLBP knockdown cells.   
 The second feature of the SLBP knockdown cells is that they have a lower amount 
of histone protein pre cell, consistent with a defect in histone protein biosynthesis.  
Initially we found this surprising since one might think that reducing histone 
protein:DNA ratios 2 fold might have a profound effect on cell physiology and 
viability.  However, in at least one situation, infection of human T lymphocytes with 
HTLV1, there is an approximately 2-fold reduction in histone:DNA ratios, which is 
mediated by a reduction in core histone mRNA expression without affecting DNA 
replication (Bogenberger and Laybourn, 2008).  In yeast one can vary the 
histone:DNA ratio by changing the dosage of the histone genes (Gunjan and 
Verreault, 2003) or in some mutants in chromatin modification (Xiao et al., 2007) and 
personal communication from B.D. Strahl) without affecting viability.  
Conclusions.   
 SLBP is essential for the proper accumulation of histones for assembly of newly 
replicated DNA into chromatin.  Our results suggests that a major consequence of 
SLBP depletion is the failure to export properly processed histone mRNA.  This 
suggests that SLBP must be associated with histone mRNA for export, and that 
SLBP may dissociate from histone mRNA after processing and additional 
nucleoplasmic SLBP may then reassociate with the histone mRNA prior to export.   
Understanding and identifying the components of the nuclear histone mRNP, as well 
as the cytoplasmic histone mRNP, will help elucidate the pathway between 
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processing of the mRNA at the site of transcription, and subsequent export and 
translation of the histone mRNA. 
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Figure 22.  SLBP knockdown cells are viable but grow at a slower rate as a 
result of various S phase defects.  (A)  Growth curve (total cell number) of control 
(C2) and SLBP (S2) RNAi populations.  Lysates from the timepoints shown in the 
graph were probed for levels of SLBP (*-represents cross-reacting band).  
(B) SLBP knockdown results in S-phase accumulation and a reduced rate of DNA 
replication.  C2 and S2 treated U2OS cells were pulsed for 1 hr with 10 M 
bromodeoxyuridine (BrdU) and harvested and analyzed by FACS for DNA content 
and DNA synthesis .  Hydroxyurea (HU, 5 mM) was added  to a parallel culture of 
C2 cells 1 hr prior to the addition of BrdU.  Cells were fixed and BrdU incorporation 
detected with an anti-BrdU antibody conjugated to FITC and for DNA content with 
propidium iodide.  Cells were analyzed using a FACScan device and Summit 
software for DNA content and intensity of BrdU incorporation.  (C) The cell cycle 
distribution (G1, early and late S phase, and G2/M) was quantified from the data in 
(B), (C2, grey bars; S2, black bars) from 3 independent experiments.  Quantities are 
expressed as a percentage of the C2 control cells.  (D)  Parallel cultures from (B) 
were fixed, stained with an antibody to the mitotic marker phospho-histone H3, and 
the antibody detected with a secondary antibody conjugated to FITC.  Cells were 
analyzed similarly as in (B) and the population of cells with fluorescent signal in the 
G2 population was quantified.  The number of phosphor-histone positive cells is 
expressed as a percentage of the C2 control cells.  (E)  (E) SLBP knockdown results 
in the activation of a Chk1-dependent cell cycle checkpoint.  Protein lysates from 
SLBP knockdown cells were analyzed for the predominant signal transduction 
pathway that responds to replication stress by Western blotting for SLBP, total Chk1 
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protein and phospho-specific Chk1 (serines 317 and 345) was analyzed by Western 
blot analysis.  HU was used a positive control for Chk1 activation.    
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Figure 23.  A minimal SLBP construct rescues the cell-cycle phenotype 
associated with SLBP knockdown.  (Top) Schematic of full-length SLBP showing 
the locations of degradation, translation, RNA binding and RNA processing domains 
as well as the siRNA target site.  (Middle, right)  Schematic of Mini2-SLBP showing 
domains included in this truncation.  (Middle, left)  FACS profiles of SLBP 
knockdown cells (red) and Mini2-SLBP rescued cells (green).  (Bottom)  Table 
showing cell cycle distributions of rescues by various mutants.  
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Figure 24.  Histone mRNA levels are reduced in SLBP knockdown cells and a 
portion of the mRNA is misprocessed and polyadenylated. (A)  Northern blot 
analysis was performed on 2 g of total RNA from C2 and S2 treated cells.  7SK 
snRNA is used as a loading control.  The percentage of histone mRNA present in 
the S2 treated cells was quantified using PhosphorImager analysis and ImageQuant 
software and normalizing mRNA to the 7SK snRNA levels.  These results are 
representative of several different experiments.  Note that a slowly migrating product 
reacting with the histone H4 probe (*) is present in the S2 cells.  (B)  3’ S1 nuclease 
protection assays were used to map the 3’ ends of histone H2A (HIST2H2AA) (lanes 
2 and 3) and histone H3 (HIST2H3A/C) (lanes 5 and 6) mRNAs.  The asterisk (*) 
protected fragment in lane 3 indicates a longer mRNA which is polyadenylated 
(panel D)..  (C) Total RNA was selected on oligo(dT) cellulose and 2 micrograms of 
total RNA (lanes 1 and 2) and polyA + RNA (lanes 3 and 4) were analyzed by 
Northern blotting for histone H4 mRNA.  The asterisk (*) indicates the longer 
polyadneylated H4 mRNA.  (D and E)  Total RNA from C2 and S2 U2OS cells were 
primed for reverse transcription with oligo(dT) fused to a T7 adaptor sequence and 
subjected to PCR using a pan-H2A ORF oligo (panel D) or a pan-H4 oligo (panel E) 
together with a T7 adaptor sequence.  The products were analyzed by gel 
electrophoresis, and the products were cloned and multiple clones from each 
reaction sequenced.    
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Figure 25.  Histone protein levels are decreased in SLBP knockdown cells and 
the normal histone mRNA degradation in response to HU is impaired.  (A)  A 
serial dilution Western blot analysis of C2 (lanes 1-4) and a direct comparision of C2 
(lane 5) and S2 (lane 6) total cell protein lysates. The levels of SLBP, histone H3 
protein and Symplekin as a loading control were analyzed.  (B)  U2OS cells were 
knocked down for SLBP and nuclear proteins prepared from the  control and SLBP 
knock down cells.  They were resolved on 15% SDS-polyacrylamide gels and 
stained with Coommassie Blue.  The core histone proteins are indicated (arrows)  
(C) Histone H2A mRNA is not degraded as efficiently in SLBP knockdown cells 
compared to control cells.  HeLa cells were treated with C2 (lanes 1-3) or S2 (lanes 
4-6) siRNAs, treated with 5 mM HU and cells harvested  30 (lanes 2 and 5) or 60 
min (lanes 3 and 6) later.  Total cell RNA was analyzed by Northern blotting (left 
panel) with probes to H2A mRNA and 7SK snRNA as a loading control.  The right 
panel represents the results from 3 independent experiments.  Standard deviations 
are indicated by vertical bars.   
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Figure 26.  Histone mRNA in SLBP knockdown cells is retained in the nucleus.  
(A)  HeLa cells synchronized by double-thymidine block were released into S phase 
for 3 hours and treated with 5 mM hydroxyurea (HU) for 0, 15, 30 and 45 minutes.  
Cells were fixed and prepared for in situ hybridization with antisense DIG-labeled 
H2a mRNA.  Cells were stained with DAPI and anti-DIG antibodies.  DAPI (blue), 
histone H2A mRNA (red).  (B and C)  Histone H3 mRNA is localized to the nucleus 
when SLBP is knocked down.  (B) Logarithmically growing HeLa cells were treated 
with the indicated siRNAs and in situ hybridization performed with antisense DIG-
labeled H3 mRNA.  Note the histone mRNA accumulates in nucleoli of HeLa cells in 
S2 treated cells (arrows).  (C)   U2OS cells were treated with the indicated siRNAs 
and in situ hybridization performed with antisense DIG-labeled H3 mRNA as in (B).  
Cells were stained with DAPI.  Note that there is no accumulation of histone mRNA 
in nucleoli (arrows) in U2OS cells.  (D and E) U2Os cells were fractionated into 
nuclear and cytoplasm and protein (panel D) or RNA (panel E) from total and 
subcellular fractions analyzed.  Total (lane 1), nuclear (lane 2), and cytoplasmic 
(lane 3) protein fractions were separated by 12% polyacrylamide gel electrophoresis 
and probed for Hsp90 (top, as a cytoplasmic marker) and fibrillarin (bottom, as a 
nuclear marker).  Proteins were analyzed by Western blotting for Hsp90, and 
fibrillarin markers.  (E) Total RNA was analyzed by Northern blot analysis and 
histone H3 mRNA and U1 snRNA (nuclear marker) simultaneously detected using a 
mixture of radiolabelled probes. 
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Figure 27.  SLBP promotes mRNA export.  A)  293T cells were transfected with 
25ng of reporter plasmid and 500 ng of MS2 fusion protein plasmid.  48h post 
transfection, cells were harvested in TEN buffer and analyzed by western blotting.  
B)  CAT assay was performed on lysates from A.  CAT activity was normalized to 
untransfected lysates and the maximum value for each data set was set to 100% 
CAT activity.  Values are for 3 independent experiments with error bars of 1 
standard deviation.  
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Figure 28.  Model of SLBP-dependent histone mRNA export.  A.  Histone mRNA 
metabolism in normal S-phase cells.  SLBP remains associated with the histone 
mRNA in the nucleus and the mRNA is efficiently exported associated with multiple 
proteins that recruit TAP.  B.  Histone mRNA metabolism in cells depleted of SLBP.  
Histone mRNA is processed normally by the residual SLBP but that SLBP 
dissociates from the processed mRNA before it can be exported, and the processed 
message remains in the nucleus where it is stable.  
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Chapter 5 
Summary and Conclusions 
 
Introduction 
 Evidence abounds from yeast (Meeks-Wagner and Hartwell, 1986) to 
Drosophila (Sullivan et al., 2001) to mammals (Arnold et al., 2008) that proper 
regulation of histone gene expression is essential.  Metazoan histone mRNAs have 
evolved a unique mechanism of regulation as a result of the novel 3’ end on these 
mRNAs.  These histone pre-mRNAs contain no introns and their 3’ ends consist of a 
stemloop structure rather than a poly(A) tail.  Thus maturation of histone mRNAs 
requires only a single endonucleolytic cleavage 3’ to the stemloop.  This 3’ end is 
bound by SLBP and the SLBP-stemloop complex remains active throughout the life 
of the histone mRNA and performs the essential functions of the poly(A)-PABP 
complex on other mRNAs.  I will summarize the findings of my dissertation and place 
them into context current knowledge of mRNA 3’ end formation and histone mRNA 
metabolism in general.  
160 
 
 
 In chapter 2 of this dissertation, I showed that proper 3’ end formation of 
histone mRNA in Drosophila requires a subset of polyadenylation factors and that 
this subset exists as a “holo-cleavage factor” which is active in both histone and 
poly(A) containing mRNA 3’ end formation.  Chapter 2 also shows that processing of 
histone pre-mRNAs occurs cotranscriptionally, and that factors required for 3’ end 
formation are recruited to histone genes in vivo.  Chapter 3 examines the 
mechanism of transcription termination of histone genes in mammals and reveals 
that, due to the U7 snRNP dependence of 3’ end formation and the surprising finding 
that CPSF73 has both endo- and exonucleolytic activities, termination of 
transcription is not Xrn2 dependent as it is for poly(A) containing genes.  And, finally, 
in Chapter 4, I describe a new role for SLBP in histone mRNA metabolism.  This 
dissertation reveals some interesting new findings in the area of the regulation of 
histone gene expression and opens up some exciting new lines of questioning for 
future studies. 
A subset of cleavage and polyadenylation factors form a “holo-cleavage 
factor” active in 3’ end formation of all mRNAs. 
 Transcription of protein coding genes yields large RNA species termed pre-
mRNAs which must be processed in multiple steps to yield mature mRNAs, which 
are capable of being exported and translated.  Processing steps include addition of a 
modified cap to the 5’ end, splicing out of introns, and proper 3’ end formation.  For 
all mRNAs except histone mRNAs, 3’ end formation consists of endonucleolytic 
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cleavage and addition of a long (~250 nt) poly(A) tail.  Cleavage and polyadenylation 
is a complex process which is guided by multiple cis-acting elements including the 
poly(A) sequence (AAUAAA) and a G/U rich DSE and carried out by a large protein 
complex containing as many as 85 polypeptides (Shi et al., 2009).  The PAS is 
located 5’ to the cleavage site (usually a CA dinucleotide) and is bound by the CPSF 
complex, while the DSE, located 3’ to the cleavage site, is bound by the CstF 
complex.  These complexes act in concert to recruit the cleavage factor and 
polyadenylation machinery and position them at the correct site.  Histone mRNAs 
have neither a PAS nor a DSE; they do, however, contain analogous cis-elements in 
the stemloop and histone downstream element.  These elements are bound by 
SLBP and the U7 snRNP respectively, which act to recruit and position the cleavage 
machinery properly.   
 Surprisingly, several components of the poly(A) machinery are shared with 
histone mRNA processing.  CPSF73 was shown to be the cleavage factor for both 
histone (Dominski et al., 2005b) and poly(A) (Mandel et al., 2006) containing mRNAs 
and Symplekin was also shown to be involved in both processes (Kolev and Steitz, 
2005; Takagaki and Manley, 2000a).  CPSF100, long known to be a critical 
component of the polyadenylation apparatus is also required for histone pre-mRNA 
processing in Drosopihila (Wagner et al., 2007) and mammals (Kolev et al., 2008).  
The finding that there are common components in the two pathways led me to ask 
how these factors interact with one another and with the accessory proteins required 
for their respective processes 
Stable complexes containing polyadenylation factors in Drosophila. 
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 Codepletion experiments in Drosophila revealed that CPSF73, CPSF100 and 
Symplekin exist as a stable complex because depletion of any one of these factors 
resulted in strong downregulation of the other two, and the three proteins were 
efficiently coimmunoprecipitated.  Knockdown of any of these factors affects both 
histone and poly(A) mRNA processing; resulting in poly(A) site switching on a 
poly(A) containing mRNA and polyadenylation of histone mRNAs.  Notably, histone 
misprocessing after knockdown of these components of the holo-cleavage factor is 
different than in knockdown of a histone specific factor such as SLBP.  While 
polyadenylation does occur, the majority of the misprocessed RNAs are very long 
and not polyadenylated indicating that removal of these proteins affects both histone 
and poly(A) cleavage site usage generating long readthrough transcripts.  These 
experiments also gave us our first hint that there are discrete complexes containing 
the holo-cleavage factor.  Knockdown of CPSF160 results in codepletion of 
Symplekin, CPSF73 and CPSF100, yet has no effect on histone 3’ end formation.  
Similarly, CstF64 downregulation results in Symplekin depletion but does not affect 
histone pre-mRNA processing.  
 I also wanted to determine how CPSF73, CPSF100 and Symplekin interact 
with one another as well as how they interact with accessory factors, in this case, 
the histone-specific processing factors SLBP and Lsm11.  IP experiments under 
stringent detergent conditions confirmed that CPSF73, CPSF100 and Symplekin are 
indeed tightly bound to one another as they reciprocally coIP one another with high 
efficiency.  Attempts to coIP these components of the cleavage factor with SLBP or 
Lsm11 were unsuccessful suggesting that the histone specific machinery is not a 
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stable component of the cleavage factor.  I was able to coimmunoprecipitate 
CPSF73 and Symplekin with SLBP and Lsm11 under low detergent conditions 
indicating that this interaction is weaker and likely more transient.  These data  
supports the notion that there is a core cleavage factor which may associate with 
proteins either from the histone or poly(A) specific processing apparatus, making 
discrete cleavage factors.  Further supporting this idea is the fact that CstF77 does 
not coIP with SLBP or Lsm11 or with CPSF73 or Symplekin.  Knockdown of this 
factor has no effect on histone pre-mRNA processing and the fact that it does not 
interact with histone-specific factors demonstrates that independent complexes may 
exist.  Many of the components of the polyadenylation machinery have been 
identified, but clearly some factors required for histone pre-mRNA processing remain 
to be identified. 
 The revelation that much of the cleavage machinery is conserved between 
histone and poly(A) mRNAs raises some interesting points.  In mammals, the cell 
cycle regulation of histone biosynthesis occurs largely at the level of RNA 
processing as histone mRNA levels are high in S-phase due to an increase in 
processing efficiency.  SLBP is a primary cell cycle-regulated factor required for 
proper histone mRNA 3’ end formation as the U7 snRNP is stable throughout the 
cell cycle.  When SLBP is synthesized, the cell is already poised to produce large 
amounts of histone mRNA since the other required components are already present.  
In Drosophila, the mechanism using different cis-elements to generate mature 3’ 
ends is conserved.  Therefore, higher eukaryotes have evolved a method of cleaving 
histone mRNAs that conserves some of the polyadenylation machinery, eliminating 
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the need for an entirely separate mechanism.  These complexes must contain 
unique factors to direct the core cleavage complex to the proper pre-mRNA.  
CPSF160 likely plays this role in poly(A) mRNAs and the factor that carries out this 
function for histone pre-mRNAs is not known. 
Histone 3’ end formation occurs cotranscriptionally. 
 Fidelity in RNA processing is essential for proper gene expression and 
regulation.  To this end eukaryotic cells intergrate many RNA processing events with 
transcription, such that as nascent RNA is extruded from RNA Pol II, it is acted upon 
by RNA processing factors responsible for capping, splicing, and 3’ end formation.  
Indeed, 3’ end formation serves to release the transcript from the chromatin 
template.  In the case of poly(A) mRNAs, this cotranscriptionality is achieved by 
recruitment of factors to the RNA by the phosphorylated CTD of RNA Pol II 
(Proudfoot, 2004).  However, the phosphorylation pattern of the CTD is distinct in 
Cajal bodies as it lacks Ser2 phosphorylation (Xie and Pombo, 2006), the 
modification which recruits the polyadenylation machinery (Licatalosi et al., 2002b).  
Initially, I wanted to determine whether or not processing of histone mRNAs was 
cotranscriptional.  When I began my dissertation work there was no direct evidence 
for cotranscriptionality and, in fact, the only paper concerning the cotranscriptional 
processing of histone pre-mRNAs posited that cotranscriptional processing was not 
more efficient than processing of a synthetic pre-mRNA in vitro (Adamson and Price, 
2003), in contrast to findings with poly(A) mRNAs (Adamson et al., 2005).  During 
the course of my studies, two groups published papers demonstrating that indeed 
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some factors such as CPSF73 are recruited to mammalian histone genes (Glover-
Cutter et al., 2008; Narita et al., 2007).   
I demonstrate in chapter 2 that Symplekin and CPSF73 associate with 
histone genes in vivo using ChIP assays.  These proteins are localized across the 
histone gene locus.  The small size of the histone genes (~400 nt) approaches the 
limit of ChIP resolution using sonication which generates 200-500 bp fragments of 
DNA making it impossible to accurately determine when they associate with the 
gene.  These factors are not located in the 1.3 kb intergenic region between the H3 
and H1 genes, indicating that they are indeed recruited to the genes themselves and 
not just in close proximity to the cluster.  The absence of RNA Pol II in this intergenic 
region also indicates that termination of transcription occurs close to the cleavage 
site, an observation I will discuss in the next section.  Notably, CstF50, a 
polyadenylation factor not involved in histone pre-mRNA processing associates with 
histone genes only at low levels relative to those with which it associates with a 
poly(A) containing gene.  CstF50 does appear to associate with histone genes at 
levels slightly above background, which may indicate that even with the proposed 
modular nature of the cleavage complex, sometimes factors not required for 
processing of a particular RNA may end up associated with those genes.  CstF50 is, 
however, strongly recruited to histone genes when polyadenylation is activated by 
depletion of SLBP.  These data demonstrate that the cleavage complex is capable of 
switching from its histone mRNA processing form to a poly(A) processing form 
rapidly when necessary.  It may be that the CstF50 associated with histone genes 
under normal conditions serves as a failsafe sensor, that is, upon activation of 
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polyadenylation, some of the required machinery is present which might serve to 
recruit additional help or it may represent background association with RNA Pol II.   
Further ChIP data presented in Chapter 2 support the hypothesis that a core 
cleavage factor acts in both histone and poly(A) pre-mRNA processing 
independently from one another.  Knockdown of CPSF160 has no effect on histone 
pre-mRNA processing, but does deplete Symplekin, CPSF73, and CPSF100.  When 
I ChIP with antibodies to Symplekin or CPSF73 in CPSF160 knockdown cells, I 
found a specific depletion of these factors from canonical poly(A) containing genes, 
but not from histone genes.  I hypothesize that this is due to depletion of only that 
subset of the holo-cleavage factor which is associated with CPSF160, and not that 
active in histone processing.  Knockdown of CstF64 has a similar affect on 
recruitment of Symplekin to poly(A) genes without affecting histone genes.  Thus 
these data support the existence of two distinct cleavage factors. 
ChIP studies using antibodies to histone-specific processing factors will need 
to be performed to enhance our understanding of the relationship between 
transcription and 3’ end formation.  One of the major questions that remains 
regarding the cotranscriptional nature of histone pre-mRNA processing is how these 
factors are recruited to the genes.  Several possibilities exist including; high local 
concentration of processing factors in HLBs, direct recruitment by RNA Pol II, or a 
combination of these.  Histone-specific processing factors could also be recruited by 
transcription factors which localize to histone genes such as NPAT.  The argument 
that high local concentration is important is an attractive one as many of the factors 
involved in histone processing are concentrated in HLBs including Symplekin and 
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U7 snRNP,  but this does not account for the fact that these factors are absent from 
an intergenic region by ChIP analysis.  Recruitment via interaction with the CTD of 
RNA Pol II is a common mechanism for recruitment of RNA processing factors to 
sites of activity, but the common modification used to recruit 3’ end processing 
factors is not present in mammalian Cajal bodies.  It is also reasonable that factors 
involved in histone pre-mRNA processing would also be recruited to RNA Pol II 
when it is transcribing polyadenylated mRNAs.  This raises the question of whether 
histone genes might signal for a novel modification of the CTD.  Traditional dogma 
states that Ser2 and Ser5 are modified along genes, but recently phosphorylation of 
Ser7 has been identified as required for snRNA 3’ end formation (Egloff et al., 
2007b).  The consensus repeat for the CTD is YSPTSPS, leaving open the 
possibility of modifications on Tyr1 or Thr4, or even a recruitment that does not 
involve the CTD.  I demonstrate that SLBP is in a complex with RNA Pol II using 
both crosslinked and uncrosslinked IPs although the interaction might not be direct.  
The only antibody that coimmunopreciptates SLBP is one which recognizes Rpb3, a 
smaller subunit of RNA Pol II, and therefore has no preference for CTD modification 
state; neither Ser2 nor Ser5 phosphospecific antibodies coimmunopreciptate SLBP.  
This mechanism of recruitment is a topic which bears further studies and will, I 
believe, be critical in the regulation of histone gene expression.   
Transcription termination of histone genes does not require Xrn2. 
 Termination of transcription is tightly linked with 3’ end formation and is 
essential for maintenance of transriptome integrity, as failure to properly disengage 
RNA Pol II from the DNA template interferes with expression of downstream genes.  
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Currently there are two competing models, the allosteric and torpedo models (Lykke-
Andersen and Jensen, 2007) which posit that an allosteric change in RNA Pol II or 
an exonuclease torpedo are responsible for termination respectively, though recent 
evidence implies that both models have a role (Luo et al., 2006a).  For 
polyadenylated mammalian transcripts, the 5’-3’ exonuclease, Xrn2, is recruited to 
genes via an interaction with CstF64 (Kaneko et al., 2007) and likely degrades the 
downstream cleavage fragment.  However the CstF complex has no role in histone 
mRNA processing which begs the question; how is transcription of histone genes 
terminated?   
 In Drosophila, there are strong polymerase pause sites just downstream of 
the cleavage site (Adamson and Price, 2003) and RNA Pol II is not associated with 
the DNA in the intergenic region between histone H3  and H1 (Chapter two), 
implying that termination is a very efficient process.  Since the Drosophila  histone 
genes are located so close together, transcription must terminate between the genes 
to avoid production of double stranded RNA.  Degradation of the downstream 
cleavage product in vitro is dependent on the U7 snRNP in both Drosophila and 
mammals (Dominski et al., 2005a), and is coupled with the processing reaction, 
consistent with a role for 3’ end formation in transcription termination on histone 
genes.  The endonuclease responsible for cleaving histone pre-mRNAs, CPSF73, 
has both endonucleolytic and 5’-3’ exonucleolytic activities (Dominski et al., 2005b), 
allowing for the possibility that it may play a role in histone gene regulation in 
addition to  cleavage.   
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Zbig Dominski and I hypothesized that CPSF73 is indeed the exonuclease 
which acts as the torpedo to terminate transcription of histone genes.  I show in 
Chapter 3 that knockdown of Xrn2 does not affect the levels of downstream 
transcripts of a mammalian histone gene, but does significantly stabilize downstream 
RNA species from the GAPDH gene which encodes a poly(A) containing mRNA.  
Interestingly, knockdown of Xrn2 does have a mild stabilizing effect on RNA farther 
(~500 nts) downstream of the cleavage site indicating that CPSF73 may not be as 
processive an exonuclease as Xrn2.  As degradation of the downstream cleavage 
product is U7 snRNP-dependent, should CPSF73 fall off of the transcript it is 
degrading, it would be unable to get back on.  At this point an exonuclease such as 
Xrn2, which can initiate degradation de novo would have to complete degradation of 
the downstream transcript, and may account for the slight stabilization of the RNA 
fragments farther downstream.   
SLBP functions in export of histone mRNA.   
 SLBP is a multifunctional protein which is active in multiple aspects of histone 
mRNA metabolism [reviewed in (Marzluff et al., 2008).  SLBP binds to the nascent 
RNA where it is essential for processing, in concert with the U7 snRNP.  After a 
proper 3’ end is formed, SLBP remains associated with the mature RNA and escorts 
it into the cytoplasm where it is active in translation.  At the end of S-phase, SLBP 
participates in degradation of histone mRNAs before being phosphorylated by 
cyclinA/Cdk2 and degraded itself.  Knockdown of SLBP by siRNA in mammalian 
cells results in an accumulation of cells in S-phase, but what is the cause of this 
accumulation?  I asked which one of the functions of SLBP was responsible for this 
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phenotype.  To test this, I created a panel of SLBP mutants each of which was 
resistant to the siRNA against SLBP; in this way I could remove endogenous SLBP, 
replace it with a mutant form lacking a known function and monitor rescue of the cell 
cycle phenotype.  Surprisingly, all of the mutants tested including a truncated form of 
the protein containing only the RNA binding, RNA processing and translation 
domains, rescued the phenotype as well as the fully functional SLBP protein.  I 
concluded that this assay was not sufficient to address the question of what the 
major lesion in histone mRNA metabolism is in cells severely depleted of SLBP and, 
along with Eric Wagner and Tom Mullen, set out to do a thorough molecular analysis 
of histone metabolism in SLBP deficient cells.  I describe these results in Chapter 4 
of this dissertation. 
 Tom Mullen determined that SLBP knockdown activates a DNA damage 
checkpoint likely due to a lack of histones available for deposition behind active 
replication forks.  Interestingly, histone mRNA levels were only down about 2-fold in 
SLBP knockdown cells and the vast majority is properly processed.  Tom and I 
discovered that there is polyadenylation of some of the RNA, but only in specific 
instances.  There is some misprocessing of histone mRNAs in mammalian cells, as 
in Drosophila, but it is restricted to a few genes which have polyadenylation signals.  
When we cloned the polyadenylated RNAs we discovered that only a few genes 
generated polyadenylated transcripts.  Intriguingly, some of these genes contained 
canonical poly(A) sites which overlapped with the histone pre-mRNA processing cis-
elements, the stemloop or histone downstream element.  These poly(A) sites would 
be masked by SLBP or the U7 snRNP under normal conditions of histone pre-mRNA 
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processing.  Their conservation indicates a potential safety mechanism to allow for 
histone biosynthesis in the event of a misprocessing event.  That they are used 
sparingly in mammals is not surprising as these RNAs are not cell cycle regulated 
and would result in histone overexpression if they accumulated to a significant 
extent.  I also demonstrated that histone protein expression is down 2-3 fold in SLBP 
knockdown cells.  The most surprising finding in these studies was that histone 
mRNA is retained in the nucleus in SLBP knockdown cells and that SLBP can 
promote export of a reporter.  This identifies a new role for SLBP in nuclear export of 
histone mRNAs and helps rationalize a series of conflicting papers in the literature.  
In Xenopus oocytes, neither SLBP nor the SL is required for histone mRNA export, 
rather mRNA length is the determining factor.  The mRNA must be sufficiently long 
for enough RNA binding proteins to assemble and recruit the TAP complex.  This 
result likely reflects the high concentration of RNA binding proteins in the Xenopus 
germinal vesicle.   
Final conclusions. 
 Processing of pre-mRNA is a vital step in regulation of gene expression, and 
the replication dependent histone genes are no exception.  These highly conserved 
genes have evolved their own mechanism of 3’ end formation that is conserved from 
Drosophila to humans.  Processing of histone pre-mRNAs, although unique, shares 
some components of the cleavage factor for canonical polyadenylated mRNAs.  
While assembly of the cleavage machinery at sites of processing is guided by 
different cis and trans elements for histone and poly(A) mRNAs, a core cleavage 
factor is common between the two.   
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 Termination of transcription is another critical event for proper gene 
regulation.  Termination of transcription for poly(A) mRNAs most likely involves two 
factors, Pcf11 and Xrn2, to disengage RNA Pol II from the DNA template.  Here 
again, histone genes appear to have evolved a separate mechanism for this 
process.  Termination of histone gene transcription is not dependent on Xrn2, rather 
using the exonuclease function of CPSF73 to achieve degradation of the 
downstream cleavage product and subsequent disengagement of RNA Pol II.  This 
particular mechanism may be particularly important in lower eukaryotes, such as 
Drosophila, where the histone genes are located immediately adjacent to one 
another, and mistakes in transcription termination would generate double-stranded 
RNAs. 
 A common factor for many steps of histone mRNA metabolism is the histone-
specific RNA binding protein SLBP.  This protein binds the nascent transcript and is 
subsequently involved in cleavage, nuclear export, translation and degradation of 
histone mRNAs.  SLBP embodies the nature of histone mRNA metabolism as it is 
unique to this class of mRNAs, yet facilitates interactions with the machinery used by 
canonical poly(A) mRNAs at all steps in the life of the RNA, yielding a unique 
mechanism of gene regulation. 
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